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ABSTRACT 
 
Pain is the predominant symptom of OA, a debilitating disease marked by changes in cartilage 
and subchondral bone, but pain pathophysiology is poorly understood. Bone is densely 
innervated and may be linked to OA-related knee pain. Quantitative computed tomography 
(QCT) is an in vivo image-based technique with the potential to quantify bone mineral density 
(BMD) to explore the role of bone in OA-related pain. When coupled with subject-specific finite 
element (FE) modeling, it may be possible to clarify the mechanical role of bone in OA-related 
knee pain. 
The objectives of this study were to assess if: 1) tibial subchondral BMD is associated 
with OA-related nocturnal knee pain using depth-specific QCT image processing, 2) tibial 
epiphyseal and metaphyseal BMD is associated with OA-related knee pain using a modified 
depth-specific CT image processing tool, 3) subchondral cyst characteristics are associated with 
OA-related knee pain, and 4) FE-derived mechanical outcomes at the proximal tibia are 
associated with OA-related pain. 
Lateral focal subchondral BMD was 33% higher in participants with severe nocturnal 
pain than participants with no nocturnal pain at the 2.5-5mm depth (p=0.028) and 32% higher at 
5-10mm from the subchondral surface (p=0.049). At the epiphyseal and metaphyseal depths, 
higher total pain was associated with lower medial epiphyseal BMD (R2=-0.40, p=0.002), and 
lower metaphyseal BMD (R2=-0.35, p=0.017). At the lateral region, subchondral cyst number 
(r=0.55, p<0.001) and cyst number per proximal tibial volume (r=0.52, p<0.001) were both 
associated with BMD, and lateral cyst number and volume were associated with joint space 
narrowing (r=0.52 to 0.68, p<0.001) and alignment (r=0.44 to 0.62, p<0.001). In our FE study, 
principal compressive stress was associated with nocturnal pain at most lateral regions (r=0.33 
to 0.50, p<0.05). Principal compressive stress at the lateral region ranged from 47% to 67% 
higher (p<0.05) in participants with severe nocturnal pain than participants with no pain.  
This series of studies suggests that pain in patients with knee OA may be associated with 
BMD throughout various depths at the proximal tibia as well as FE-based bone mechanical 
outcomes, such as principal compressive stress. These findings suggest previously unexplored 
associations between OA-related knee pain and BMD or mechanical outcomes, emphasizing that 
bone may have a mechanical role in OA-related pain pathogenesis.   
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GLOSSARY 
 
TERM DEFINITION 
 
  
Areal bone mineral density Bone mineral mass per unit area (aBMD) 
 
Anisotropic Material with different physical properties (e.g., material 
stiffness) in different directions.  
 
Anterior Front plane of a body; referring to surface facing forward. 
 
Attrition Flattening of cortical bone near articular surface of a joint.  
 
Axial Oriented along the long axis of the body.  
 
Bone mineral density Bone mineral mass per unit volume (BMD)  
 
Bone marrow lesion Region of increased signal in bone marrow on fat-suppressed 
T2-weighted MIR images. 
 
Coronal Plane that divides the body into anterior and posterior 
sections.  
 
Cortical bone Bone tissue referring to bone of the cortex or outer shell of 
bone. 
 
Distal Pertaining to the end of an extremity situated furthest from 
the center of a body (e.g., the distal femur is located at the 
tibiofemoral joint).  
 
Epiphyseal Pertaining to the epiphysis 
 
Epiphysis Region of bone between subchondral bone and epiphyseal 
plate (or line). 
 
Ex vivo Experiment done on a tissue out of its natural environment.  
 
In vitro Experiment taking place outside a living organism.  
 
In vivo Latin term for “within the living”; experiment using an entire 
living organism.  
 
Inferior Bottom plane of a body; referring to the bottom surface of 
region.  
 
 xxiv 
Isotropic Object with equal dimensions in all directions (e.g., isotropic 
voxel); a material with similar physical properties (e.g., 
material stiffness) in all directions.  
 
Joint space narrowing Reported change in joint space width on radiographs.  
 
Lateral Located at or extending to the side.  
 
Medial Located at or extending to the center.  
 
Metaphyseal Pertaining to the metaphysis.  
 
Metaphysis Narrow region of bone between the epiphysis and the 
diaphysis (shaft). 
 
Osteophyte Bony projection that forms along the periphery of joints.  
 
Patellofemoral joint Joint comprised of articulating surfaces of the patella and the 
femur.  
 
Peripheral  Located at the edge of a surface.  
 
Pixel A picture element; two-dimensional unit of a digital image.  
 
Posterior Back plane of a body; referring to a surface facing rearward.  
 
Proximal Pertaining to the end of an extremity situated nearest to the 
center of a body (e.g., the proximal tibia is located at the 
tibiofemoral joint).  
 
Sagittal Plane that divides a body into left and right portions.  
 
Sclerosis Region of increased bone mineral density as apparent on 
radiographs; stiffening of hardening of a structure.  
 
Structural stiffness Describes bone’s response to deflection; dependent upon 
both material stiffness properties and displacement.  
 
Subchondral bone Bone region below cartilage; pertaining to the region of bone 
immediately adjacent to articular cartilage.  
 
Subchondral cyst Spherical of ellipsoidal cavities within the subchondral bone 
region.  
 
Superior Top plane of a body; referring to the top surface or region.  
 
 xxv 
Tibiofemoral joint Joint comprised of articulating surfaces of the tibia and the 
femur.  
 
Trabecular bone Bone tissue referring to bone with vertical or horizontal 
trabeculae, creating a spongy, cellular-like tissue; less dense 
than cortical bone. 
 
Transverse Plane that divides the body into superior and inferior 
sections; also referred to as the axial plane.  
 
Valgus Outward angulation of the distal segment of a bone or joint; 
synonymous with “knock-kneed”; opposite of varus.  
 
Varus Inward angulation of the distal segment of a bone or joint; 
synonymous with “bow-legged”; opposite of valgus.  
 
Voxel A volume element; three-dimensional unit corresponding to a 
pixel for a given slice thickness in CT images.  
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1. INTRODUCTION 
1.1.  Overview 
Osteoarthritis (OA) is a painful debilitating disease characterized by cartilage degeneration and 
changes to the underlying subchondral bone1, 2. OA affects approximately 37% of Canadians 
aged 20 or older; of these, 29% experience knee pain3, which can lead to diminished quality of 
life4, 5. Pain is the dominant symptom of OA, which often initiates clinical intervention, and pain 
reduction as the primary focus of most treatment strategies1. Unfortunately, the source of OA-
related knee pain is poorly understood. 
 Knee OA is commonly characterized by cartilage degeneration and subchondral bone 
changes including osteophytes, sclerosis, attrition, subchondral cysts, bone marrow lesions 
(BML), altered bone mineral density (BMD), and altered morphology or mechanical properties. 
Cartilage is aneural and insensate6, but subchondral bone is densely innervated7, 8 and a plausible 
site for OA-related pain initiation. Bone can also be viewed and assessed using various clinical 
imaging techniques, such as X-rays, quantitative computed tomography (QCT), magnetic 
resonance imaging (MRI), and dual-x-ray absorptiometry (DXA), each permitting in vivo 
evaluation of the associations between these bony features and OA-related pain.  
 Multiple studies have investigated the relationship between image-based bone features 
and OA-related pain. Although there are many reported associations between bony features and 
OA-related knee pain9-12, there are few consistent relationships between pain severity and bony 
feature severity. Alterations in BMD and the relationships between BMD and pain may be 
promising metrics to evaluate as it is associated with many other bony features, such as 
sclerosis13, BMLs14, 15, attrition16, and subchondral cysts17, 18, and can be evaluated using 
multiple imaging modalities.  
 Recent work using QCT-based depth-specific image processing at the patella19, 20 has 
reported that OA patients with more severe pain at rest have lower BMD in trabecular regions of 
the patella. As tibial BMD is associated with OA severity21-23, similar associations may present 
in subchondral cortical or trabecular bone at the tibia. Additionally, as commonly overlooked 
epiphyseal and metaphyseal trabecular bone is associated with OA severity24, BMD at these 
regions may also have a role in OA-related pain pathogenesis. These alterations in subchondral14, 
22 and trabecular23 bone during OA, may also alter the mechanical environment of the proximal 
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tibia. This could have an effect various structural elements, such as mechanical properties25, 
loading patterns26-28, or localized bone remodeling29, each potentially relating to pain.  
 Subject-specific finite element (FE) modeling is a promising non-invasive image-based 
tool that can be used to investigate the structural role of bone in OA. Recent work in developing 
subject-specific FE models of the proximal tibia has shown differences in stress distributions 
through the proximal tibia of healthy participants and participants with OA30, 31. These same 
techniques could also be used to evaluate the relationship between mechanical outcomes and 
pain in OA patients. This work would aid in determining the mechanical role of bone in OA-
related pain.  
 The overall aim of this dissertation research was to explore relationships between knee 
pain in patients with OA with QCT-based BMD at various depths of the proximal tibia 
(subchondral BMD, epiphyseal BMD, metaphyseal BMD, cysts) as well as FE-based mechanical 
outcomes (stress, strain, stiffness). Findings from this in vivo research will help to determine how 
mechanics environment may influence pain in OA, and may provide insight into OA-related pain 
pathogenesis.  
1.2.  Scope 
Chapter 2 provides a review of current literature evaluating relationships between image-based 
bony features and OA-related knee pain, the relationship between BMD and mechanical 
environment of the proximal tibia, and the rationale behind this research. Chapter 3 includes my 
research questions, and objectives. Chapter 4 presents our study evaluating tibial subchondral 
BMD in patients with and without nocturnal knee pain. Chapter 5 describes our study exploring 
associations between proximal tibial epiphyseal and metaphyseal BMD and WOMAC pain. 
Chapter 6 describes our study exploring associations between proximal tibial cyst parameters 
(number, size, etc.) and characteristics of OA, including pain, as well as regional BMD. Chapter 
7 presents our study using FE techniques to determine differences in mechanical outcomes 
(stress, strain, stiffness) between OA patients with and without nocturnal pain. Chapter 8 
presents the overall contribution of this research, strengths, limitations, study conclusions, and 
recommendations for future research.   
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2. LITERATURE REVIEW 
2.1. Functional Anatomy and the Knee Joint 
The human knee is a complex joint composed of three bones: the proximal tibia, the distal femur, 
and the patella, and two distinct articulating joints: the patellofemoral (PF) joint and the 
tibiofemoral (TF) joint (Figure 2-1). The TF joint, which can be divided into medial and lateral 
plateaus (Figure 2-2), provides flexing and extending motion of the leg, and is also the main 
load-bearing joint within the knee. Load-bearing tissues at the knee joint include meniscus, 
cartilage, and bone. The knee is a commonly affected site for osteoarthritis (OA) with 
approximately 40-85% of cases occurring at the TF joint32, 33, with ~50% of cases occurring at 
the medial compartment 33. 
 
Figure 2-1 Anterior views of the bone of the knee joint, including the patella (A) and with the patella 
removed (B). Bones include the distal femur, proximal tibia, and proximal fibula. Modified from Grey’s 
Anatomy34. 
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Figure 2-2. Anatomical features of the proximal tibia include the medial and lateral plateaus as well as 
the intercondylar tubercles (or tibial spine). Adapted from teachmeanatomy.com. 
 
 The meniscus is composed of two fibrous, C-shaped fibrocartilage wedges located 
between the articulating surfaces of the distal femur and proximal tibia (Figure 2-3). These 
structures are semi-rigidly attached to the medial and lateral proximal tibial surface and function 
to transfer and distribute load through the underlying articular cartilage during movement and 
loading35, 36. Approximately 50% of the load on the proximal tibia is distributed through the 
meniscus to articular cartilage37, 38.  
 
 
Figure 2-3. Axial view of the articulating surface of the proximal tibia, including medial and lateral 
menisci overlying articular cartilage. Modified from Grey’s Anatomy34 
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 The joint surfaces of the proximal tibia, distal femur, and patella are covered with 
articular cartilage: a viscoelastic, fibre-reinforced material serving as a low-friction surface 
bearing material able to transmit loads to the underlying subchondral bone. Cartilage is 
avascular8 and aneural7, 39, with consequently low levels of regeneration after damage or trauma.  
 Immediately adjacent to the articular cartilage at the proximal tibia, are various layers of 
bony tissues including40: 
• the tidemark, a thin outer border of the articulating bone surface and the boundary 
between articular and calcified cartilage (Figure 2-4);  
• calcified cartilage, a partially mineralized cartilage layer interconnected with subchondral 
bone (Figure 2-4); 
• subchondral cortical bone (or subchondral plate or endplate), a thin layer of compact 
highly mineralized layer of bone (Figure 2-4, Figure 2-5); 
• subchondral trabecular bone, a layer of cancellous (or trabecular) bone immediately 
adjacent to the subchondral cortical bone which supports the overlying cortical shell 
(Figure 2-4, Figure 2-5); 
• epiphyseal trabecular bone, a layer of trabecular bone between the subchondral trabecular 
bone and the epiphyseal scar which forms the proximal tibial epiphysis (Figure 2-4, 
Figure 2-5); 
• epiphyseal scar (or epiphyseal line), a faint to distinct line distinguishing the epiphyseal 
and metaphyseal regions of the proximal tibia as a remnant of the epiphyseal or 
childhood growth plate41 (Figure 2-5); and  
• metaphyseal trabecular bone, trabecular bone forming the proximal tibial metaphysis 
(Figure 2-5).  
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Figure 2-4. Representative diagram of the tissue layers of cartilage and subchondral bone regions, 
including articular cartilage, tidemark, calcified cartilage, subchondral cortical bone, subchondral 
trabecular bone, and epiphyseal trabecular bone. Adapted from Madry et al. (2010)40.  
 
 
Figure 2-5. Computed tomography (CT) image in the sagittal plane of the proximal tibia including 
subchondral cortical bone, subchondral trabecular bone, epiphyseal line (epiphyseal scar)41, epiphyseal 
trabecular bone, and metaphyseal trabecular bone.  
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 “Subchondral bone” is a term used to describe the bony structure immediately adjacent to 
the articular cartilage, including both cortical and trabecular bone. This structure functions as the 
knee joint’s primary supportive and energy-transferring structure42. Subchondral bone and 
cartilage both have a role in the development and pathogenesis of OA42-45, but the distinct role 
and mechanical changes at various stages of disease severity still remains unknown. 
Additionally, bone at the epiphyseal and metaphyseal depths may be involved in OA 
development and progression24, but their role or contribution are still unknown.  
2.2. Osteoarthritis 
Osteoarthritis (OA) is a degenerative joint disease affecting approximately 37% of Canadians 
over 20 years of age3 and 85% of Canadians over 75 years of age46. OA is characterized by 
various clinical symptoms, such as joint pain, swelling, stiffness, and loss of function45, 47-49, and 
morphological or physiological joint changes, such as cartilage degeneration, subchondral bone 
sclerosis, osteophyte presence, and changes in bone mineral density (BMD)2, 47-50 (Figure 2-6). 
Pain is the dominant symptom of OA51, but the source of OA-related pain is poorly understood. 
Unfortunately, OA is not typically detected or diagnosed until the patient begins to feel pain or 
joint discomfort, often after significant joint tissue damage.  
 OA is a complex disease involving many known and potential risk factors. Known risk 
factors can be systemic or biomechanical, and include: age, sex, hormonal status, bone metabolic 
biomarkers, joint mechanical environment, obesity, joint injury, and joint alignment48. As there 
is no known single risk factor, current disease management strategies focus on pain management, 
where treatments range along a spectrum from non-invasive pharmaceutical or physical 
interventions to invasive surgical joint replacements. It is very likely that OA onset and 
progression is a result of a combination of risk factors, therefore treatment strategies typically 
incorporate a variety of methods1.  
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Figure 2-6. Characteristics of OA include cartilage wear, joint space narrowing, osteophytes, and 
sclerosis. Adapted from Felson 20061. 
 
 Disease characteristics include clinical symptoms, morphological changes, and 
biomechanical alterations to the joint environment. Symptoms can include a combination of pain, 
joint dysfunction, limited or reduced motion, swelling, or stiffness1, 2. Morphological changes to 
the joint environment may include articular cartilage loss, synovial inflammation, or subchondral 
bone alterations including sclerosis, osteophytes, attrition, cysts, or bone marrow lesions 
(BMLs)10, 52-54. Biomechanical changes include alterations in cartilage mechanical properties 
(lower compressive stiffness, lower shear stiffness, lower tensile stiffness)55 and altered 
mechanical stiffness in subchondral bone56 which could be the result of altered loading 
patterns57, 58. 
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2.3.  Clinical Classification and Diagnosis 
OA is clinically assessed using semi-quantitative scales either focusing on radiographic (or 
structural) progression or symptomatic progression. Radiographic OA is commonly assessed 
using radiographic atlases, such as the Kellgren-Lawrence (KL) scale59 or Osteoarthritis 
Research Society International Radiographic Atlas (OARSI Atlas)60, 61, to evaluate and quantify 
evidence of visual radiographic changes, such as osteophyte presence, joint space narrowing, or 
sclerosis, within the knee joint. Symptoms of OA (e.g., pain, joint stiffness, inflammation, or loss 
of function) may or may not be present in all cases of radiographic OA62. For example, in a study 
of 6880 individuals, 14.6% reported knee pain but only 3.7% exhibited evidence of radiographic 
OA62. Of the individuals with radiographic OA, only 47% reported any symptoms; however, in 
those who reported symptoms, only 15% had radiographic evidence of OA. Severe radiographic 
OA may exist without pain or symptoms, and patients may experience painful symptoms of OA 
without radiographic evidence of severe OA33, 62, 63. The relationship between radiographic 
evidence of OA and related symptoms is unclear.  
2.3.1.  Imaging OA 
Clinical imaging techniques currently used to assess OA and morphological OA-related 
characteristics include radiography or x-rays, dual-energy x-ray absorptiometry (DXA), 
magnetic resonance imaging (MRI), and computed tomography (CT). 
2.3.1.1.  Radiography and Radiographic OA 
Radiographs are the most common and most accessible imaging tool to diagnose and measure 
OA severity. The most commonly used clinical radiographic OA scoring system is the KL 
scale59 (Table 2-1). The KL system uses radiographic images to grade radiographic OA severity 
according to qualitative, subjective assessments of sclerosis, osteophyte presence and size, and 
joint space narrowing (JSN). A KL score of 0 indicates no OA, a score of 1-2 indicates mild OA, 
whereas a score of 3-4 indicates moderate to severe OA. A similar scoring tool is the OARSI 
Atlas60, 61. In addition to the overall joint score, the OARSI system can be used for scoring 
specific qualities, such as only osteophyte size or JSN, providing additional freedom to evaluate 
and isolate certain radiographic qualities associated with OA. Radiographic scoring techniques 
could also be applied to sequential or reformatted CT images64  
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Table 2-1. Kellgren-Lawrence (KL) scoring system for radiographic OA severity59.  
Grade Qualifier Radiographical features 
0 None Normal, no osteophytes, no evidence of OA 
1 Doubtful Possible osteophytic lipping 
2 Minimal Definite osteophytes, possible joint space narrowing, multiple 
of moderate osteophyte, definite joint space narrowing 
3 Moderate Evidence of sclerosis, possible deformity of bone ends, 
possible bony attrition 
4 Severe Large osteophytes, marked joint space narrowing, severe 
sclerosis, definite deformity of bone ends, definite bony 
attrition 
 
2.3.1.2.  Magnetic Resonance Imaging (MRI) 
MRI offers non-ionizing three-dimensional (3D) imaging and also has the capability to observe 
changes in bone and surrounding soft tissues, thus providing an alternative to radiography to 
quantify OA severity.  MRI is becoming more available, and can be used to evaluate joints with 
OA with severity scoring techniques, such as the Whole-Organ Magnetic Resonance Imaging 
Score (WORMS)65. This system evaluates 14 characteristics related to both bony and soft 
tissues: cartilage signal and morphology, subarticular bone marrow abnormalities, subarticular 
cysts, subarticular bone attrition, marginal osteophytes, medial and lateral meniscal integrity, 
anterior and posterior cruciate ligament integrity, medial and lateral collateral ligament integrity, 
synovitis, loose bodies, and periarticular cysts/bursae65. In addition to multiple tissue evaluation, 
the WORMS system also accommodates for regional analysis, dividing the knee joint into 
medial, lateral, posterior, central, and anterior regions. Each element is scored on individual 
scales, where bony feature scoring uses scales of 0 to 3 (subarticular bone marrow abnormalities, 
subarticular cysts, subarticular bone attrition) or 0 to 7 points (marginal osteophytes) (Table 2-2). 
Although the radiographic methods are the current “gold standard”, the WORMS scale is widely 
used in MRI-based studies in patients with OA9, 66-68.  
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Table 2-2. Whole-Organ Magnetic Resonance Imaging Score (WORMS) for scoring OA 
severity using MRI65.  
Articular feature Severity scoring scale 
Subarticular bone 
marrow 
abnormalities 
0 = none, 1 = <25% of region, 2 = 25% to 50% of region, 3 = >50% of region 
Subarticular cysts 0 = none, 1 = <25% of region, 2 = 25% to 50% of region, 3 = >50% of region 
Subarticular bone 
attrition 
0 = normal, 1 = mild, 2 = moderate, 3 = severe 
Marginal 
osteophytes 
0 = none, 1 = equivocal, 2 = small, 3 = small-moderate, 4 = moderate,  
5 = moderate-large, 6 = large, 7 = very large 
 
2.3.2  Symptomatic OA 
Common symptoms of OA can include a combination of pain, stiffness, joint dysfunction, 
limited or reduced motion, or swelling. Pain is the dominant symptom of OA, with pain 
reduction as the primary focus of most treatment strategies1. Unfortunately, pain may not be 
apparent in early stages of OA69, 70, making early diagnosis and detection difficult. In many 
cases, joint degeneration may already be present within the knee joint before the patient seeks 
treatment71. Of note to this work is nocturnal pain, or pain lying in bed at night. Nocturnal pain is 
of particular concern to patients and clinicians as it disturbs sleep quality, thus disturbing quality 
of life5, and is most often unpredictable4, 72. Nocturnal pain is most likely to occur in late to final 
stages of OA progression73, typically manifesting after pain going up or downstairs, walking, 
standing, or sitting. Also, nocturnal pain, or pain lying down in bed at night, is often a required 
criteria for surgical interventions74.  
 The most common technique to assess and quantify OA-related symptoms at the knee is 
the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC)75, which 
assesses OA-related pain, stiffness, and physical function (Table 2-3). The pain subsection 
assesses pain while going up/down stairs, walking, standing, sitting, and lying down in bed at 
night. Patient responses can either be based on a self-reported visual analog scale (VAS), where 
the patient marks their level of pain for each element on a scale from 0 to 10075, or as a 
questionnaire where patients are posed a series of questions, which are scored on a 5-point Likert 
scale and summed for a total possible pain score of 20 points (Table 2-4)75. Pain, stiffness, and 
function subsections can be used independently or collectively. Although the WOMAC tool is 
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most often reported in clinical studies, the Knee Osteoarthritis Outcome Scale (KOOS)76 or 
simply the presence or absence of pain63 are also used.  
Table 2-3. Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) 
questionnaire subsections with corresponding question elements75. 
Subsection Question elements 
Pain Up/down stairs, Walking, Standing, Sitting, Lying in bed at night 
Stiffness Morning stiffness, Stiffness later in the day 
Physical Function Descending stairs, Ascending stairs, Rising from sitting, Standing, 
Bending to the floor, Walking on a flat surface, Getting in/out of car, 
Going shopping, Putting on socks or shoes, Taking off socks of shoes, 
Rising from bed, Lying in bed, Getting in/out of the bath, sitting, 
Getting on/off the toilet, Performing heavy domestic duties, Performing 
light domestic duties 
 
Table 2-4. Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) 5-point 
Likert scale scoring values75.  
Response Score 
None 0 
Mild 1 
Moderate 2 
Severe 3 
Extreme 4 
 
2.4 OA-related Pain 
Evaluating and quantifying pain is challenging as pain is a subjective and patient-specific 
experience. As the knee is composed of many different tissues, with many different 
characteristics, the source of OA-related knee pain is poorly understood and could be the result 
of multiple factors or multiple tissues71. Interestingly, patients with OA-related pain show similar 
changes in brain structure as patients with other diseases with chronic pain (fibromyalgia and 
complex regional pain syndrome) illustrating that although pain may be joint-specific, there may 
be additional underlying factors to consider such as pain duration (in years) and prolonged pain 
intensity77 . Also, within the knee joint, pain may be related to local changes in pain pathways, 
which could cause normal function and stimuli (which would otherwise be painless) to become 
painful1.  
 13 
 The large majority of our current understanding of OA pain pathogenesis relies primary 
on studies focusing on articular cartilage78. Although there is evidence of relationships between 
cartilage degeneration and OA-related pain79-82, cartilage is generally aneural and insensate83, 
and may not be the source of pain generation within the joint. Bone, on the other hand, is densely 
innervated7, 8 and may be a plausible site of pain initiation. Evidence from both human and 
animal studies suggest that subchondral bone may play a role in OA disease severity21, 
initiation45, 84, progression43, 85, and OA-related pain19. 
 OA-related pain may be attributed to abnormal joint biomechanics45, 47. One such theory 
suggests that a major element of OA initiation and progression is through adaptation and 
subchondral bone remodelling of the affected joint to compensate for biomechanical 
abnormalities45 (Figure 2-7). If abnormal mechanics are successfully controlled, the joint self-
stabilizes. If abnormal mechanics are not successfully controlled, then the joint will continue to 
adapt through bone remodelling in an attempt to alter joint shape, potentially further altering 
local joint mechanics in a positive feedback loop, resulting in more severe pain.  
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Figure 2-7. Schematic diagram of a hypothetical process of pain pathogenesis and joint remodelling, 
emphasizing that subchondral bone remodelling could be the primary source of OA-related pain. In this 
model, the joint attempts to regulate abnormal biomechanics through joint remodelling and subchondral 
bone changes. If abnormal biomechanics are successfully controlled, the joint self-stabilizes; if abnormal 
biomechanics are not successfully controlled, then the joint continues to proceed through bone 
remodelling, in an attempt to alter joint shape. Joint repair depends largely on the response and 
remodelling of subchondral bone; with increased bone turnover potentially increasing joint pain. Adapted 
from Dieppe 199945.   
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2.5.  Image-based relationships between bone and pain  
Clinical imaging (radiographs, DXA, MRI, and CT) can provide in vivo measurement techniques 
of bony structures in patients with OA. Commonly assessed structural bony features include 
alignment, osteophytes, sclerosis, attrition, subchondral cysts, BMLs, and BMD. As these are in 
vivo measurements, they also permit for non-invasive analysis of associations between bony 
features and OA-related pain.  
2.5.1.  Alignment 
Alignment is not typically considered an imaged bony feature, but it is possible to measure (or 
estimate) knee alignment using radiographs, CT, or MRI. As previously mentioned, knee 
alignment is a commonly investigated risk factor for OA49, 86. In a neutrally aligned knee, the 
medial compartment supports from 60 to 80% of total joint load87. Minor alterations in 
alignment, either malalignment laterally (valgus), or medially (varus) (Figure 2-8), may result in 
abnormal load distribution across the tibial plateau88. Although malalignment is commonly 
associated with OA progression89, 90, it may91-93 or may not94-96 be associated with OA-related 
pain. Malalignment may also contribute to other OA-related bony features such as osteophytes97 
or attrition98.  
 
 
Figure 2-8. Tibial position in varus (left), neutral (middle), and valgus (right) alignment. Adapted from 
teachmeanatomy.com.  
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2.5.2.  Osteophytes 
Osteophytes, or bone spurs or outgrowths along the joint margin, are perhaps the defining bony 
feature most associated with OA60, 61, 99 (Figure 2-9). Although the genesis or function of 
osteophytes within the knee joint is unclear, they may be assessed using radiographic (x-ray, 
DXA, or CT) or MR imaging tools, perhaps contributing to the volume of studies evaluating the 
association between osteophyte presence and OA-related knee pain. Osteophytes may9, 10, 47, 63, 66, 
69, 99-108, or may not be92, 109-113 associated with OA-related knee pain (summarized in Table 2-5). 
Most often, more severe osteophytes were related to more severe pain9, 63, 69, 107. In addition, the 
relationship between osteophyte presence or size and pain may change with OA progression105, 
106.  
 
 
Figure 2-9. Sample CT images of knees with no osteophytes (left) and severe medial and lateral 
osteophytes on both the femur and tibia (right).  
 Table 2-5. Summary of image-based studies evaluating relationships between osteophytes and OA-related pain.  
Author Study design Imaging modality Pain measurement tool Findings Comments 
Ai et al.109 Cross-sectional MRI 3-pt verbal rating scale No significant relationship with pain. n=31 knees from 28 patients (16 
male, 12 female) Osteophytes were 
either present or absent.  
Boegård et al.100  Cross-sectional X-ray Presence/absence of 
pain 
Presence at inferior patellar pole, p<0.05. n=40, Only assessed PF joint. 
Osteophytes were either present or 
absent.  
Boegård et al.101  Cross-sectional X-ray Presence/absence of 
pain 
Presence at medial tibial plateau, p<0.05. n=42, Only assessed TF joint, 
Osteophytes graded according to 
Altman61 scale.  
Chang et al.111  Cross-sectional X-ray WOMAC OR=0.97 (95% CI: 0.14 to 6.65), NS (adjusted 
for: age, sex, height, body weight, BMI, TF 
angle). 
 
n=151 knees from 107 patients (104 
females, 3 males). Osteophytes 
graded using: absent (0), <1cm (0.5), 
>1cm (1). 
Chang et al.92 Cross-sectional X-ray WOMAC PF presence: β= -0.380 (SE=0.843), NS. 
Medial TF presence: β=0.877 (SE=0.952), NS. 
Lateral TF presence: β=0.301 (SE=1.037), NS.  
(All tests adjusted for: age, sex, BMI). 
n=341 knees from 217 patients (208 
females, 9 males). Osteophytes 
graded using: absent (0), <1cm (0.5), 
>1cm (1). 
Cicuttini et al.103  Cross-sectional X-ray Presence/absence PF osteophytes in skyline view: OR=7.66 
(95% CI: 3.68 to 15.90), Chi statistic for trend 
= 40.30, p<0.001. 
PF osteophytes in lateral view: OR=1.83 (95% 
CI: 2.40 to 10.43), Chi statistic for trend = 
1.34, p=0.25. 
n=504 knees from 252 female 
patients. Osteophytes graded using a 
4-point scale (0-3)114 . 
Cicuttini et al.102  Cross-sectional X-ray Presence/absence Anteroposterior view: OR=5.00 (95% CI: 0.14 
to 6.65), Chi statistic for trend: p<0.001 
Lateral view: OR=2.87 (95% CI: 1.41 to 5.82), 
Chi statistic for trend: p<0.001. 
Skyline view: OR=7.56 (95% CI: 3.85 to 
14.81), Chi statistic for trend: p<0.001. 
n=500 knees from 200 female 
patients. Osteophytes graded using a 
4-point scale (0-3)114. 
Dieppe et al.110 Longitudinal X-ray 4-pt Likert scale and 
presence/absence of 
night pain 
Medial presence and change in pain over 37 
months: NS 
Lateral presence and change in pain over 37 
months: NS 
Total n=415 (135 males, 280 
females), for osteophyte presence and 
pain n=101. Osteophytes graded as 
either absent (0), present (1), or 
severe (2).  
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Dieppe et al.47  Cross-sectional X-ray 4-pt Likert scale and 
presence/absence of 
night pain 
Global pain: r, Not mentioned, NS. 
Night pain: OR=0.7 (95% CI: 0.1 to 6.2), 
significant. 
n=90 knees from 75 patients (33 
males, 42 females). Osteophytes 
graded using a 4-point scale (0-3)61.  
Hayashi et al.104 Cross-sectional X-ray, 
Tomosynthesis 
WOMAC Femur: 
X-ray, lateral: OR=5.0, p=0.004, 
X-ray, medial: OR=8.4, p=0.001, 
CT, lateral: OR=4.4, NS, 
CT, medial: OR=6.4, p=0.001. 
Tibia: 
X-ray, lateral: OR=5.9, p=0.002, 
X-ray, medial: OR=6.3, p=0.001, 
CT, lateral: OR=4.2, NS, 
CT, medial: OR=5.7, p=0.002. 
n=80 knees from 40 patients (10 
males, 30 female). Osteophytes were 
graded using a 4-point scale (0-3)60. 
Hayes et al.63 Cross-sectional MRI Presence/absence of 
pain 
Positive association between pain and 
osteophyte severity, p<0.001. 
n=117 females; no OA/no pain=30, 
OA/no pain=29, no OA/pain=30, 
OA/pain=28. Osteophytes assessed 
using: absent (0), <5mm (0.5), >5mm 
(1). 
Javaid et al.9  Cross-sectional X-ray Presence/absence of 
pain and WOMAC 
X-ray: 
Any: OR=1.94 (95% CI: 1.10 to 3.43), 
p=0.022, 
Severe: OR=4.20 (95% CI: 2.11 to 8.37), 
p<0.001. 
MRI: 
Any: OR=1.47 (95% CI: 0.83 to 2.63), NS, 
Severe: OR=2.67 (95% CI: 1.61 to 4.40), 
p<0.001. 
Total n=636 (226 male, 410 female), 
with pain n=283 (112 male, 171 
female), without pain n=353 (114 
males, 239 female). Osteophytes 
graded on 8-point scale (0-7) on MR 
images65, and 4-point scale (0-3) on 
x-rays61.  
Kinds et al.105 Longitudinal X-ray Presence/absence of 
pain and WOMAC 
T0: OR=1.43 (95% CI: 1.09 to 1.88), p=0.01. 
T2: OR 1.42 (95% CI: 1.06 to 1.91), p=0.02. 
T5: OR=1.47 (95% CI: 1.08 to 2.01), p=0.02. 
n=1713 knees from 1004 patients 
assessed at baseline (T0), 2 years (T2), 
and 5 years (T5). Osteophyte area 
(mm2) included the sum of lateral and 
medial femur and tibia.  
Kornaat et al.106 Cross-sectional MRI Presence/absence of 
pain 
Any: OR=1.05 (95% CI:0.38 to 2.91), NS. 
Central presence: OR=1.65 (95% CI: 0.67 to 
4.10), NS. 
PF presence: OR=2.25 (99% CI: 1.06 to 4.77), 
p=0.005. 
TF presence: OR=1.19 (95% CI: 0.46 to 3.09), 
NS. 
n=205 (42 males, 163 females), n=97 
with radiographic OA. Osteophytes 
assessed using: absent (0), minimal 
<3mm (1), moderate 3-5mm (2), 
severe >5mm (3).  
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 Lanyon et al.107 Cross-sectional X-ray Presence/absence of 
pain 
Maximum grade osteophyte over whole knee: 
>1: OR: 2.5 (95% CI 1.6 to 3.4), 
>2: OR: 5.2 (95% CI 2.9 to 9.3), 
>3: OR: 5.5 (95% CI 2.1 to 14.6). 
n=452 (158 male, 294 female). 
Osteophytes graded on 4-point scale 
(0-3)61.  
Link et al.112 Cross-sectional MRI WOMAC No significant relationship between pain and 
osteophytes at any location. 
n=50 (20 male, 30 female). 
Osteophytes scored as either absent, 
mild (<0.5cm), or severe (>0.5cm) at 
6 regions of the knee. 
Neogi et al.69 Cross-sectional X-ray WOMAC Pain frequency: p=0.007 for trend. 
Pain consistency: not significant for trend 
(adjusted for JSN). 
n=1032 (346 male, 686 female). 
Osteophytes graded on 4-point scale 
(0-3)115.  
Sanghi et al.113 Cross-sectional X-ray WOMAC and VAS VAS: r=0.10, NS. 
WOMAC: r=0.05, NS. 
n=180 (57 male, 123 female). 
Osteophytes graded using a 
standardized60.  
Sowers et al.10 Cross-sectional MRI WOMAC Medial: Positive association with pain, 
p<0.0001. 
Lateral: Positive association with pain, 
p<0.0001. 
n=543 females. Osteophytes graded 
on a 4-point scale: absent (0), <5mm 
(1), 5-10mm (2), >10mm (3).  
Spector et al.99 Cross-sectional X-ray Presence/absence of 
pain 
Medial: OR=3.73 (95% CI: 2.60 to 5.35), 
significant. 
Lateral: OR=3.16 (95% CI: 2.25 to 4.43), 
significant. 
n=1954 knees from 977 women. 
Osteophytes graded using a 3-point 
scale116.  
Szebenyi et al.108 Cross-sectional X-ray VAS Presence at TF only, NS. 
Presence at PF only, NS. 
Presence at TF and PF, p<0.05. 
n=167 (55 male, 112 female). 
Osteophytes graded using a 
standardized atlas61.  
Torres et al.66 Cross-sectional MRI VAS Unstandardized β=0.50 (95% CI: 0.07 to 0.94), 
significant (Adjusted for age, BMI). 
n=143 (31 male, 112 female). 
Osteophytes graded using an 8-point 
scale (0-7)65.  
BMI: Body mass index. CI: Confidence interval. JSN: joint space narrowing. MRI: magnetic resonance imaging. NS: Not significant. OR: Odds ratio, odds of 
having pain. PF: Patellofemoral joint. r: Spearman’s or Pearson’s correlation coefficient. SE: Standard error. TF: Tibiofemoral joint. VAS: Visual analog scale. 
WOMAC: Western Ontario and McMaster Scoring. X-ray: radiographs. β: regression coefficient. 
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2.5.3.  Sclerosis 
Subchondral sclerosis is another image-based defining feature of OA. Sclerosis is most 
commonly assessed using radiographic techniques, appearing as subchondral plate thickening 
and is likely the result of subchondral bone remodelling50, 117, 118 (Figure 2-10). Although 
sclerotic regions may appear to have higher density, these regions may include trabecular 
thickening119, poorly organized trabeculae120, or poorly mineralized bone54. Like osteophytes, the 
association between OA-related pain and sclerosis is variable, with some studies reporting 
relationships between sclerosis and OA-related pain9, 63, 105, 113 and others reporting no 
relationships47, 92 (Table 2-6).  
 
 
Figure 2-10. Sample radiographs of knees with no sclerosis (left) and severe medial tibial sclerosis 
(right). Adapted from Altman 200760. 
 Table 2-6. Summary of image-based studies evaluating relationships between sclerosis and OA-related pain.  
Author Study design Imaging modality Pain measurement tool Findings Comments 
Chang et al.92 Cross-sectional X-ray WOMAC Medial: β=-1.578 (SE=0.865), NS. 
Lateral: β=0.029 (SE=1.153), NS (Adjusted for 
age, sex, BMI). 
n=341 knees from 217 patients (208 
females, 9 males). Sclerosis was 
either absent (0) or present (0.5).  
Dieppe et 
al.47 
Longitudinal X-ray 4-pt Likert scale and 
presence/absence of 
night pain 
Medial: presence, NS. 
Lateral: presence, NS. 
n=90 knees from 75 patients (33 
males, 42 females). Sclerosis was 
either present or absent.  
Hayes et al.63 Cross-sectional MRI Presence/absence of 
pain 
Positive association between subchondral sclerosis 
and pain, p<0.001. 
n=117 females; no OA/no pain=30, 
OA/no pain=29, no OA/pain=30, 
OA/pain=28. Sclerosis assessed 
using: absent (0), extending less than 
5mm (1), extending greater than 
5mm (2).  
Javaid et al.9 Cross-sectional X-ray Presence/absence of 
pain (WOMAC) 
Any: OR=2.50 (95% CI: 1.49 to 4.20), p=0.001. 
Severe: OR=4.44 (95% CI: 2.16 to 9.16), p<0.001. 
Total n=636 (226 male, 410 female), 
with pain n=283 (112 male, 171 
female), without pain n=353 (114 
males, 239 female). Sclerosis was 
assessed using a standardized atlas61. 
Kinds et al.105 Longitudinal X-ray WOMAC and 
presence/absence 
T2: OR=1.14 (95% CI: 0.21 to 2.07), p=0.02. n=1713 knees from 1004 patients 
assessed at baseline (T0), 2 years (T2), 
and 5 years (T5). Sclerosis was 
measured as mmAl equivalents and 
included the sum of lateral and 
medial femur and tibia regions. 
Sanghi et 
al.113 
Cross-sectional X-ray WOMAC and VAS VAS: NS. 
WOMAC: Positively associated with higher 
subchondral sclerosis, p=0.04. 
n=180 (57 male, 123 female). 
Sclerosis scored using a standardized 
atlas60. 
BMI: Body mass index. CI: Confidence interval. MRI: magnetic resonance imaging. NS: Not significant. OR: Odds ratio, odds of having pain. PF: 
Patellofemoral joint. r: Spearman’s or Pearson’s correlation coefficient. SE: Standard error. TF: Tibiofemoral joint. VAS: Visual analog scale. WOMAC: 
Western Ontario and McMaster Scoring. X-ray: radiographs. β: regression coefficient. 
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2.5.4.  Attrition  
Subchondral attrition is the flattening or depression of the subchondral bone surface121, 122(Figure 
2-11). Using radiographs, attrition may also be considered as a loss of bone along the 
subchondral surface47. The initiation and progression of attrition is not yet understood, but it may 
be due to malalignment or mechanical overloading123 and may be present in early OA124. 
Currently, there is no clear relationship between attrition and OA-related pain as studies have 
shown that attrition is9, 66, 124 and is not47, 92, 111, 125 associated with OA-related pain (Table 2-7). 
Subchondral attrition may also be associated with pain in patients without radiographic OA125.  
 
 
Figure 2-11. Sample radiographs of knees with no attrition (left) and severe attrition at the medial tibial 
plateau (right). Adapted from Altman et al.61 
 Table 2-7. Summary of image-based studies evaluating relationships between attrition and OA-related pain.  
Author Study design Imaging modality Pain measurement tool Findings Comments 
Chang et 
al.111 
Cross-sectional X-ray WOMAC OR=0.71 (95% CI: 0.30 to 1.69), NS (Adjusted for 
age, sex, BMI, height, body weight, TF angle). 
n=151 knees from 107 patients (104 
females, 3 males). Attrition was 
either absent (0) or present (1).  
Chang et al.92 Cross-sectional X-ray WOMAC PF joint only: β =1.391 (SE=0.939), NS (age, sex, 
BMI). 
n=341 knees from 217 patients (208 
females, 9 males). PF attrition was 
either absent (0) or present (1). 
Dieppe et 
al.47 
Longitudinal X-ray 4-pt Likert scale and 
presence/absence of 
night pain 
Global pain: OR=0.1, (95% CI: -0.1 to 0.4), NS. 
Night pain: OR=4.2 (95% CI: 0.5 to 34.9), NS. 
n=90 knees from 75 patients (33 
males, 42 females). Attrition was 
scored on a 4-pt scale (0-3)126. 
Hernandez-
Molina et 
al.125 
Cross-sectional MRI Presence/absence of 
pain 
Overall pain: OR=0.9 (95% CI: 0.6 to 1.4), NS 
(Adjusted for age, sex, OA severity, BMI, 
presence of BML, effusion). 
Night pain: OR=1.0 (95% CI: 0.5 to 2.1), NS 
(Adjusted for age, sex, OA severity, BMI, 
presence of BML, effusion). 
n=1627 knees (662 males, 965 
females) from 1273 patients. Attrition 
was scored from 0-365.  
Javaid et al.9 Cross-sectional X-ray, MRI Presence/absence of 
pain (WOMAC) 
X-Ray: 
Any: OR=7.25 (95% CI: 2.55 to 20.62), p<0.001. 
MRI: 
Any: OR=2.40 (95% CI: 1.51 to 3.83), p<0.001, 
Severe: OR=3.00 (95% CI: 1.67 to 5.38), p<0.001. 
Total n=636 (226 male, 410 female), 
with pain n=283 (112 male, 171 
female), without pain n=353 (114 
males, 239 female). Attrition was 
graded on 4-point scale (0-3)65 using 
MRI, and with a standardized atlas61 
on radiographs. 
Reichenbach 
et al.124 
Cross-sectional X-ray, MRI Presence/absence of 
pain 
Day pain: OR=2.37 (95% CI: 1.48 to 3.80), 
p<0.001. 
Night pain: OR=0.94 (95% CI: 0.58 to 1.53), 
p<0.001 (All tests adjusted for age, sex, BMI, KL, 
effusion). 
n=656 (266 male, 390 female). 
Attrition was graded on a 4-point 
scale: none (0), <5mm (1), 5-10mm 
(2), >10mm (3).  
Torres et al.66 Cross-sectional MRI VAS Unstandardized β= 1.91 (95% CI: 0.68 to 3.13), 
significant (Adjusted for age and BMI). 
n=143 (31 male, 112 female). 
Attrition graded using a 4-point scale 
(0-3)65. 
BMI: Body mass index. CI: Confidence interval. KL: Kellgren-Lawrence scoring. MRI: magnetic resonance imaging. NS: Not significant. OR: Odds ratio, odds 
of having pain. PF: Patellofemoral joint. r: Spearman’s or Pearson’s correlation coefficient. SE: Standard error. TF: Tibiofemoral joint. VAS: Visual analog 
scale. WOMAC: Western Ontario and McMaster Scoring. X-ray: radiographs. β: regression coefficient. 
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2.5.5.  Subchondral cysts 
Subchondral cysts are voids within the subchondral bone, typically observable with MRI and CT 
but also identifiable in x-ray images (Figure 2-12). The genesis and development of cysts is not 
fully understood; however, there are two primary hypotheses: (1) the ‘bony contusion theory’127, 
128, which proposes that excessive localized loading or trauma can induce trabecular micro 
fractures, necrotic bone, and localized bone resorption, eventually leading to cyst development; 
and (2) the ‘synovial fluid intrusion theory’129, 130, which proposes that the calcified barrier 
between cartilage and subchondral bone is damaged and breached, allowing fluid to seep into 
adjacent subchondral bone, creating a fluid-filled lesion. Cysts near the subchondral surface may 
change local stress distributions131, which could potentially lead to pain or discomfort. There is 
evidence presenting that subchondral cyst presence is associated with OA-related pain9, 63, 104, but 
there is also contradictory evidence presenting that subchondral cysts are not associated with 
OA-related pain10, 66, 104, 106, 112 (Table 2-8). Discrepancies in these studies may due to differences 
in imaging modalities. As cysts are a 3D structure, it may be beneficial to evaluate the 
association between subchondral cysts and pain using 3D imaging modalities, such as QCT.  
 
 
Figure 2-12. Sample CT images in coronal (left) and sagittal (right) views of OA patient with mild 
subchondral cysts (top row) and severe subchondral cysts (bottom row). 
 Table 2-8. Summary of image-based studies evaluating relationships between subchondral cysts and OA-related pain.  
Author Study design Imaging modality Pain measurement tool Findings Comments 
Hayashi et al.104 Cross-sectional X-ray, CT WOMAC Femur: 
X-ray, medial and lateral: NS, 
CT, lateral: OR=17.8, p=0.004, 
CT, medial: OR=4.3, NS. 
Tibia: 
X-ray, lateral: OR=2.6, NS, 
X-ray, medial: OR=3.8, NS, 
CT, lateral: OR=3.6, NS, 
CT, medial: OR=6.7, p=0.03. 
n=80 knees from 40 patients (10 males, 30 
female). Subchondral cysts were scored as 
either absent or present, using both x-ray 
and tomosynthesis.  
Hayes et al.63 Cross-sectional MRI Presence/absence of 
pain 
Positive, p<0.001. n=117 females; no OA/no pain=30, OA/no 
pain=29, no OA/pain=30, OA/pain=28. 
Subchondral cysts assessed using: absent 
(0), <10mm (1), >10mm (2). 
Javaid et al.9 Cross-sectional MRI Presence/absence of 
pain (WOMAC) 
X-Ray: 
Any: OR=4.50 (95% CI: 1.84 to 0.68), p=0.001. 
MRI: 
Any: OR=1.61 (95% CI: 1.03 to 2.52), p=0.037, 
Severe: OR=1.90 (95% CI: 1.11 to 3.27), 
p<0.001. 
Total n=636 (226 male, 410 female), with 
pain n=283 (112 male, 171 female), 
without pain n=353 (114 males, 239 
female). Subchondral cysts graded on a 4-
point scale (0-3) on MRI65. 
Kornaat et al.106 Cross-sectional MRI Presence/absence of 
pain 
Presence: OR=1.71 (99% CI: 0.81 to 3.63), NS. 
PF: OR=1.83 (99% CI: 0.80 to 4.16), NS. 
TF: OR=1.14 (99% CI: 0.44 to 2.92), NS (All 
tests adjusted for age, sex, and BMI). 
n=205 (42 males, 163 females), n=97 with 
radiographic OA. Subchondral cysts 
assessed using: absent (0), minimal <3mm 
(1), moderate 3-5mm (2), severe >5mm 
(3). 
Link et al.112 Cross-sectional MRI WOMAC NS. n=50 (20 male, 30 female). Subchondral 
cysts were scored as either absent or 
present.  
Sowers et al.10 Cross-sectional MRI WOMAC NS. n=543 females. Subchondral cysts were 
scored as absent, <1cm or >1cm. 
Torres et al.66 Cross-sectional MRI VAS pain Unstandardized β= 0.82 (95% CI: -0.50 to 2.14), 
NS (Adjusted for age and BMI). 
n=143 (31 male, 112 female). Subchondral 
cysts graded on a 4-point scale (0-3)65. 
BMI: Body mass index. CI: Confidence interval. CT: Computed tomography. MRI: Magnetic resonance imaging. NS: Not significant. OR: Odds ratio, odds of 
having pain. PF: Patellofemoral joint. r: Spearman’s or Pearson’s correlation coefficient. SE: Standard error. TF: Tibiofemoral joint. VAS: Visual analog scale. 
WOMAC: Western Ontario and McMaster Scoring. X-ray: radiographs. β: regression coefficient. 
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2.5.6.  Bone Marrow Lesions 
Bone marrow lesions (BML) are indicated by regions of increased signal within the subchondral 
region on fat-suppressed T2-weighted MR images29, 132 (Figure 2-13). BMLs are dynamic in 
nature and have been observed to change during OA progression133, and may even be present in 
patients without radiographic OA134. Histologically, BMLs are comprised of necrotic tissue, 
trabecular abnormalities, and fibrosis135, suggesting that BMLs may be regions of bone trauma or 
turnover15, 136. BMLs are the imaged feature most consistently associated with pain, found in 
78% of patients with painful knee OA136, 30% of patients with non-painful knee OA136, and in 
38% of patients with pre-radiographic OA137. BML presence may be consistently associated with 
pain, but relationships between BML size and pain tend to be less consistent, as some studies 
report that greater pain is associated with larger BMLs78, 138, whereas others report that BML size 
is not associated with pain133 (Table 2-9). Recent work has reported that regions adjacent to 
BMLs show localized higher BMD15, 139, suggesting that BMD may also be associated with OA-
related pain.  
 
 
Figure 2-13. Sample MR image of OA patients with grade 1 BML (A) and grade 3 BML (B). Adapted 
from Seah 2012140 
 Table 2-9. Summary of image-based studies evaluating relationships between bone marrow lesions (BML) and OA-related pain.  
Author Study design Imaging modality Pain measurement tool Findings Comments 
Ai et al.109 Cross-sectional MRI 3-pt verbal rating scale NS. n=31 knees from 28 patients (12 
male, 16 female). BML graded on a 
4-point scale: absent (0), <1cm (1), 1-
2cm (2), >2cm (3).  
Baert et al.141 Cross-sectional MRI KOOS NS. n=87 female patients. BML scores 
summed over both PF and TF joint 
using semi-quantitative scoring 
(BLOKS)142.  
Bilgici et al.143 Cross-sectional MRI WOMAC Pain is higher in patients with BML, 
p<0.001. 
n=34 (10 male, 24 female). BML 
graded using 4-point scale (0-3) and 
summed over 14 regions of the knee 
(WORMS)65.  
Dore et al.144 Longitudinal MRI WOMAC Change in pain vs. change in BML over 5 
years, NS (All tests adjusted for age, sex, 
BMI, leg strength, baseline pain, and quality 
of life). 
n=392 (192 male, 200 female). BML 
graded at baseline and follow-up (2.0 
to 4.7 years) with a 4-point scale (0-
3); largest BML was used for 
analysis.  
Driban et al.133 Longitudinal MRI WOMAC Baseline pain vs. total volume: β=0.16, 
p=0.014. 
Pain change vs. baseline total volume: 
β=0.01, NS. 
Pain change vs. volume change: β=0.121 
p=0.004 (All tests adjusted for age, sex, 
weight and height). 
n=404 (205 male, 199 female). BML 
volume was measured at baseline and 
follow-up (24months or 48 months).  
Felson et al.136 Cross-sectional MRI WOMAC BML presence and pain, p<0.001. 
Large BML and pain, p<0.001. 
n=351 patients with knee pain (235 
male, 116 female) and n=50 patients 
without knee pain (26 male, 24 
female). BML graded using 4-point 
scale (0-3). 
  
27 
  
Felson et al.145 Longitudinal MRI WOMAC Increase in BML with incident pain: 
OR=1.61 (95% CI: 1.24 to 2.09), significant 
Increase in pain and increase in BML size 
over 15 months, p=0.002 for trend (All tests 
adjusted for age, sex, race, BMI, CES-D, 
baseline quadriceps strength, KL, effusion, 
baseline BML, change in effusion, 
alignment). 
Case: n=110 knees from 102 patients 
(31 male, 79 female); Control n=220 
knees from 220 patients (88 male, 
132 female). BML graded using 4-
point scale (0-3) and summed over 9 
regions of the tibia and patella65.  
Ip et al.137 Cross-sectional MRI WOMAC (VAS) Total pain, NS. 
Walking pain, NS. 
Pain while climbing stairs: 
Maximal BML r=0.60 (95% CI 0.04 to 
1.17), p<0.05 (All tests adjusted for age, sex, 
BMI, OA severity, effusion, and meniscal 
damage). 
No OA: n=33 (14 male, 19 female); 
Pre-radiographic OA: n=124 (56 
male, 68 female); Radiographic OA: 
n=98 (39 male, 59 female). BML 
graded using a 4-point scale and 
summed over 6 regions of the knee. 
Javaid et al.9 Cross-sectional MRI Presence/absence of pain 
(WOMAC) 
Any BML: OR=1.70 (95% CI: 1.08 to 2.67), 
p=0.021. 
Severe BML: OR=1.91 (95% CI: 1.24 to 
2.92), p=0.003. 
Total n=636 (226 male, 410 female), 
with pain n=283 (112 male, 171 
female), without pain n=353 (114 
males, 239 female). BML graded on 
4-point scale (0-3) in 14 regions of 
the knee65. 
Kim et al.67 Cross-sectional MRI Presence/absence of pain 
and WOMAC 
Any TF region: OR=2.61 (95% CI 1.32 to 
5.16), p<0.001 for trend. 
Lateral TF: OR=1.54 (95% CI 0.84 to 2.82), 
p<0.001 for trend. 
Medial TF: OR=3.43 (95% CI 1.62 to 7.26), 
P<0.001 for trend. 
(All tests adjusted for age, sex, BMI, and OA 
severity). 
n=358 (184 male, 174 female). BML 
graded on 4-point scale (0-3) and 
summed over 10 regions of the 
knee65.  
Kornaat et al.146 Longitudinal MRI WOMAC NS (Adjusted for age, sex, BMI). n=182 patients (25 male, 157 female) 
over 2 years. BML graded on 4-point 
scale (0-3): absent (0), <5mm (1), 5-
20mm (2), >20mm (3), and summed 
over 9 regions of the knee.  
Link et al.112 Cross-sectional MRI WOMAC NS. n=50 patients (20 male, 30 female). 
BML were classified as either absent, 
mild (<1cm), moderate (1-2cm), or 
severe (>2cm).  
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 Lo et al.78 Cross-sectional MRI WOMAC (weight-
bearing, non-weight-
bearing) 
Weight-bearing pain, p for trend <0.05 
Non-weight-bearing pain, NS (All tests 
adjusted for age, sex, BMI, effusion, and 
synovitis). 
n=160 patients (80 male, 80 female). 
BML graded on 4-point scale (0-3) 
and summed over 9 regions of the 
knee. 
Ratzlaff et al.147  Cross-sectional MRI WOMAC (weight-
bearing) 
Total BML: positive, p<0.01. 
Femur BML: positive, p<0.01. 
Tibia BML: NS (All tests adjusted for age, 
sex, BMI, race, and minimum JSN). 
n=115 patients (60 male, 55 female). 
BML were graded on 4-point scale 
(0-3)65 and summed over 3 lateral or 
3 medial tibial compartments.  
Seah et al.140 Cross-sectional MRI WOMAC (nocturnal) NS. n=37 (16 male, 21 female). BML 
parameters include: contrast uptake 
rate, contrast uptake area, surface 
permeability, and washout rate.  
Sowers et al.10 Cross-sectional MRI WOMAC OR range from 1.75 to 14.93, 5 regions, all 
significant. 
n=543 females. BML graded with 4-
point scale (0-3) at 7 regions of the 
knee. 
Stefanik et al.148 Cross-sectional MRI Presence/absence of pain, 
VAS pain 
Any BML: 
OR=1.5 (95% CI: 1.1 to 2.0), 
OR=2.4 (95% CI: 1.7 to 3.5). 
Large BML: 
OR=1.2 (95% CI: 0.7 to 2.1), 
OR=1.4 (95% CI: 0.6 to 3.1), 
All significant (age, sex, BMI, depressive 
symptoms). 
n=2017 patients (450 male, 1261 
female). BML graded with 4-point 
scale (0-3)65. Considered any BML as 
score of 1-3, and large BML as score 
of 2-3. 
Torres et al.66 Cross-sectional MRI VAS pain Adjusted coefficient = 53.72 (95% CI: 1.76 
to 5.68), significant (age, BMI). 
n=143 (31 male, 112 female). BML 
graded on a 4-point scale (0-3)65. 
Wildi et al.68 Longitudinal MRI WOMAC 12-month follow-up:  
Global BML, r= -0.036, NS, 
PF BML, r= -0.239, p<0.01. 
24-month follow-up: 
Global BML, r= -0.085, NS, 
PF BML, r= -0.154, NS. 
n=161 (54 male, 107 female). BML 
graded on a 4-point scale (0-3)65.  
BMI: Body mass index. BML: bone marrow lesion. CI: Confidence interval. JSN: joint space narrowing. MRI: magnetic resonance imaging. NS: Not significant. 
OR: Odds ratio, odds of having pain. PF: Patellofemoral joint. r: Spearman’s or Pearson’s correlation coefficient. SE: Standard error. TF: Tibiofemoral joint. 
VAS: Visual analog scale. WOMAC: Western Ontario and McMaster Scoring. β: regression coefficient. 
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2.5.7.  Bone Mineral Density 
Imaged BMD is the amount of bone mineral mass within unit of volume (BMD or vBMD) or a 
unit of area (aBMD) depending on the imaging tool. BMD can be measured using computed 
tomography (CT) or MRI, whereas areal BMD (aBMD) is measured using dual-energy 
absorptiometry (DXA). Although each of these metrics provides a measurement of bone 
quantity, each differs slightly from one another, thus it is important to note that it is challenging 
to compare BMD values between studies using differing imaging modalities. Also, as the actual 
amount of bone differs between different depths from the subchondral surface, it is important to 
take note of the depth and the region of interest (ROI) used for each BMD measurement. 
Regions within the same subject at differing depths19, 23, ROIs149, 150, or using different image 
processing tools21 may include different types of subchondral bone (subchondral cortical, 
subchondral trabecular, epiphyseal trabecular), which may be affected differently by OA44, and 
have differing BMD values20, and thus may have different associations with OA-related pain.  
2.5.7.1. DXA and Areal Bone Mineral Density (aBMD) 
The majority of studies evaluating the association of bone density and OA use DXA14, 28, 149, 151-
154. DXA is a projection-based imaging tool used to measure the amount of bone within a 
specified two-dimensional (2D) area (mg/cm2) expressed as areal BMD (aBMD), or amount of 
bone per unit area (Figure 2-14). Some of these studies have reported that patients with OA have 
higher aBMD14, 28, 152, some have reported lower aBMD152, 155, while others have reported no 
differences in aBMD153, 156 when compared to asymptomatic controls. These discrepancies are 
most likely due to inherent limitations of DXA. Specifically, DXA images represent a 3D 
structure as a 2D projection image, thus are sensitive to patient size, positioning, and chosen 
ROI. Larger individuals will contain more bone material within a specified 2D area, potentially 
under-estimating aBMD, and vice versa for smaller individuals. Deviations in patient 
positioning, such as joint rotation, may also alter aBMD measurements within a fixed ROI157. 
The size and placement of ROI may also contribute to variation in aBMD measurements. For 
example, Dore et al.149 evaluated aBMD using 6 ROIs at the proximal tibia, ranging in height 
from 10mm to 20mm, using different joint landmarks for placement (e.g., from the edge of the 
image to the highest point of the lateral or medial spine). The reproducibility (intra-class 
correlation coefficients, ICC) of each respective ROI was excellent, ranging from 0.98 to 1.00, 
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but aBMD values varied as some ROIs contained both subchondral cortical and subchondral 
trabecular bone. To date, only two studies have reported the association between aBMD and OA-
related knee pain, reporting higher medial aBMD158 and lower lateral aBMD149 is associated with 
OA-related knee pain (Table 2-10). 
 
 
Figure 2-14. Representative ROI used in studies evaluating proximal tibial aBMD159.  
 Table 2-10. Summary of image-based studies evaluating relationships between bone mineral density (BMD) and OA-related pain.  
Author Study Design Imaging modality Pain measurement tool Findings Comments 
aBMD      
Akamatsu et 
al.158 
Cross-sectional DXA VAS Tibia, medial: β=0.372, p<0.001. 
Tibia, lateral: β=-0.058, NS. 
Tibia, M:L: β=0.388, p<0.001. 
Femur, medial: β=0.367, p<0.001. 
Femur, lateral: β=-0.038, NS. 
Femur, M:L: β=0.343, p<0.001 (All tests 
adjusted for age and BMI). 
n=192 patients. aBMD was measured 
at the lateral and medial tibial 
plateaus and femoral condyles 
Dore et al.149 Cross-sectional DXA WOMAC Medial: r=0.07, NS. 
Lateral: r=-0.308, p=0.035 (All tests adjusted 
for age, sex, and BMI). 
n=50 patients (27 male, 23 female). 
aBMD was measured at the lateral 
and medial tibial plateaus using six 
different ROIs.  
BMD      
Burnett et al.19 Cross-sectional QCT WOMAC Medial: 52mg/cm3 (95%CI: -99 to -5, 
p=0.033) at 2.5-5mm and 58 mg/cm3 (95% 
CI -104 to -12, p=0.016) lower BMD in 
patients with moderate-to-severe pain at rest. 
Lateral 56mg/cm3 (95% CI -110 to -3, 
p=0.041) at 0-2.5mm, 64 mg/cm3 (95% CI -
116 to -12, p=0.017) at 2.5-5mm, and 72 
mg/cm3 (95% CI -120 to -24, p=0.004) lower 
BMD in patients with moderate-to-severe 
pain at rest.  
n=41 patients (17 male, 24 female), 
19 with mild-to-no pain at rest and 22 
with moderate-to-severe pain at rest. 
BMD was measured at 0-2.5mm, 2.5-
5mm, and 5-7.5mm from the 
subchondral surface of the lateral and 
medial patellar facets.  
aBMD: areal bone mineral density. BMI: Body mass index. CI: Confidence interval. DXA: dual x-ray absorptiometry. M:L: medial to lateral bone mineral 
density ratio. MRI: magnetic resonance imaging. NS: Not significant. OR: Odds ratio, odds of having pain. PF: Patellofemoral joint. QCT: quantitative computed 
tomography. r: Spearman’s or Pearson’s correlation coefficient. ROI: region of interest. SE: Standard error. TF: Tibiofemoral joint. VAS: Visual analog scale. 
BMD: (volumetric) bone mineral density. WOMAC: Western Ontario and McMaster Scoring. X-ray: radiographs. β: regression coefficient 
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2.5.7.2.  Bone Mineral Density (BMD) 
Quantitative CT (QCT) is a 3D imaging technique that uses a calibrated phantom to convert 
grayscale CT Hounsfield units (HU) to equivalent volumetric BMD (mg/cm3), providing means 
to measure varying BMD throughout the proximal tibia at differing ROIs from the subchondral 
surface. CT, combined with custom image processing, has been used to measure depth-specific 
BMD at the acetabulum160, proximal femur161, proximal tibia21, 22, 162, patella19, 20, and distal 
tibia163. Concerning the relationship between BMD and knee OA severity or progression, few 
studies are available. This may be due to recent improvements in image slice thickness. 
Previously, image slice thicknesses were larger (1-4mm), hindering the ability to measure BMD 
adjacent to the subchondral surface and capture other bony features such as small osteophytes 
and subchondral cysts164. Newer scanners provide thinner slice thickness (0.3–0.625mm) 
allowing for more reliable imaged reconstructions with isotropic voxels, permitting analysis at 
any point within an imaged volume through using image-processing tools.  
 Studies evaluating the relationship between BMD and knee OA have been performed at 
both the proximal tibia21-23 and the patella19, 20. At the proximal tibia, patients with OA have 
higher BMD at the subchondral trabecular region21 (Figure 2-15), and lower BMD at the 
epiphyseal trabecular region23, when compared to patients without OA. Similar results were 
reported at the patella, where participants with OA had lower BMD than healthy participants20. 
Prior to this work, a single study at the patella has reported associations between BMD and OA-
related pain, where participants with moderate-to-severe pain at rest had 10% lower BMD in 
subchondral cortical regions, and 20% - 28% lower BMD in subchondral trabecular regions than 
participants with mild-to-no pain at rest19 (Table 2-10, Figure 2-16).  
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Figure 2-15. Tibial subchondral BMD measurements of patients with OA (top row) and healthy 
participants (bottom row) at three depths from the subchondral surface (0-2.5mm, 2.5-5mm, 5-10mm) 
using depth specific QCT imaging techniques.22 
 
 
Figure 2-16. Patellar subchondral BMD measurements of OA patients with low pain at rest (top row) and 
high pain at rest (bottom row) at three depths from the subchondral surface (0-2.5mm, 2.5-5mm, 5-
7.5mm) using depth-specific QCT imaging techniques. 19.  
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 Although these findings suggest associations between BMD and OA severity and related 
pain, the underlying mechanisms of this association are unclear. Primary hypotheses infer that 
observed BMD alterations are associated with mechanical behaviour such as altered bone 
stiffness165 or loading patterns27, 45. As BMD alterations may be a promising metric of OA-
related knee pain, mechanical behaviour and loading patterns as interpreted through mechanical 
outcomes (such as stress, strain, and stiffness) may be worthwhile investigating as well, thereby 
providing additional understanding of the mechanical role of bone in OA.  
2.6. Finite Element Modeling 
2.6.1.  Overview 
Finite element (FE) modeling provides a non-invasive in vivo technique to study the structural 
role of bone in OA as well as the effect of OA-related alterations to overall mechanical 
behaviour of bone. This technique can allow the evaluation of complicated structures, such as the 
proximal tibia, under varying loading conditions. Simplified models can be generated using 
idealized geometry166, which provide a conceptual and general evaluation, but they do not 
provide the ability measure inter-subject variability. To overcome this, imaged volumes 
(typically using QCT or high resolution QCT images) can be used to construct models which 
incorporate subject-specific geometry, material property distribution, and alignment30, 31, as well 
as the possibility to link with clinical data such as OA progression or symptoms, such as pain.  
2.6.2.  Subject-specific FE models 
Image-based subject-specific QCT FE techniques have been successfully used at the proximal 
tibia to determine how altered subchondral morphology167, mechanical properties168, cyst 
formation131, and joint alignment169 may impact stress and strain distributions, as well as 
structural stiffness. Briefly, segmented QCT images are converted to imaged volumes to create 
an FE model. As these model volumes are based on images from a specific individual, they are 
able to incorporate joint and bone geometry as well as mapped material property distribution 
throughout the model.  
 Imaged BMD is related to bone’s elastic modulus, or Young’s modulus (E), through 
experimentally derived equations170, 171, then mapped to the FE mesh, providing subject-specific 
distribution of material properties. These density-modulus equations (commonly referred to as E-
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BMD equations) are typically obtained through mechanical tests on bone specimens at different 
skeletal sites170. E-BMD relationships are site-specific, as well as dependent on various test-
related factors such as: specimen size172, specimen geometry173, testing boundary conditions174, 
and displacement measurement method175. It is crucial to ensure that appropriate E-BMD 
relationships are used for subject-specific FE models as they can affect the accuracy and 
precision of the FE model. Recent work by Nazemi et al.176 compared nine different E-BMD 
relationships across 21 subject-specific QCT-based FE models of 13 medial and lateral proximal 
tibial plateaus with known localized structural stiffness values obtained through experimental 
testing. Material properties were mapped using: (1) only trabecular-specific E-BMD 
relationships25, 173, 177-181, and (2) trabecular-specific E-BMD relationships combined with two 
cortical-specific E-BMD relationships (Snyder & Schneider182, Rho et al. 180). Authors report 
that a combination of E-BMD equations, using Goulet et al.179 for trabecular bone and either 
Snyder & Schneider182 or Rho et al.180 for cortical bone provided the most appropriate E-BMD 
relationships for FE models at the proximal tibia, with R2 of 0.75 to 0.77 between experimental 
stiffness values and FE predictions. Though, models using a single E-BMD equation (Goulet et 
al.179) explained similar variance in stiffness (R2 = 0.70) as models including both trabecular and 
cortical bone (R2 ranging from 0.56 to 0.77). 
2.6.2.  Subject-specific FE Analysis of OA Bone 
There are limited studies reporting the use of in vivo subject-specific FE modeling techniques at 
the proximal tibia in patients with OA. Early work from McErlain et al.131 evaluated the effect of 
simulated subchondral cysts on stress distributions at the proximal tibia in 20 patients with early 
OA. Authors report trends where maximum stress values often appeared in the region 
surrounding the simulated subchondral cysts and adjacent to the joint space. Additionally, an 
increase in cyst diameter contributed to an increase in stress values surrounding the simulated 
cyst region (r2=0.372, p=0.004) (Figure 2-17).  
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Figure 2-17. Comparison of von Mises stress distribution at the proximal tibia in participants with early 
OA with (right) and without (left) simulated subchondral cysts. Adapted from McErlain et al131.  
 A recent precision study30, 31 of in vivo subject-specific FE modeling at the proximal tibia 
reported differences in stress (von Mises and minimum compressive stress), in a small sample 
(n=7) of participants with OA compared to healthy participants (n=7). Differences in von Mises 
stress were greatest at medial cortical regions along the peripheral of the subchondral depth 
(101% greater in participants with OA) and along the outer epiphyseal depth (113% greater in 
participants with OA), and at lateral cortical regions along the peripheral of the subchondral 
region (31% greater in participants with OA) and along the outer epiphyseal depth (38% greater 
in participants with OA) (Figure 2-18). Participants with OA also had greater von Mises stress at 
medial trabecular regions at both the subchondral (37% greater) and epiphyseal (45% greater) 
depths. The difference in stress was up to 20 times the precision error, indicating that it may be 
possible to differentiate mechanical differences between healthy and OA tibiae using subject-
specific QCT-based FE techniques. It may also be possible to differentiate pain in participants 
with OA using similar techniques. Given that both studies report higher stress distributions at the 
proximal tibia, either due to subchondral alterations related to OA progression131 or OA 
presence30, higher stress may also be related to OA-related knee pain.  
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Figure 2-18. Representative von Mises stress distributions between OA and healthy participants at the 
proximal tibia. Yellow indicates high stress, while black indicates low stress30, 31. 
2.6.3.  Subject-Specific FE and pain 
To date, a single study183 in patients with patellofemoral (PF) pain has used subject-specific FE 
modelling to determine relationships between mechanical outcomes and pain. This study used 
subject-specific FE models to evaluate hydrostatic pressure and octahedral shear stress in patellar 
and femoral cartilage in patients with and without PF pain. Compared to pain-free controls, 
individuals with PF pain exhibited greater peak hydrostatic pressure by 19% to 30% at the 
patella and by 25% to 29% at the femur. Mean octahedral shear stress was 10% to 50% greater at 
the patellar cartilage surface, and 20% to 33% greater at the femoral cartilage surface. Although 
this research evaluated mechanical behaviour of cartilage, it does support the hypothesis that 
mechanical changes within the knee joint may also be associated with OA-related pain.   
2.7.  Summary 
1. OA is a debilitating and painful disease affecting a large portion of the Canadian 
population. Pain is the primary symptom of OA, but the joint tissues may already be 
mechanically compromised when the patient first feels pain.  
2. Subchondral bone is heavily innervated and may be a likely location for pain initiation, as 
opposed to cartilage which is aneural and insensate.  
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3. Image-based bony features, such as joint alignment, osteophytes, sclerosis, attrition, 
subchondral cysts, and BMLs are often associated with OA-related pain, but relationships 
are inconsistent among various imaging modalities.  
4. BMD, a surrogate measure of mechanical properties in bone, is associated with various 
image-based outcomes, and can be quantified in vivo using clinical QCT. 
5. Lower trabecular BMD at the patella is related to pain at rest. Similar relationships may 
be present between OA-related pain and proximal tibial subchondral, epiphyseal, or 
metaphyseal BMD.  
6. As BMD alterations may be a promising metric of OA-related knee pain, mechanical 
behaviour and loading patterns as interpreted through mechanical outcomes, such as 
stress, strain, and stiffness, may be worthwhile investigating. 
7. Recent work using subject-specific FE modeling has shown differences in von Mises 
stress and minimum principal stress between healthy patients and patients with OA, and 
may be able to discriminate differences in mechanical outcomes between patients with 
differing levels of OA-related pain.   
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3. RESEARCH QUESTIONS AND OBJECTIVES 
3.1.  Research Questions 
The fundamental question motivating my research is: What are the relationships between bone 
and OA-related knee pain? To help answer this question, the goal of my dissertation was to use 
and modify previously developed depth-specific QCT imaging techniques22 and FE techniques30 
to evaluate relationships between OA-related pain and image-based CT and FE outcomes in a 
group of patients with OA. I aimed to answer the following research questions: 
1. What are the relationships between tibial subchondral BMD and knee pain in patients 
with OA? 
2. What are the relationships between tibial epiphyseal and metaphyseal BMD and knee 
pain in patients with OA? 
3. What are the relationships between tibial subchondral cysts and knee pain in patients with 
OA? 
4. What are the relationships between tibial FE-derived mechanical outcomes and knee pain 
in patients with OA? 
3.2.  Research Objectives: 
To answer the questions posed in this study, the objectives were to: 
1. Investigate if tibial regional subchondral BMD is associated with OA-related nocturnal 
knee pain using a depth-specific CT image processing tool,  
2. Investigate if tibial epiphyseal and metaphyseal BMD is associated with OA-related knee 
pain using a modification of the previously used depth-specific CT image processing 
tool, 
3. Modify our depth-specific imaging technique to measure subchondral cyst parameters 
and use this technique to determine if subchondral cyst characteristics are associated with 
OA-related knee pain,  
4. Investigate if FE-derived mechanical outcomes at the proximal tibia are associated with 
OA-related pain.  
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4. SUBCHONDRAL BMD AND NOCTURNAL PAIN 
4.1. Synopsis 
This chapter outlines details of our study investigating relationships between proximal tibial 
subchondral BMD and nocturnal pain in patients with knee OA. In this study, we report that 
participants with severe nocturnal pain had higher lateral focal BMD than participants with no 
pain at subchondral trabecular depths of 2.5-5mm and 5-10mm from the subchondral surface. 
This study suggests that local subchondral BMD may have a role in OA-relates pain 
pathogenesis.  
4.2. Introduction 
Knee OA is a leading cause of chronic pain and disability in the elderly184. Pain is the dominant 
symptom of OA2 and is often the first indication that patients may be afflicted with OA. OA-
related pain is complex47, 69, 70, 72, 78, as it is a combination of social, psychological, and biological 
factors, with no simple unitary concept linking symptoms with structural damage71, 185. Within 
the joint structure, pain could be due to the presence of various contributing factors (e.g., altered 
joint alignment, joint instability, osteophyte presence both peripherally and within the joint, 
inflammation, cyst presence, altered subchondral bone properties). Importantly, underlying 
sources of pain may be masked by specific structural factors, such as altered joint alignment, 
osteophyte presence, and inflammation, which would likely be present during dynamic weight-
bearing activities such as climbing stairs or walking. To isolate potential underlying sources of 
pain, it is advantageous to study pain with non-weight bearing activities, such as lying in bed at 
night. Understanding potential sources of pain during non-weight bearing activities, such as 
nocturnal pain, is also relevant as it is related to sleeplessness and other disruptions to quality of 
life in OA patients5.  
 Subchondral bone is one of the many tissues involved in OA pathogenesis and 
progression1, 2, 84. Importantly, it is densely innervated8 and thus could be a factor in OA-related 
pain. Deeper tissues within the subchondral region, composed primarily of subchondral 
trabecular bone, have a greater concentration of nerve endings than the shallower, highly 
mineralized subchondral tissues (e.g., cortical bone)186 and could be of particular importance for 
OA-related pain. Ex vivo studies have shown altered subchondral bone thickness187, bone 
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volume fraction188-190, and volumetric density21, 24 with OA. These alterations may influence 
local innervation191, 192 and/or the local mechanical behaviour of bone193, possibly leading to 
pain.  
 Our current understanding of the relationship between pain and altered density, 
specifically subchondral BMD, relies on evidence from studies using 2D DXA149, 158. However, 
these studies provide8 conflicting results, reporting that both higher aBMD158 and lower 
aBMD149 are associated with OA-related pain. These conflicting results may be due to the 
inherent limitations of 2D projection techniques, such as patient size and positioning157, 
unstandardized regions of interest139, 149, 150, and the inability to evaluate distinct regions or 
depths157, 194. Three-dimensional CT-based depth-specific imaging techniques have the ability 
distinguish differences in subchondral volumetric BMD between normal and OA tibiae21, 162, and 
may have the ability to identify regional BMD differences in patients with and without pain. 
Depth-specific imaging techniques also have the potential to determine approximate contrasts 
between subchondral cortical BMD and less dense trabecular BMD layers195, which may have 
different roles in OA-related pain.  
 Using a depth-specific CT-based image processing tool, the objective of this study was to 
determine whether there are associations between proximal tibial subchondral BMD and OA-
related nocturnal pain. 
4.3. Methods 
4.3.1. Study Participants 
Fifty-two participants (23M: 29F; mean age 64, SD ± 9.4years) with OA were recruited prior to 
total knee replacement. Study exclusion criteria included: pregnant women, patients having a 
revision replacement instead of primary knee replacement, and patients with a prior history of 
bone pathology at the knee joint. CT images with excessive imaging artifacts, motion artifacts, or 
incomplete images were excluded, resulting in 42 study participants (17M: 25F; 64 ± 10 years). 
The Institutional Research Board of the New England Baptist Hospital approved the study. 
Informed consent was obtained from all study participants. 
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4.3.2. Patient Assessment 
OA severity was classified using the KL grade59 and OA-related pain severity was measured at 
the affected knee joint using a 5-point Likert scale (0 to 4) of the pain subsection of WOMAC75. 
Participants were asked to assess the level of pain in the affected knee joint within the past 24-
hours while walking on a flat surface, going up or down stairs, nocturnal pain at night in bed, 
sitting or lying down, and standing upright. This study was focused on non-weight bearing 
nocturnal pain at night in bed.  
4.3.3. CT Acquisition 
We used a clinical single-energy QCT scanner (Lightspeed 4-slice, General Electric, Milwakee, 
WI, USA) with a solid QCT reference phantom (Model 3T, Mindways Software Inc., Austin, 
TX, USA) to collect CT data and convert grayscale CT HU to equivalent apparent BMD 
(mg/cm3 K2HPO4). Participants were oriented supine within the CT gantry and both legs were 
simultaneously scanned. Scans included the distal femur, patella, proximal tibia, and the 66% 
tibial shaft site proximal to the distal tibial end-plate196. Only the proximal tibia and the 66% 
tibial shaft site were used in the current analysis.  
 CT scanning parameters included: 120kVp tube voltage, 150mA tube current, axial 
scanning plane, 0.625mm isotropic voxel size (0.625 slice thickness, 0.625mm x 0.625mm in-
plane pixel size), ~250 slices, ~60s scan time, and 0.073mSv effective dosage. A standard bone 
kernel (BONE) was used for CT image post-processing. Effective radiation dosage was 
~0.073mSv per scan, estimated using shareware software (CT-DOSE, National Board of Health, 
Herley, Denmark). For comparison, the average effective radiation dosage during a transatlantic 
flight from Europe to North America is about 0.05mSv197.  
4.3.4. CT Image Analysis 
We used a validated depth-specific image processing technique (computed tomography 
topographical mapping of subchondral density, CT-TOMASD)22, 162 to measure subchondral 
proximal tibial subchondral BMD . This method uses surface projection image processing to 
quantify volumetric subchondral bone density at user-defined depths from the subchondral bone 
surface. Briefly, equivalent volumetric BMD (mg/cm3 K2HPO4) values were converted from 
grayscale HU using linear regression equations developed from known densities within the QCT 
phantom included in each image (r2>0.99) (Matlab 2010b; MathWorks, Natick, MA, USA). 
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Subject-specific half maximum height thresholds198, 199 were then determined to define the 
proximal tibial subchondral surface. Serial images were individually segmented using semi-
automatic region growing and manual correction techniques using commercial software 
(Analyze10.0; Mayo Foundation, Rochester, MN, USA) and an interactive touch-screen tablet 
(Cintiq 21UX; Wacom, Krefeld, Germany), then grouped to build a 3D image volume. Medial 
and lateral plateau surfaces were then defined by manually selecting boundary points. Each 
plateau was then realigned and reconstructed relative to “best-fit” planes passing through the 
defined boundary points (Matlab 2010b) for surface projection analyses. Previously defined 
boundary points were then manually adjusted (using knot points and natural cubic splines), to 
ensure that the analysis region did not overlay high-density cortical edges, the tibial spine, or 
osteophytes22, 162. 
 To allow for subject-to-subject comparisons, subject-specific depth was normalized based 
on user-defined depth, relative proximal tibia volume (volume superior to lateral inferior ridge of 
the proximal fibular head), and area (both lateral and medial plateaus) by using the following 
equation: 
 
where: volumess/volumem is a relative volume ratio defined by dividing each subject-specific 
proximal tibia volume by the mean proximal tibia volume	of all specimens, areass is the subject-
specific (segmented) area of the medial and lateral plateaus, aream is mean area of all subjects, d 
is the desired user-defined normalized depth (i.e., 2.5 mm), and dss is the actual subject-specific 
depth corresponding to the user-defined normalized depth162. 
 Regional analysis included total lateral and total medial plateau BMD, as well as average 
maximum BMD of a 10mm diameter core or ‘focal spot’ which searched each lateral and medial 
plateau for a maximum value22 (Figure 4.1). We included focal analyses to locate small regions 
of high density bone possibly masked by whole compartment analyses. All analyses were 
performed at three normalized depths of 0-2.5mm, 2.5-5mm, and 5-10mm from the subchondral 
surface.  
dss ⋅areass
d ⋅aream
= volumessvolumem
 45 
4.3.5. Internal Control 
We compared cortical cross-sectional area and density of the tibia shaft (66% of tibia length, 
proximal from distal tibia plateau)196 to assess possible between-group differences in local (e.g., 
mechanical loading) and systemic factors (e.g., nutrition, medication)200.  
4.3.6. Statistical Analysis 
To examine associations between nocturnal pain at night in bed and proximal tibial subchondral 
BMD, we used Spearman’s rank correlation. We report Spearman’s rank correlation coefficients 
(ρ) for all associations.  
 We categorized participants into three groups based on their WOMAC score of pain at 
night in bed. Patients with a score of 0 or 1 were considered to have ‘no pain’, patients with a 
score of 2 were considered to have ‘moderate pain’, and patients with a score of 3 or greater 
were considered to have ‘severe pain’140. To compare differences in proximal tibial subchondral 
BMD across patients with ‘no pain’ and patients experiencing either ‘moderate pain’ or ‘severe 
pain’ at night in bed, we used multivariate analysis of covariance (MANCOVA) and selected 
age, sex, and BMI as covariates200. We report the F-statistic for regions with significant between-
group differences. We also performed pairwise comparisons with Bonferroni adjustment for 
multiple comparisons to determine individual group differences between pain (‘severe pain’ and 
‘moderate pain’) and ‘no pain’ at each region. We report mean and standard deviation (SD), 
adjusted mean differences, and 95% confidence intervals. We also used MANCOVA to compare 
cortical cross-sectional area and density at the tibia shaft across pain groups, also adjusting for 
age, sex and BMI200. Statistical significance was defined as p<0.05, and statistical analyses were 
performed using SPSS 21.0 (IBM, Armonk, NY, USA).  
4.4. Results 
The characteristics of study participants are shown in Table 4-1. Patients had OA severity of KL 
grade ranging from 3 to 4. In the WOMAC assessment of non-weight bearing pain at night in 
bed, scores ranged from 0 (none) to 4 (extreme). Participants were divided into three groups 
based on pain at night in bed: ‘no pain’ (n=17), ‘moderate pain’ (n=16), and ‘severe pain’ (n=9).  
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Table 4-1. Background characteristics and clinical data for study participants and groups.  
Characteristic All Participants ‘No Pain’ 
(n=17) 
‘Moderate Pain’ 
(n=16) 
‘Severe Pain’ 
(n=9) 
WOMAC 
(in bed at night) 
 0 or 1 2 3 or 4 
Sex ratio (M:F) 17:25 7:10 7:9 3:6 
Age (mean ±SD) 64.1 ± 10.1 67.5 ± 9.1 61.8 ± 11.0 61.8 ± 9.3 
BMI ((mean ±SD) 28.7 ± 3.7 28.3 ± 4.1 29.1 ± 3.6 28.7 ± 3.0 
Side (L:R) 18:24 7:10 6:10 5:4 
OA Severity (KL) 3 to 4 3 to 4 3 to 4 3 to 4 
 
 Spearman’s rank coefficients showed a significant association between pain at night in 
bed and lateral focal BMD at a depth of 2.5-5mm from the subchondral surface (ρ = 0.388, 
p=0.011). There were no other significant associations between pain scores and other BMD 
metrics (Table 4-2).  
Table 4-2. Spearman rank correlation coefficients (ρ) for relationship between BMD 
measurements and WOMAC pain score while lying down. Bolded values indicate p<0.05. 
Side Region Depth from subchondral surface 
0-2.5mm 2.5-5mm 5-10mm 
Medial Total -0.284 (p=0.069) -0.244 (p=0.120) -0.218 
(p=0.165) 
Focal BMD -0.211 (p=0.181) -0.223 (p=0.157) -0.248 
(p=0.113) 
Lateral Total 0.290 (p=0.062) 0.301 (p=0.053) 0.203 (p=0.198) 
Focal BMD -0.156 (p=0.323) 0.388 (p=0.011) 0.290 (p=0.063) 
 
 After adjusting for covariates, there was a significant between-group difference in lateral 
focal BMD at depths of 2.5-5mm (F (2,36) = 3.915, p<0.05) and 5-10mm (F (2,36) = 3.258, 
p<0.05) from the subchondral surface. Individual group differences showed that participants with 
‘severe pain’ had higher lateral focal BMD than participants with ‘no pain’ at depths of 2.5-5mm 
(33% higher; adjusted mean difference: 114 mg/cm3; 95% CI: 9.6 to 218 mg/cm3; p=0.028) and 
5-10mm (32% higher; adjusted mean difference: 60 mg/cm3; 95% CI: 0.3 to 120 mg/cm3; 
p=0.049) (Table 4-4). There were no significant differences in regional BMD between groups at 
depths of 0-2.5mm from the subchondral surface, or at the total lateral or medial plateaus 
(Figures 4-1. and 4-2, Tables 4-3 and 4-4).  However, there was a statistically non-significant 
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trend for a lower BMD at the medial plateau (across all depths) across the groups with increasing 
pain (Figures 4-1 and 4-2, Tables 4-3 and 4-4).  
 At the tibial shaft, there were no significant differences in cortical cross-sectional area (F 
(2, 36)=0.208, p > 0.05) or density (F (2,36)=0.186, p >0.05) between groups. 
 
 
Figure 4-1. Representative topographical maps of tibial BMD at depths of 0-2.5mm (top row) and 2.5-
5mm (bottom row) in one participant reporting ‘no pain’, ‘moderate pain’, and ‘severe pain’ while lying 
down. Regional analysis includes average BMD of the lateral and medial plateaus, and average maximum 
BMD of a 10mm diameter focal spot (shown in upper left-hand image) localized on the maximum value 
of each lateral and medial plateau.  
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Figure 4-2. Adjusted mean regional BMD of each group (‘no pain’, ‘moderate pain’, and ‘severe pain’) at 
depths of 0-2.5mm, 2.5-5mm, and 5-10mm from the subchondral surface. Statistically significant 
differences (p<0.05) between groups are noted with brackets. Error bars represent 95% confidence 
intervals.   
 Table 4-3. Pair-wise comparison of tibial bone mineral density (BMD) measurements in patients with knee osteoarthritis with ‘no pain’ 
and ‘moderate pain’ while lying down, including mean ± standard deviation (SD), adjusted mean difference, percent difference from 
‘no pain’, 95% confidence interval (CI), and p-value.  
Region Depth 
BMD (mg/cm3 K2HPO4) Adjusted mean difference+ 
from No Pain (%) 
95% Confidence Interval 
(mg/cm3 K2HPO4) p-value No Pain Moderate Pain 
Mean ± SD Mean ± SD Lower Limit Upper Limit 
Medial Plateau        
Total 0-2.5 mm 480 ± 93 437 ± 116 -53 (-10.9%) -146 41 0.50 
 2.5-5 mm 322 ± 98 296 ± 91 -36 (-11.0%) -122 49 0.90 
 5-10 mm 203 ± 85 177 ± 61 -35 (-17.0%) -102 31 0.57 
Focal BMD 0-2.5 mm 658 ± 94 631 ± 108 -38 (-5.6%) -127 51 0.88 
 2.5-5 mm 499 ± 130 474 ± 123 -37 (-7.4%) -152 77 1.00 
 5-10 mm 347 ± 135 309 ± 94 -49 (-14.0%) -152 54 0.71 
Lateral Plateau        
Total 0-2.5 mm 339 ± 62 356 ± 112 19 (5.6%) -58 96 1.00 
 2.5-5 mm 198 ± 52 214 ± 80 17 (8.4%) -44 77 1.00 
 5-10 mm 127 ± 38 128 ± 45 0 (0%) -38 38 1.00 
Focal BMD 0-2.5 mm 596 ± 81 602 ± 124 11 (1.8%) -79 100 1.00 
 2.5-5 mm 352 ± 80 407 ± 120 61 (17.4%) -28 150 0.29 
 5-10 mm 193 ± 49 205 ± 60 15 (8.1%) -36 66 1.00 
+. Mean values adjusted for age (64.1), sex (1.6), and BMI (28.7).  
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 Table 4-4. Pair-wise comparison of tibial bone mineral density (BMD) measurements in patients with knee osteoarthritis with ‘no pain’ 
and ‘severe pain’ while lying down, including mean ± standard deviation (SD), adjusted mean difference, percent difference from ‘no 
pain’, 95% confidence interval (CI), and p-value. Bolded values indicate p<0.05. 
Region Depth 
BMD (mg/cm3 K2HPO4) Adjusted mean difference+ 
from No Pain (%) 
95% Confidence Interval 
(mg/cm3 K2HPO4) p-value No Pain Severe Pain 
Mean ± SD Mean ± SD Lower Limit Upper Limit 
Medial Plateau        
Total 0-2.5 mm 480 ± 93 406 ± 110 -76 (-15.8%) -186 33 0.27 
 2.5-5 mm 322 ± 98 251 ± 107 -74 (-22.7%) -174 26 0.22 
 5-10 mm 203 ± 85 154 ± 80 -54 (-25.8%) -132 24 0.28 
Focal BMD 0-2.5 mm 658 ± 94 595 ± 114 -66 (-9.9%) -170 39 0.37 
 2.5-5 mm 499 ± 130 399 ± 148 -102 (-20.3%) -237 33 0.20 
 5-10 mm 347 ± 135 258 ± 134 -90 (-25.7%) -211 30 0.21 
Lateral Plateau        
Total 0-2.5 mm 339 ± 62 427 ± 74 85 (25.1%) -6 176 0.07 
 2.5-5 mm 198 ± 52 261 ± 61 62 (31.2%) -10 133 0.11 
 5-10 mm 127 ± 38 150 ± 38 22 (17.5%) -22 66 0.64 
Focal BMD 0-2.5 mm 596 ± 81 652 ± 54 58 (9.7%) -47 163 0.53 
 2.5-5 mm 352 ± 80 461 ± 71 114 (32.7%) -10 218 0.028 
 5-10 mm 193 ± 49 249 ± 55 60 (31.6%) 0 120 0.049 
+. Mean values adjusted for age (64.1), sex (1.6), and BMI (28.7). 
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4.5. Discussion 
Our depth-specific imaging technique identified a positive association between lateral focal 
BMD at the 2.5-5mm depth and non-weight bearing pain at night in bed. Isolated comparisons 
identified higher lateral focal BMD at depths 2.5-5mm and 5-10mm from the proximal tibial 
subchondral surface in patients experiencing ‘severe pain’ than in patients experiencing ‘no pain’ 
at night in bed. This is the first study to assess the relationship between depth-specific proximal 
tibial subchondral BMD and symptomatic OA. These findings suggest that there may be 
previously overlooked characteristics in proximal tibial subchondral BMD, such as focal BMD at 
depths greater than 2.5mm from the subchondral surface, which may have a role in OA-related 
pain pathogenesis. 
 The results of this study give some insight into why the results from previous studies 
linking OA-related knee pain and proximal tibial subchondral bone density are conflicting. One 
study found an association between high aBMD and pain158, where another found a relationship 
between low aBMD and pain149. The reasons for disagreement may be due to inherent limitations 
of DXA. For example, patient size and positioning sensitivities may affect aBMD measurements 
whereby larger and malpositioned patients have more bone in the projection direction, resulting 
in an overestimation of aBMD157. Also, there are no standardized regions of interest (ROI) with 
DXA to evaluate proximal tibial subchondral aBMD, with ROIs varying in size and placement 
from study to study139, 149, 150, 201. These ROIs most likely contain both subchondral cortical and 
trabecular bone. The results of this study suggest that sites distal to the subchondral surface 
(which contain primarily trabecular bone) appear to be most affected by OA. As such, aBMD 
measures containing both subchondral cortical and trabecular bone may not be sensitive enough 
to capture OA-effects on local bone density. Conversely, by evaluating BMD at specific depths 
from the subchondral surface, the depth-specific imaging technique used in this study was able to 
approximate individual effects of OA on regions composed of mostly mineralized subchondral 
cortical bone (0-2.5 mm layer) and trabecular bone (2.5-5 and 5-10 mm layers).  
 Another possible reason for disagreement between higher and lower aBMD and pain may 
be because previous studies reporting aBMD appear to have evaluated entire compartments of 
the proximal tibia149, 158. This study found no associations between pain severity and BMD at the 
total lateral or medial plateau. Instead, our findings suggest that pain may be related to localized 
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BMD differences15, as indicated by the higher lateral focal ‘spot’ BMD in patients with ‘severe 
pain’ versus ‘no pain’ at depths of 2.5-5mm and 5-10mm from the subchondral surface. Further 
investigations, with depth-specific imaging techniques capable to measure localized regional 
BMD, are needed to clarify the possible role of local subchondral bone density in OA-related 
pain.  
 Our results show higher BMD at the lateral plateau and a tendency for lower BMD at the 
medial plateau and as pain severity intensifies. These observations may be due to cyst presence 
and associated knee alignment. First, cyst presence may have been indirectly captured as low 
BMD measures, especially in the medial plateau. In this study, 78% of the individuals with 
‘severe pain’ had CT evidence of cysts of moderate size and number, focused predominately in 
the medial plateau. Conversely, only 12% of the individuals with ‘no pain’ had radiographic 
evidence of cysts of similar size and number. Interestingly, our regional BMD measures 
appeared to indirectly reflect cyst size and number. Second, patients with severe pain appear to 
have altered joint alignment. Of the 9 knees with severe pain, 44% had valgus alignment and 
33% had evidence of joint laxity with medial shifting of the femur relative to the tibia. 
Conversely, of the 17 knees with no pain, most were in either varus (71%) or neutral alignment 
(24%), with only 1 knee in valgus. This malalignment could result in loading-induced adaptation 
and lower medial BMD and higher lateral BMD28, 201, 202. This malalignment may a consequence 
of advancing disease progression203 or a consequence of self-adjusted joint alignment to help 
alleviate joint pain caused by other factors, such as medial cyst presence. Given that the lateral 
compartment has a smaller contact area then the medial compartment, and higher associated 
contact and interosseous stresses, it is possible that patients with valgus alignment are simply 
more susceptible to severe knee pain. It is possible that higher lateral BMD has influenced local 
innervation191, 192, leading to pain. Though, as noted earlier, observed higher lateral BMD may be 
a secondary effect caused by medial cyst presence.  
Cyst findings generate an interesting hypothesis to explain why individuals with ‘severe 
pain’ had a trend for lower medial bone density than individuals with ‘no pain’. Severe pain may 
be partly due to greater bone resorption and necrotic cyst development, both manifesting as low 
BMD. The ‘bony contusion theory’ 127, 128 proposes that excessive loading or trauma causes 
trabecular micro fractures, necrotic bone and focal bone resorption, eventually resulting in cyst 
development near the subchondral bone surface. Inflammatory macrophages within the lining of 
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cysts are capable of forming into osteoclasts 204, which could promote further bone resorption 
and cyst expansion 205. Bone surrounding cysts have been reported to be necrotic and lacking of 
blood vessels or normal marrow components206, which could contribute to pain207, 208. Local 
subchondral bone cyst presence is also thought to increase intra-osseous stress distributions, 
leading to pain and disability131. Further research is needed to isolate cysts from surrounding 
subchondral bone to investigate this hypothesis further. 
 Strengths of this study include sample characteristics, the use of an internal control, 
normalization of our depth-specific measurements, and the use of a validated imaging technique. 
Our study sample was a homogeneous group of patients with similar OA severity and known 
covariates (age, sex, and BMI) between pain groups, possibly reducing the effect of possible 
confounding factors affecting BMD and pain. Also, we used tibial shaft cortical area and density 
measurements to account for possible between-group differences in systemic and/or local factors 
that may be associated with subchondral BMD. All BMD measurements were normalized 
according to mean proximal tibial volume and plateau surface area, and all imaged volumes were 
rotated and reoriented in similar 3D orientations relative to manually selected landmark 
boundary points and best-fit planes. This permitted reliable comparisons between groups. Lastly, 
we used a validated precise depth-specific image processing technique to assess plateau and local 
BMD22. The observed differences in local BMD between ‘severe pain’ and ‘no pain’ groups 
were ~7x greater than associated precision errors22, and are therefore trustworthy.  
 This study has certain limitations. First, pain severity and assessment was based on the 
entire knee joint, including all joint surfaces (tibiofemoral and patellofemoral) and tissues (e.g., 
bone, menisci, synovium), and it is uncertain if pain originated at the proximal tibial surface, 
other tissues, or a combination of surfaces and tissues. Second, although OA severity was 
homogeneous throughout study participants, all were in late stages of OA and it may not be 
possible to apply our findings to patients with less severe OA. Larger longitudinal studies, with 
participants at varying stages of OA, should be completed to confirm our findings and clarify the 
relationship between BMD and OA-related pain, particularly nocturnal pain.  
4.6. Conclusion 
Depth-specific imaging techniques demonstrated higher lateral maximum focal BMD in patients 
with “severe pain’, compared to patients with ‘no pain’ at night in bed, at depths of 2.5-5mm, 
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and 5-10mm from the proximal tibial subchondral surface. This study suggests that deep 
subchondral bone layers, as opposed to the bone immediately adjacent to the subchondral 
surface, may have a role in OA-related pain pathogenesis. 
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5. EPIPHYSEAL AND METAPHYSEAL BMD AND PAIN 
5.1.  Synopsis 
This chapter outlines details of our study investigating relationships between proximal tibial 
epiphyseal and metaphyseal BMD and WOMAC pain in patients with knee OA. In this study, we 
report that higher total WOMAC pain is associated with lower total metaphyseal and epiphyseal 
BMD, as well as lower medial epiphyseal BMD. This study suggests that lower proximal tibial 
trabecular BMD may have a role in OA-relates pain pathogenesis.  
5.2.  Introduction 
Knee OA is a debilitating and painful disease characterized by changes in cartilage and 
subchondral bone. Pain is a complex combination of social, psychological and biological 
factors72; and is often the primary sign that a patient may be afflicted with OA2. Unfortunately, 
the local biological pain pathogenesis within the knee joint is poorly understood185 as it could be 
related to many structural factors (e.g., altered joint alignment91, BMLs78, cyst presence106). Knee 
OA is commonly characterized by altered subchondral properties, including altered subchondral 
bone thickness187, bone volume fraction188, and BMD24. Importantly, altered BMD may disrupt 
local innervation192 and/or the local mechanical behaviour of bone193, and thus may be a factor in 
OA-related knee pain.  
 To date, research investigating associations between OA-related knee pain and bone has 
focused primarily on bone near the subchondral surface (e.g., subchondral cortical and 
subchondral trabecular bone)158, 209. Adjacent trabecular bone (e.g., epiphyseal bone, 
metaphyseal bone) is also affected by OA24, with observations of thinner trabeculae, lower bone 
volume fraction, and lower density with progressing OA severity23, 190, 210. To date, there are no 
studies reporting relationships between epiphyseal or metaphyseal trabecular BMD and pain. A 
recent FE study conducted by Amini et al.166 has suggested that low epiphyseal trabecular bone 
density in OA23, 190, 210 , which is directly linked to the elastic modulus of epiphyseal bone211, 
may explain OA proximal tibiae being less stiff than normal166. Importantly, a less stiff proximal 
tibia would result in higher bone deformation potentially explaining (at least to some degree) 
OA-related knee pain.  
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 A clear understanding of pain pathogenesis is crucial for rational therapeutic targeting122. 
Further, as pain is the reason patients seek medical care, rational treatment targeting requires 
specific understanding of which structures contribute to pain122. With the aim of furthering our 
understanding of potential factors that my influence knee pain, the objective of this study was to 
investigate relationships between proximal tibial epiphyseal and metaphyseal trabecular BMD 
and OA-related knee pain.  
5.3. Methods 
5.3.1. Study Participants 
Forty-two participants (17M: 25F; mean age 64, SD ± 10.1 years; mean BMI 28.7 ± 3.7; 18L: 
24R) with OA were recruited prior to TKR209. Study exclusion criteria included: pregnant 
women, patients having a revision replacement instead of primary knee replacement, and patients 
with a prior history of bone pathology at the knee joint. The Institutional Research Board of the 
New England Baptist Hospital approved the study. Informed consent was obtained from all study 
participants.  
5.3.2. Participant Assessment  
OA severity was classified using KL scoring59; participants ranged in severity from scores of 2 to 
4. Pain severity was measured at the affected knee joint using the pain subsection of WOMAC75. 
Participants were asked to assess the level of pain in the affected knee joint within the past 24-
hours while walking on a flat surface, going up or down stairs, nocturnal pain at night in bed, 
sitting or lying down, and standing upright using a 5-point Likert scale (0 to 4). Individual 
element pain scores were then summed for a possible WOMAC pain score of 20. Summed pain 
scores ranged from 4 to 16. We also used the Self-Administered Comorbidity Questionnaire212 to 
assess participants for any potential confounding comorbidities (e.g., diabetes, heart disease).  
5.3.3. CT Acquisition 
We used a single energy clinical CT scanner (Lightspeed 4-slice, General Electric, Milwakee, 
WI, USA) for bone imaging. A solid QCT reference phantom of known bone mineral densities 
(Model 3T, Mindways Software Inc., Austin, TX, USA) was placed under the participants and 
included in all CT scans. Participants were oriented supine within the CT gantry and both legs 
were simultaneously scanned. Scans included the distal femur, patella, proximal tibia, and the 
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66% tibial shaft site proximal to the distal tibial end-plate196. Only the proximal tibia and the 
66% tibial shaft site were used in the current analysis.  
 CT scanning parameters included: 120kVp tube voltage, 150mAs tube current-time 
product, axial scanning plane, 0.625mm isotropic voxel size (0.625 slice thickness, 0.625mm x 
0.625mm in-plane pixel size), ~250 slices, ~60s scan time. A standard bone kernel (BONE) was 
used for CT image post-processing. Effective radiation dose was ~0.073mSv per scan, estimated 
using shareware software (CT-DOSE, National Board of Health, Herley, Denmark). For 
comparison, the average effective radiation dose during a transatlantic flight from Europe to 
North America is about 0.05mSv197.  
5.3.4. CT Image Analysis 
We used a custom algorithm, developed specifically for this study, (Matlab 2010b; MathWorks, 
Natick, MA, USA) combined with manual segmentation to determine epiphyseal and 
metaphyseal trabecular BMD. We considered the epiphyseal region (subarticular region) as the 
proximal tibial volume between the subchondral surface and the epiphyseal line41. A single user 
(WDB) performed all segmentations and analyses. As this algorithm was developed specifically 
for this study, we assessed repeatability in a precision study performed on an independent sample 
of healthy participants and participants with OA22 using recommended methods213. In summary, 
14 participants were scanned 3 times with repositioning between each scan (42 scans, 28 degrees 
of freedom (DOF)). The repeatability expressed as precision error, of each BMD measurement 
was assessed using root mean square coefficients of variation (CV%) and ranged from 0.7% to 
3.6%.  
 To derive BMD, grayscale HU were converted to equivalent volumetric BMD (mg/cm3 
K2HPO4) using subject-specific linear regression equations developed from known densities 
ranging from -50 to 375 mg/cm3 K2HPO4 within the QCT phantom included in each individual 
axial image (r2>0.99)162 and interpolation to determine equivalent volumetric BMD values. 
Higher density values were linearly extrapolated. (Figure 5-1A). Subject-specific half maximum 
height thresholds199 were then determined to define the proximal tibial subchondral and cortical 
surfaces. Two 3D image volumes were built, one including the entire proximal tibia as 
previously described162, 209 and another by segmenting individual serial images using semi-
automatic region growing and manual correction at the epiphyseal line (Figure 5-1B). Both sets 
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of imaged volumes were segmented using commercial software (Analyze10.0; Mayo 
Foundation, Rochester, MN, USA) and an interactive touch-screen tablet (Cintiq 21UX; Wacom, 
Krefeld, Germany). Imaged volumes were reoriented to a neutral position where medial and 
lateral plateaus were approximately parallel. We then divided the imaged volumes into medial 
and lateral compartments, measured by using 40% of the maximum medial-lateral axis of each 
respective side23 (Figure 5-1C).  
To ensure that trabecular BMD measures did not include cysts (which would lead to 
arbitrarily low measures of BMD)209, 214 or peripheral high density cortical bone, the most 
proximal 7.5 mm region (relative to the subchondral surface) was removed from the 
segmentations (Figure 5-1D), as was 2.5 mm of peripheral cortical bone (Figure 5-1D). The 7.5 
mm depth was based upon observed cyst locations from our earlier work209, 214 and work by 
Chiba et al.18, which limited depth analyses to 5 mm from the subchondral surface. In extreme 
cases, large cysts extended from the subchondral cortical region (0-2.5mm) through the 
subchondral trabecular region (2.5-5mm) and occasionally into depths greater than 5mm from 
the subchondral surface. By using a conservative 7.5mm depth from the subchondral surface, we 
ensured the exclusion of large cysts from our analysis. Following material removal, we measured 
epiphyseal trabecular BMD from the 7.5mm depth to the epiphyseal line (Figure 5-1E), which 
was located approximately 15 mm from the subchondral surface. Metaphyseal trabecular BMD 
was measured 10mm distal to the epiphyseal line (Figure 5-1E).  
We included cortical BMD of the tibia shaft (66% of tibia length, proximal from distal 
tibia plateau)196 to assess whether associations with pain were systemic or joint-specific. More 
specifically, if similar associations between pain and BMD were observed at the proximal tibia 
and tibial shaft, this would indicate systemic effects with low BMD being a plausible secondary 
effect of other factors, such as mechanical loading, nutrition or medication200. Tibial shaft 
cortical BMD was segmented using subject-specific half-maximum-height thresholds, and 
measured using commercial software (Analyze10.0; Mayo Foundation, Rochester, MN, USA).  
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Figure 5-1. Methodological process consists of converting CT grayscale intensities to BMD using a QCT 
reference phantom (A), followed by building two imaged volumes for each tibia, one with manual 
correction at the epiphyseal line and one using the full tibia (B). Imaged volumes were divided into lateral 
and medial regions (C), then the outer 2.5mm and subchondral 7.5mm depth were removed from each 
imaged volume (D). BMD measurements included epiphyseal BMD between the epiphyseal line and 
7.5mm from the subchondral surface and metaphyseal BMD 10mm distal from the epiphyseal line (E).  
 
5.3.5. Statistical Analysis 
We first checked all underlying assumptions for multiple linear regression (assumptions of linear 
relationships, homoscedasticity, independency and normality of residuals) using standardized 
residual scatter plots, P-P plots, and histograms215. We identified any outliers using modified 
Thompson tau (τ) test216.  
 We illustrated univariate associations between pain and BMD using scatter plots and 
reporting coefficients of determination (R2) for linear regression. We used hierarchical multiple 
regression analyses to explain the variance in total WOMAC pain. We selected age, sex, and 
BMI as covariates for our base model based on observed correlation in univariate analysis (age) 
and literature (age, sex, and BMI) evaluating relationships between BMD and pain149, 158. All 
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BMD measurements (total and regional epiphyseal BMD, total metaphyseal BMD, and tibial 
shaft cortical BMD) were individually added to our base model. We assessed multicollinearity 
between all independent variables in each model using variance inflation factor (VIF), setting the 
maximum tolerance value as 10. We report adjusted R2, change in R2 from the base model (Δ), 
standardized beta (β)-coefficients, and p-values. Statistical significance was defined as p<0.05, 
and analyses were performed using SPSS 21.0 (IBM, Armonk, NY, USA). 
5.4. Results 
Characteristics of all study participants, including age, sex, BMI, KL grades, joint space 
narrowing score (JSN), non-weight-bearing alignment scores, and BMD measures are shown in 
Table 5-1. Unadjusted relationships between total WOMAC pain and total or regional epiphyseal 
or metaphyseal BMD measurements are presented in Figure 5-2. As per the modified Thompson 
τ test216, we identified a single outlier based on total WOMAC pain score with a τ-value outside 
of the sample’s rejection zone (τ >5.56), and removed it from the analysis. All underlying 
assumptions for linear regression were appropriately met. There was no evidence of 
multicollinearity between independent variables in any of our models.  
 Regression models predicting variance in pain are presented in Table 5-2. After adding 
total epiphyseal BMD to the base model, (of age, sex, and BMI) the coefficient of determination 
(R2) in total pain improved (ΔR2=0.13). Our models improved when medial epiphyseal BMD 
(ΔR2=0.14) and metaphyseal BMD (ΔR2=0.13) were independently added to our base model. 
There was no association between cortical BMD at the 66% tibial site and pain.   
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Table 5-1. Descriptive statistics for background characteristics of study participants. 
Characteristic Without outlier (n=41) 
Age (mean ±SD) 64.1 ± 10.2 
Sex (M:F) 17:24 
BMI (mean ±SD) 28.6 ± 3.7 
Side (L:R) 17:24 
OA Severity (KL) (0/1/2/3/4) 0/0/2/19/18 
WOMAC Score 9.7 ± 2.8 
Medial Joint Space Narrowing (0/1/2/3/4) 0/6/9/24* 
Lateral Joint Space Narrowing (0/1/2/3/4) 30/5/0/4* 
Non-weight-bearing alignment 27 varus, 6 neutral, 8 valgus 
Total epiphyseal BMD, mg/cm3 K2HPO4 (mean ±SD) 106 ± 37 
Lateral epiphyseal BMD, mg/cm3 K2HPO4 (mean ±SD) 106 ± 34 
Medial epiphyseal BMD, mg/cm3 K2HPO4 (mean ±SD) 141 ± 68 
Total metaphyseal BMD, mg/cm3 K2HPO4 (mean ±SD) 90 ± 36 
*JSN scores not available for 2 participants.  
 
Figure 5-2. Scatter plots and coefficients of determination (R2) of the relationships between total 
WOMAC score and A) total epiphyseal BMD (p=0.040), B) lateral epiphyseal BMD(p=0.187), C) medial 
epiphyseal BMD (p=0.015), and D) total metaphyseal BMD (p<0.009). The single outlier is noted as a 
circle, and was not included in the bivariate analysis.  
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Table 5-2. Adjusted coefficients of determination (R2), standardized beta coefficients (β), and 
level of significance (p) of the base model (age, sex, and BMI) and change in base model R2 (Δ) 
when including bone mineral density (BMD) at the total and regional proximal tibia to predict 
variance in total WOMAC pain. Significant R2, Δ, and β are bolded.  
  Total WOMAC 
  R2 β p-value 
Base Model  0.16  0.023 
 Age  -0.41 0.011 
 Sex  0.19 0.206 
 BMI  0.12 0.448 
     
Total epiphyseal  0.27  0.004 
 Δ 0.12  0.017 
 Age  -0.41 0.006 
 Sex  0.08 0.572 
 BMI  0.18 0.242 
 BMD  -0.37 0.017 
     
Lateral epiphyseal  0.19  0.020 
 Δ 0.05  0.140 
 Age  -0.40 0.011 
 Sex  0.145 0.338 
 BMI  0.16 0.308 
 BMD  -0.23 0.140 
     
Medial epiphyseal  0.30  0.002 
 Δ 0.15  0.006 
 Age  -0.39 0.008 
 Sex  0.12 0.388 
 BMI  0.19 0.186 
 BMD  -0.40 0.006 
     
Total metaphyseal  0.27  0.004 
 Δ 0.12  0.017 
 Age  -0.35 0.019 
 Sex  0.12 0.416 
 BMI  0.15 0.302 
 BMD  -0.35 0.017 
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5.5. Discussion 
Our regression models suggested that tibial epiphyseal and metaphyseal BMD independently 
explained variance in total pain in OA patients prior to TKR, where patients with lower 
epiphyseal and metaphyseal BMD tended to have higher levels of pain. Regionally, our models 
indicated that medial epiphyseal BMD was a significant predictor of total OA-related pain, again 
where lower BMD was associated with higher levels of pain. This is the first study to assess the 
relationship between tibial epiphyseal and metaphyseal BMD and pain in a sample of patients 
with clinically assessed OA using clinical QCT. These findings suggest that there may be 
potentially overlooked characteristics in proximal tibial BMD, such as trabecular BMD, which 
may have a role in OA-related pain pathogenesis.  
 Study findings support our previous work (using the same cohort), which investigated 
links between OA-related nocturnal pain and subchondral cortical and subchondral trabecular 
bone near the subchondral surface (0-10mm from the surface). This previous study found a 
(nonsignificant) trend for low medial BMD209 in patients with severe nocturnal pain, which is in 
agreement with study findings of low medial epiphyseal, total epiphyseal and metaphyseal BMD 
in patients with high levels of pain. We209, and others214, however questioned whether our 
previously observed trend for low medial BMD was due to cyst presence or diminished bone 
architecture and/or mineralization. Subsequent follow-up analyses indicated that both cyst 
presence and BMD were independently associated with pain217. The novelty of this study was 
that we focused our analyses in epiphyseal and metaphyseal trabecular regions largely void of 
cysts to determine any potential independent associations between BMD and pain.  
 Of note, study findings both support and contrast with the previous study which also 
identified high lateral focal BMD in the subchondral trabecular region (2.5-10mm below surface) 
of patients with severe nocturnal pain209. High lateral focal BMD may be explained by BML 
presence, chondroprotection, or altered loading. First, prior research with this cohort identified a 
positive association between nocturnal pain and bone marrow lesion (BML) presence140. Given 
that BMLs have higher local BMD than surrounding bone tissue15, a positive association 
between nocturnal pain and BMD is foreseeable. Future research needs to evaluate whether high 
focal BMD measures exactly overlay BML locations. Second, high lateral focal BMD may be a 
consequence of chondroprotection developed via low trabecular bone density. To explain, recent 
finite element (FE) simulations indicated that reduced proximal tibial trabecular bone density 
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results in lower subchondral bone stiffness166 and lower cartilage stresses167, the latter 
presumably due to improved congruence between articulations218. As many of the study 
participants had evidence of medial OA, low trabecular BMD may be a physiologic response to 
lower medial cartilage stresses. At the same time, this chondroprotective process would also 
naturally transfer more load to the lateral compartment since the two compartments function in 
parallel. This altered loading should result in loading-induced adaptation; specifically, higher 
lateral BMD near the subchondral surface to meet the mechanical demands of higher load 
transmission. Third, many of the study participants with evidence of medial OA may be self-
altering their knee kinematics and stance to off-load the medial compartment, with the aim of 
alleviating joint pain. This altered loading could result in loading-induced adaptation with higher 
lateral BMD and lower medial BMD28. Fourth, as higher BMD appears to be focused in 
subchondral regions (<10mm from the tibial surface)209, joint load may be primarily transferred 
through the subchondral cortical endplate and subchondral trabecular bone to the peripheral 
cortex, off-loading epiphyseal and metaphyseal trabecular bone, thus explaining lower BMD 
found in these regions. However, this explanation warrants further research given that we did not 
find associations between pain and alignment217. Studies using subject-specific FE modeling are 
needed to investigate load transmission as well as subchondral bone stiffness at different stages 
of pain severity and disease progression.  
 By removing adjacent cortical bone and isolating trabecular BMD, we were able to focus 
on the potential mechanical relationship between low epiphyseal trabecular BMD and high OA-
related pain. As noted earlier, a recent FE study166 suggested that low epiphyseal trabecular bone 
density observed in OA23, 190, 210 results in lower stiffness of OA proximal tibiae166. Less stiff 
trabecular bone could be subject to higher strain, deformation, and flexibility. Pain may result 
from potential micro-fractures or through a more flexible structure which may disturb local 
innervation192. These results suggest that epiphyseal trabecular bone may be just as important in 
OA-related pain pathogenesis as the more commonly examined subchondral bone.  
 This study has various strengths to consider. First, our study sample comprised of a 
homogeneous group of OA patients of similar age and BMI, as well as similar OA status, 
possibly reducing possible confounding factors affecting BMD and pain. Second, we used 
clinical QCT imaging to measure relationships between tibial epiphyseal BMD and OA-related 
pain. Our 0.625mm isotropic voxel size and the ability to build an imaged volume of the entire 
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proximal tibia allows for 3D measurements of larger regions previously not available using other 
imaging modalities such as pQCT or fractal signature analysis (FSA). Third, even with manual 
correction along the epiphyseal line, all precision errors associated with our segmentation and 
image-processing techniques were all under 5%.  
 This study has certain limitations. First, pain severity and assessment was based on the 
entire knee joint, including all joint surfaces (tibiofemoral and patellofemoral) and tissues (e.g., 
bone, menisci, synovium), and it is uncertain if pain originated within the proximal tibial bony 
structure, other tissues, or a combination of tissues. Second, although OA severity was 
homogeneous throughout study participants, all were in late stages of OA and it may not be 
possible to apply our findings to patients in early stages of OA. Third, our study sample size was 
small (n=41). Further analysis with larger samples including healthy participants and participants 
with various stages of OA severity and pain, are needed to verify these preliminary study 
findings. Of note, our sample was comprised of participants with severe OA (primarily with KL 
scores of 3 to 4). This limited range constrained our ability to include it in the statistical model. 
Also, with a basic rule of a minimum of 10 events (or samples) per predictor219, we were limited 
to four predictors (independent variables) in each model: one independent variable (BMD) and 
three covariates (age, sex, BMI), and thus could not add additional known predictors of pain to 
our statistical analysis (e.g., smoking/alcohol history, activity level, mental health status, specific 
medications). Of note, we attempted to account for possible differences in physical activity 
(mechanical loading/unloading) through usage of cortical BMD measures at the 66% tibial shaft 
site. Previous works have noted differences in tibial shaft cortical BMD between highly active 
individuals (e.g., sprinters, endurance runners, triple- and high-jumpers, hurdlers) and less active 
controls220. However, in this study, we did not note any associations between pain and tibia shaft 
cortical BMD, potentially indicating, at least to some degree, similar levels of activity and 
mechanical loading amongst study participants. Fourth, in our interpretation of the effect of 
mechanical stiffness on OA-related knee pain, we have presumed that low epiphyseal and 
metaphyseal BMD is indicative of low proximal tibial bone stiffness. This presumption is based 
on a recent FE simulation study166 and established relationships between bone density and elastic 
modulus211. Further research is needed using subject-specific FE modeling to directly investigate 
potential links between knee pain and proximal tibial mechanical behaviour (e.g., stiffness, 
stress/strain distribution). Fifth, our 0.625mm isotropic voxel size prevented assessment of 
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trabecular microarchitecture and limited us measures of volumetric BMD. Accordingly, it is 
unclear if low BMD is due to trabecular thinning or wide trabecular spacing. For future research, 
it would be advantageous to investigate links between pain and trabecular micro-architecture 
with advanced texture analysis and smaller voxel sizes188.  
It is worthwhile noting that we present statistically significant relationships as opposed to 
clinically significant relationships. As a statistically significant relationship does not measure the 
clinical effect of a result221, it is important to consider the clinical effect that changes in 
epiphyseal or metaphyseal BMD may have on OA-related knee pain. According to Angst et 
al.222, the minimal clinically important difference for OA-related pain is a change in WOMAC 
score greater than 6% of its maximum value (which is 20 for WOMAC). In other words, a 
change in pain will not be perceived unless the WOMAC score changes by 1.2 points. With this 
in mind, we can identify the BMD change that will correspond with a 1.2-point pain change. 
Based on our model, a 44 g/cm3 reduction in epiphyseal or metaphyseal BMD will be marked by 
a perceived change in pain status. Assuming an average BMD of 100 g/cm3 for epiphyseal and 
metaphyseal bone, this would equate with ~50% change in density. Accordingly, a rational 
therapeutic approach would be to monitor bone while simultaneously striving to maintain bone 
and limit bone loss. Density changes in these regions could be monitored using QCT, dual 
energy-absorptiometry (DXA) or x-ray. With regards to maintaining bone, potentially, this could 
be achieved through exercise interventions or pharmacological therapies. Our preliminary 
findings may also be clinically important for TKR preparation and planning. Patients with low 
pre-operative BMD have been shown to be at higher risk of implant failure by loosening or 
migration223, higher risk for revision surgery224, and risk of failure following revision 
procedures224. Current tibial implant design components typically include a single central post, 
which is inserted through the tibial epiphysis and extends into the tibial shaft. Based on our 
findings, there may be low quantities of bone stock in individuals with higher levels of OA-
related pain, potentially placing them at risk for inadequate osseointegration and implant 
fixation225 and possibly implant loosening226. As there is an expected normal decrease in tibial 
BMD during healing227, reduced amounts of tibial epiphyseal bony support structure prior to 
TKR could compromise implant fixation and success in early stages, potentially compromising 
long-term implant success. It may be beneficial to use imaging and complementary image-
processing techniques to evaluate pre-operative bone density, especially in the commonly 
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overlooked tibial epiphyseal and metaphyseal regions, to compliment customized surgical 
approaches in patients with higher levels of pain.  
5.6. Conclusion 
In our study, low tibial epiphyseal and metaphyseal BMD, as well as low medial epiphyseal 
BMD, was associated with OA-related pain in patients prior to TKR. This study suggests that 
there may be overlooked characteristics within trabecular bone that may be related to OA-related 
pain pathogenesis. These preliminary findings from current and previous studies209 may be 
valuable in guiding outcome selection in OA studies addressing subchondral bone and pain, 
particularly in determining regions of interest of the proximal tibia for potential epidemiological 
studies.  
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6. SUBCHONDRAL CYSTS AND PAIN 
6.1.  Synopsis 
This chapter outlines details of our study investigating relationships between proximal tibial 
cysts parameters and clinical characteristics of OA (alignment, joint space narrowing, OA 
severity, WOMAC pain) and subchondral BMD in patients with knee OA. In this study, we 
report that at the lateral region, greater cyst number and greater cyst volume are associated with 
higher subchondral BMD, valgus alignment, and lateral joint space narrowing. We also report 
that pain and OA severity were not associated with any evaluated cyst parameters. This study 
suggests that there may be disease-associated changes in tibial loading distribution leading to 
cyst development and further joint deterioration in patients with painful severe OA.  
6.2. Introduction 
Knee OA is a painful and debilitating disease characterized by cartilage deterioration and altered 
subchondral bone. Recently, there has been increasing interest in the role of subchondral bone 
cysts in OA progression; in particular how subchondral bone cysts may influence pain9, 209, 217, or 
how subchondral bone cysts influence subchondral bone mechanical behaviour131. 
 Subchondral cysts are typically spherical or ellipsoidal cavities within the subchondral 
bone region and are related to both altered subchondral bone and cartilage degeneration in 
patients with OA17, 18, 228. Recent studies have indicated associations between subchondral bone 
cysts and pain9 as well as BMLs in patients with knee OA228, though, evidence of relationships 
between cysts and other patient characteristics (e.g., disease severity, joint space narrowing, 
alignment) is limited. A clear understanding of disease pathogenesis is crucial for rational 
therapeutic targeting122, particularly understanding of which structures contribute to pain122. As 
subchondral cysts are related to many elements in the progression of OA206, 229, it is meaningful 
to investigate and improve our understanding OA subchondral bone cysts in patients with knee 
OA using clinical imaging tools and to determine if cyst parameters, specifically number and 
size are related to disease severity and pain.  
 It is believed that subchondral cyst presence promotes higher localized stress131, which 
could stimulate bone remodelling or bone alterations. Ex vivo studies at both the hip using HR-
QCT18, and the tibia using micro-CT17 report changes in BMD, especially in regions adjacent to 
cysts. These ex vivo studies are able to evaluate cyst number and size, but are not able to 
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correlate cyst properties with important clinical symptoms such as pain. Clinical techniques, such 
as MRI and QCT have the potential to offer 3D characterizations of cyst structure. Using MRI 
techniques, cysts can be distinguished from other bony features, such as BMLs106, 230, but it is 
difficult to reliably quantify BMD. Clinical QCT has potential to characterize cysts in vivo, to 
explore relationships with clinical OA symptoms (such as pain), to determine tibial BMD, and 
could potentially be used to evaluate 3D cyst development throughout disease progression to 
determine the role of cysts in OA. However, it is unclear which specific cyst parameters (e.g., 
number, size) are associated with clinical symptoms, and which parameters are associated with 
BMD.  
 The objective of this study was to use QCT and image-processing techniques to 
determine relationships between subchondral cyst parameters and subchondral BMD as well as 
clinical characteristics of OA (OA severity, OA-related pain, alignment, joint space narrowing) 
in patients with knee OA. 
6.3. Methods 
6.3.1. Study Participants 
Forty-two participants (17M: 25F; mean age 64, SD ± 10.2 years; mean BMI 28.6 ± 3.7; 
18L:24R) with OA were recruited before total knee replacement. Study exclusion criteria 
included: pregnant women, patients having a revision replacement instead of primary knee 
replacement, and patients with a prior history of bone pathology at the knee joint. The 
Institutional Research Board of the New England Baptist Hospital approved the study. Informed 
written consent was obtained from all study participants.  
6.3.2. Participant Assessment  
OA severity was classified using KL scoring59 on standardized radiographs. Participants ranged 
in severity from scores of 2 to 4. We included medial and lateral joint space narrowing (JSN), as 
a surrogate measure of lateral or medial cartilage degradation, and CT-measured knee alignment 
in our analysis. Knee alignment was categorized as varus, neutral, or valgus and measured using 
coronal and sagittal CT reconstructions to determine an estimate of mechanical alignment217. In 
brief, medial and lateral joint space widths were evaluated at equal distances from the tibial spine 
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permitting an estimation of alignment between the femoral and tibial axes. Neutral alignment 
was defined as 176 to 180°, and malalignment of ± 2° from the neutral position was considered 
as either varus (-2°) or valgus (+2°)217. For this analysis, alignment was treated as a categorical 
variable, where participants exhibited either varus (-1), neutral (0), or valgus (1) alignment. Pain 
severity was measured at the affected knee joint using the pain subsection of the WOMAC75. 
Participants were asked to assess the level of pain in the affected knee joint within the past 24-
hours while walking on a flat surface, going up or down stairs, lying down in bed at night, sitting 
or lying down, and standing upright using a 5-point Likert scale (0 to 4). Individual element pain 
scores were then summed for a possible total WOMAC pain score of 20, with scores ranging 
from 4 to 14. We also included pain lying down in bed at night (nocturnal pain), scored from 0 
(none) to 4 (extreme) as a patient characteristic to correspond with our earlier work evaluating 
pain and subchondral BMD209 We used the Self-Administered Comorbidity Questionnaire212 to 
assess participants for any potential confounding comorbidities (e.g., diabetes, heart disease). 
6.3.3. QCT Acquisition 
We used a single energy clinical CT scanner (Lightspeed 4-slice, General Electric, Milwaukee, 
WI, USA) for bone imaging. A solid QCT spine reference phantom of known bone mineral 
densities (Model 3T, Mindways Software Inc., Austin, TX, USA) was included in all CT scans. 
Participants were oriented supine within the CT gantry and both legs were simultaneously 
scanned. Scans included the distal femur, patella, proximal tibia, but only the proximal tibia was 
analyzed with this study.  
 CT scanning parameters included: 120 kVp tube voltage, 150 mAs tube current-time 
product, axial scanning plane, 0.625 mm isotropic voxel size (0.625 mm slice thickness, 0.625 
mm x 0.625 mm in-plane pixel size), ~250 slices, ~60 second scan time. A standard bone kernel 
(BONE) was used for CT image post-processing. Effective radiation dose was ~0.073 mSv per 
scan, estimated using shareware software (CT-DOSE, National Board of Health, Herley, 
Denmark). For comparison, the average effective radiation dose during a transatlantic flight from 
Europe to North America is about 0.05 mSv231.  
 Equivalent volumetric BMD (mg/cm3 K2HPO4) values were obtained by converting 
grayscale Hounsfield units (HU) to BMD using subject-specific linear regression equations 
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developed from known densities within the QCT phantom included in each axial image 
(r2>0.99)162. 
6.3.4. CT Image Analysis 
6.3.4.1. Isolate Subchondral Region 
We used a custom algorithm (Matlab 2016a, MathWorks, Natick, MA, USA) to isolate the 
subchondral region of the proximal tibia, by measuring a depth of 7.5mm from the subchondral 
surface (Figure 6-1A), using 3D imaged volumes of the proximal tibia from our previous 
work232.  
6.3.4.2. Cysts 
Cysts were identified and manually segmented using commercial software (Analyze 10.0; Mayo 
Foundation, Rochester, MN, USA) and an interactive touch-screen tablet (Cintiq 21UX; Wacom, 
Krefeld, Germany). A single user (WDB) performed all segmentations. Cysts were considered as 
an elliptical or spherical volume of lower BMD (lower greyscale) surrounded entirely by an area 
of higher BMD (higher greyscale). Based Chiba et al.18 and our previous studies evaluating 
cortical and trabecular subchondral bone209 and the epiphyseal region of tibia232, we only 
considered cysts within the subchondral region at a depth of 7.5mm from the subchondral 
surface (Figure 6-1B). All identified cysts were segmented using semi-automatic region growing 
guided by subject-specific and cyst-specific threshold values defining the 50% midpoint intensity 
values between cyst interior and adjacent bone, similar to the half maximum height threshold 
(HMH) technique199. Smaller cysts were manually segmented (Figure 6-1C). Any cyst volumes 
smaller than 8 voxels (1.95 mm3) were not included in this analysis to mitigate any errors due to 
noise.  
 We used a custom algorithm (Matlab 2016a) to measure the following cyst parameters18: 
number of cysts, cyst number per total volume of the 0-7.5 mm depth region (number/cm3), cyst 
volume per total volume (%), total cyst volume (mm3), maximum cyst volume (mm3), average 
cyst volume (mm3), minimum cyst volume (mm3), and standard deviation of cyst volume (mm3) 
as a metric of cyst volume variability. To assess the repeatability of the cyst outcomes, a 
precision study was performed using recommended techniques (14 subjects scanned 3 times 
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each)213. Precision errors (root mean square coefficients of variation, CV%RMS) ranged from 
0.7% to 3.6%. 
6.3.4.3. BMD 
We also determined relationships between cyst parameters and regional proximal tibial BMD. 
Segmented cyst volumes were subtracted from the previously defined subchondral volume of the 
proximal tibia (Figure 6-1D), to determine mean proximal tibial BMD excluding cysts. To assess 
the repeatability of BMD outcomes, a precision study was performed using recommended 
techniques (14 subjects scanned 3 times each)213. Precision errors (root mean square coefficients 
of variation, CV%RMS) ranged from 0.9% to 2.4%. 
6.3.5. Regional Analysis 
Proximal tibia imaged volumes were reoriented to a neutral position where medial and lateral 
plateaus were approximately parallel and divided into medial, central and lateral compartments, 
measured by using 40% of the maximum medial-lateral axis of each respective side (Figure 6-
1D). We evaluated BMD and cyst parameters over the medial and lateral proximal tibial regions.  
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Figure 6-1. Process for identifying, isolating, and measuring cysts included isolating the subchondral 
region of 7.5mm from the subchondral surface (A), cyst identification on CT images (B), and segmenting 
individual cysts using semi-automatic region growing for larger cysts  manual segmentation for smaller 
cysts (C). Segmented image volumes were then used to measure cyst parameters, and regional BMD 
excluding cysts which included total, lateral, and medial regions (D).  
 
6.3.6. Statistical Analysis 
We determined associations between cyst parameters and participant characteristics (age, sex, 
BMI) and clinical characteristics of OA (medial and lateral JSN, alignment, OA severity, total 
WOMAC pain, nocturnal pain, BMD) using Pearson’s correlation coefficients for continuous 
variables and Spearman’s rank correlation for categorical or ordinal variables. Due to the 
exploratory nature of this study with multiple correlations, we report the level of significance for 
both p<0.01 and p<0.05. 
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6.4. Results 
Patient characteristics are found in Table 6-1. Total cyst number varied from none (0) to up to 30 
over the total proximal tibia and up to 29 in the medial compartment (Table 6-2). Cysts were 
present in 88% of participants. Of these participants with subchondral cysts, 32% had cysts both 
medially and laterally, 14% had cysts only laterally, and 54% had cysts only medially. The ratio 
of cyst volume to tibial volume ranged from 0% to up to 14.8% over the total proximal tibia, and 
up to 13.7% in the medial region. For many cyst volume parameters, the standard deviation was 
similar to or greater than mean volume, indicating a large distribution in cyst volume within this 
sample (Table 6-2).  
 
Table 6-1. Descriptive statistics for characteristics of study participants 
Characteristic Parameters  
Age, years (mean ±SD) 64.1 ± 10.1 
Sex (M:F) 17:25 
BMI, kg/m2 (mean ±SD) 28.7 ± 3.7 
Side (L:R) 18:24 
OA Severity (KL) 
(0/1/2/3/4) 
0/0/2/21/19 
WOMAC Score (score range: 0 to 20) 9.8 ± 2.9 
Medial Joint Space Narrowing (JSN) 
(0/1/2/3/4) 
10/6/10/14* 
Lateral Joint Space Narrowing (JSN) 
(0/1/2/3/4) 
30/5/1/4* 
Non-weight-bearing alignment 28 varus, 6 neutral, 8 valgus 
Total BMD, mg/cm3 K2HPO4 (mean ±SD) 279 ± 51 
Lateral BMD, mg/cm3 K2HPO4 (mean ±SD) 240 ± 58 
Medial BMD, mg/cm3 K2HPO4 (mean ±SD) 311 ± 88 
*Data missing for 2 participants  
 Table 6-2. Cyst parameters, mean ± SD (range). 
 Total Lateral Medial 
Cyst Number (Cyst.N) 7.0 ± 6.7 (0-30) 1.9 ± 3.0 (0-11) 3.9 ± 5.7 (0-29) 
Cyst #/vol (Cyst.N/TV) (cm3) 0.27 ± 0.26 (0-1.3) 0.2 ± 0.3 (0-1.3) 0.4 ± 0.6 (0-2.6) 
Cyst vol/vol (Cyst.V/TV) (%) 1.3 ± 2.7 (0-14.8) 0.2 ± 0.5 (0-2.9) 1 ± 2.5 (0-13.7) 
Total cyst volume (Tot.Cyst.V) (mm3) 133.5 ± 245.8 (0-1253) 16.5 ± 44.1 (0-241.0) 98.6 ± 232.3 (0-1156) 
Maximum cyst volume (Max.Cyst.V)(mm3) 70.4 ± 140.6 (0-685.8) 9.5 ±32.5 (0-201.9) 58.0 ± 141.5 (0-685.8) 
Average cyst volume (Avg.Cyst.V) (mm3) 16.7 ± 25.8 (0-139.2) 2.6 ± 4.5 (0-21.9) 21.9 ± 49.9 (0-289.1) 
Minimum cyst volume (Min.Cyst.V) (mm3) 3.5 ± 5.9 (0-34.4) 1.0 ± 1.3 (0-4.2) 6.9 ± 19.2 (0-120.4) 
Cyst volume SD (SD.Cyst.V)(mm3) 28.4 ± 51.5 (0-252.1) 9.3 ± 16.2 (0.2-59.7) 40.8 ± 80.2 (0-338.8) 
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 There were no significant associations between cyst parameters and age, OA severity 
(KL grade), total WOMAC pain, or nocturnal pain (Tables 6-3, 6-4 and 6-5). Over the total 
proximal tibia, we found significant positive relationships a) between alignment and total cyst 
number and b) between alignment and cyst number per tibial volume (Table 6-3). At the medial 
region, there were no significant associations between any cyst parameters and any participant 
characteristics (Table 6-4). At the lateral region (Table 6-5), valgus alignment was associated 
with most cyst parameters, including cyst number and volume. Similarly, greater JSN was 
associated with greater cyst number and volume. There were significant positive relationships 
between lateral BMD and cyst number as well as volume (Figure 6-2).  
 
 
Figure 6-2. Scatterplot and Pearson’s correlation coefficient (r) of the relationship between lateral BMD 
and lateral cyst number (Cyst.N), suggesting that more numerous cysts in the lateral region contributed to 
higher lateral BMD surrounding cysts.  
 Table 6-3. Correlation coefficients between cyst parameters and patient and clinical OA characteristics over the total proximal tibia. 
Pearson’s correlation coefficient was used for all continuous variables. Spearman’s correlation coefficient (italics) was used for all 
categorical variables where noted. Significant associations are marked.  
 Cyst.N Cyst.N/TV Cyst.V/TV Tot.Cyst.V Max.Cyst.V Avg.Cyst.V Min.Cyst.V SD.Cyst.V 
Age 0.20 0.17 0.09 0.14 0.16 0.05 0.01 0.06 
Sex  0.25 0.37 0.18 0.11 0.04 -0.03 -0.06 -0.11 
BMI -0.22 -0.27 -0.20 -0.18 -0.18 -0.08 0.04 -0.15 
Alignment  0.33* 0.38* 0.19 0.16 0.09 0.02 0.01 -0.16 
KL  0.30 -0.07 -0.08 0.37 0.32 0.31 0.11 0.17 
Total WOMAC Pain 0.09 0.11 -0.03 -0.09 -0.11 -0.03 0.01 -0.11 
Nocturnal Pain 0.26 0.25 0.07 0.09 -0.01 -0.09 -0.11 -0.12 
Total BMD 0.05 0.02 -0.02 0.02 -0.003 -0.05 -0.04 -0.06 
* p<0.05  ** p<0.001 
 
Table 6-4. Correlation coefficients between cyst parameters and patient and clinical OA characteristics at the medial region. Pearson’s 
correlation coefficient was used for all continuous variables. Spearman’s correlation coefficient (italics) was used for all categorical 
variables. Significant associations are marked. 
 Cyst.N Medial Cyst.N/TV 
Medial 
Cyst.V/TV 
Medial 
Tot.Cyst.V 
Medial 
Max.Cyst.V 
Medial 
Avg.Cyst.V 
Medial 
Min.Cyst.
V 
Medial 
SD.Cyst.V 
Age 0.16 0.12 0.08 0.13 0.15 -0.04 -0.15 0.07 
Sex  -0.05 0.06 -0.02 -0.05 -0.03 0.01 0.09 0.05 
BMI -0.07 -0.11 -0.12 -0.11 -0.10 -0.05 0.20 -0.17 
Alignment -0.10 -0.09 -0.14 -0.14 -0.14 0.00 -0.04 -0.41 
Medial JSN 0.08 0.06 0.13 0.13 0.12 0.02 0.08 0.16 
KL -0.12 -0.13 -0.02 -0.02 0.03 0.05 0.04 0.19 
Total WOMAC Pain -0.06 -0.04 -0.04 -0.10 -0.08 0.06 0.06 -0.02 
Nocturnal Pain -0.09 -0.12 -0.11 -0.08 -0.08 -0.002 0.04 -0.003 
Medial BMD 0.27 0.25 0.14 0.18 0.12 0.03 0.08 -0.02 
* p<0.05  ** p<0.001  
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 Table 6-5. Correlation coefficients between cyst parameters and patient and clinical OA characteristics at the lateral region. Pearson’s 
correlation coefficient was used for all continuous variables. Spearman’s correlation coefficient (italics) was used for all categorical 
variables. Significant associations are marked. 
 Lateral Cyst.N 
Lateral 
Cyst.N/TV 
Lateral 
Cyst.V/TV 
Lateral 
Tot.Cyst.V 
Lateral 
Max.Cyst.V 
Lateral 
Avg.Cyst.V 
Lateral 
Min.Cyst.V 
Lateral 
SD.Cyst.V 
Age 0.16 0.15 0.12 0.14 0.09 0.19 0.21 -0.03 
Sex  0.62** 0.62** 0.62** 0.62** 0.62** 0.64** 0.61** - 
BMI -0.30 -0.31* -0.35* -0.34* -0.34* -0.36* -0.26 -0.37 
Alignment  0.60** 0.60** 0.61** 0.61** 0.62** 0.62** 0.44** 0.41 
Lateral JSN  0.66** 0.66** 0.68** 0.67** 0.68** 0.68** 0.52** 0.40 
KL  -0.13 -0.13 -0.11 -0.11 -0.10 -0.07 -0.08 0.22 
Total WOMAC Pain 0.14 0.14 -0.10 -0.10 -0.14 -0.05 0.18 -0.46 
Nocturnal Pain 0.24 0.25 0.23 0.23 0.22 0.20 0.17 -0.45 
Lateral BMD 0.55** 0.52** 0.34* 0.36* 0.26 0.39* 0.17 0.07 
* p<0.05  ** p<0.001 
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6.5. Discussion 
In this exploratory study using 3D in vivo QCT for analysis of proximal tibial subchondral cysts, 
we report cyst characteristics as well as associations between total, medial, and lateral cyst 
parameters and patient characteristics. The results showed that lateral cyst number and volume 
was related to BMD, as well as alignment and JSN. We found no relationships between cyst 
parameters and total WOMAC pain, nocturnal pain, or OA severity. This is the first in vivo study 
to use clinical QCT imaging at the knee to evaluate associations between cyst parameters and 
WOMAC pain, OA severity, and volumetric subchondral BMD.  
 Our findings are consistent with prior research exploring ex vivo cyst characteristics at 
the hip18 and at the tibia17, where high cyst number per volume was also associated with high 
BV/TV (analogous to BMD)18 and high trabecular thickness17. Our findings were especially 
pronounced in the lateral region, where high lateral cyst number and volume were associated 
with higher lateral BMD. Cysts, which present as voids in bone, create stress concentrations 
predisposing to localized high BMD, especially in the lateral region131. High BMD is likely a 
response to higher stress, with the response being multiple cyst formation may be related to 
regions with higher BMD or sclerotic bone formation131, potentially as a result of local bone 
remodelling and altered bone structure near the subchondral surface17, 233. High subchondral 
BMD, resulting from bone remodelling, may counterbalance structural instability due to cyst 
presence and higher stress.  
 Although the mechanism of cyst formation in patients with knee OA is still unknown, 
there are two primary hypotheses: the “bony contusion theory”127, 128—which proposes that 
excessive loading or trauma can lead to trabecular microfractures, necrotic bone, and focal bone 
resorption, eventually resulting in cyst development—and the “synovial fluid intrusion 
theory”129, 130—which proposes that the calcified barrier between cartilage and subchondral bone 
is damaged, allowing for fluid to seep into the subchondral bone, creating a fluid-filled cyst 
lesion.  
 In this work, there may be indications of each of these mechanisms in cyst formation, 
either independently or in combination. Over the total tibial region, the strongest associations 
were observed between cyst number and alignment, while at the lateral region similar 
associations were observed between cyst parameters and alignment as well as lateral JSN. These 
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results suggest that cartilage degeneration may be associated with proportionally larger and more 
numerous cysts. Chen et al.17 report similar findings, where subchondral cyst presence was 
associated with JSN and cartilage degeneration. Most likely, cyst development is a response to 
altered loading resulting in potential changes to bone congruence, contact forces, potentially 
changing load distribution through the proximal tibia218, 234, possibly through JSN with disease 
progression or knee alignment. Although alignment was measured based on imaged 
reconstructions217, it may be worthwhile hypothesizing why total cyst number and most lateral 
cyst parameters were associated with valgus alignment. As the lateral compartment is 
predisposed to higher tibial loads in patients with valgus alignment235, 236, patients with valgus 
alignment may be predisposed to higher cyst numbers and volume, even before clinical signs of 
OA, such as pain. Based on this finding, it would be expected that varus alignment would be 
associated with medial cyst number and volume, but this relationship was not significant in our 
study. Previous works have reported that patients with valgus alignment also tend to have higher 
medial tibial loads237, thus may also be more susceptible to lateral cyst development. We 
recommend further studies evaluating the effect of alignment on cyst characteristics and 
development in participants with OA. 
 As these patients are all in late-stage OA with severe to extreme pain, excessive lateral 
loading could also be the result of patients’ efforts to actively unload the medial compartment in 
efforts to relieve initial knee pain58, thus shifting load to the lateral plateau. Unloading the medial 
compartment may lead to lower BMD, as observed in our previous study of this sample209, and 
reduced medial stiffness. To determine if this may be contributing to our observations, we 
performed post hoc analysis of relationships between medial BMD and lateral cyst number and 
cyst number per volume, both of which showed significant relationships between lower medial 
BMD and more numerous cysts. Medial plateau unloading, combined with lower medial BMD 
and reduced stiffness, may compress the medial plateau. During disease progression, medial 
plateau compression could lead to in an increase in lateral contact loads, creating a precursor to 
lateral cyst formation and propagation. Current studies using finite element (FE) modelling with 
simulated cysts propose that cyst presence alters load distribution within the subchondral 
region131. It would be worthwhile to monitor cyst development throughout the OA process, using 
both imaging and modelling methods to determine if this effect is unique to this sample, or if it is 
more widespread through the OA population.  
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 Although our previous work evaluating relationships between BMD and pain in this 
sample reported an association with high lateral focal BMD and pain209, we found no 
relationships between cyst parameters and WOMAC pain. In patients with late-stage OA, cyst 
presence or size may not be related to pain in later stages of cyst development where bone 
remodelling levels may be reduced, or the internal cyst surface is well formed and resistant to the 
effects of high stress. We recommend further work with patients with varying stages of OA and 
degrees of pain to evaluate associations between cysts, BMD and pain during disease 
progression.  
 The findings of this study present various potential clinical impacts. Using clinical QCT 
we were able to measure relationships between cyst parameters (number, size, volume) and 
participant characteristics in vivo as had previously only been done ex vivo using non-clinical 
imaging tools such as micro-CT17 and HR-QCT18. This presents a promising clinical QCT-based 
technique for monitoring similar cyst parameters and regional BMD in a clinical sample and the 
ability to incorporate clinical symptoms such as pain. Clinical studies using MRI-based 
techniques present that cyst presence may9, 63 or may not10, 66, 106 be related to pain in patients 
with OA. Although these studies show that it is possible distinguish cysts and cyst-like lesions 
using MR, resolution limitations inhibit the ability to distinguish and measure smaller 
subchondral cysts. QCT provides higher resolution, as well as the ability to easily quantify cyst-
adjacent BMD. This work further demonstrates the complexities of cyst presence in relation to 
pain in patients with OA, especially in late-stage OA, but may provide a comprehensive 
technique able to distinguish cysts, as well as regional or localized BMD in vivo.  
 This study has certain limitations to consider. First, our measurements use a larger voxel 
size than ex vivo approaches such as micro-CT and may ignore smaller cysts. It was difficult to 
reliably quantify any cysts smaller than 8 voxels (2x2x2 voxels or 1.95mm3). It was also 
challenging to differentiate between small cysts and surrounding bone. Second, it was 
challenging to determine individual cysts with adjacent large cysts that would sometimes connect 
with one another in some participants. In these cases, these were counted as a single large cyst, 
but could also be regarded as multiple smaller cysts, which could have merged into a large cyst-
like void. This could account for multiple large cysts within our study. Third, our alignment 
measurement was a custom in-house approach using CT reconstructions and relative joint space 
widths to approximate mechanical alignment. Although this technique has not been validated 
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against full-limb radiographs, in these patients with late OA malalignment was evident with 
values ranging from -18° to 8° from neutral position217. Fourth, as this was an in vivo study, we 
did not include biochemical or histological analysis, and are thus uncertain of cyst genesis or 
development. Fifth, our sample has various limitations including participants at late stage of OA 
severity and pain measurement. Our sample represented patients at late stages of OA and 
findings may not be applicable to patients with early OA. WOMAC pain severity and assessment 
was based on the entire knee joint, including all joint surfaces (tibiofemoral and patellofemoral) 
and tissues (e.g., bone, menisci, synovium), and it is uncertain if pain originated within the 
proximal tibial bony structure, other tissues, or a combination of tissues. Further prospective 
evidence from participants at varying initial stages of OA and OA-related pain could 
complement these preliminary findings and clarify the relationship between cyst parameters and 
patient characteristics, as well as the role of subchondral cysts in knee OA and OA-related pain.  
6.6. Conclusion 
In this exploratory study, we used clinical QCT to analyze subchondral cysts at the proximal 
tibia of OA patients to determine relationships between subchondral cyst parameters and clinical 
characteristics of OA. There was a large range in cyst number and volume in our sample, 
suggesting that cyst development and progression may vary from patient to patient. At the lateral 
region, cyst number and volume were strongly associated with several patient characteristics 
including joint alignment, JSN, and BMD, suggesting that there may be disease-associated 
changes in tibial loading distribution leading to cyst development and further joint deterioration. 
We found no associations between cyst number or cyst volume with OA-related knee pain in 
patients with late-stage OA. As such, it may be further worthwhile to explore other bone-related 
outcomes (e.g., BMLs, BMD), when investigating which structures contribute to pain  
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7. MECHANICAL FE OUTCOMES AND NOCTURNAL PAIN 
7.1.  Synopsis 
This chapter outlines details of our study investigating relationships between finite element 
derived mechanical outcomes (stress, strain, stiffness) at the proximal tibia and nocturnal pain in 
patients with knee OA. In this study, we report that participants with severe nocturnal pain had 
higher lateral minimum principal stress than participants with no pain at all depths including 
trabecular bone (subchondral, epiphyseal, and metaphyseal) and most depths including cortical 
bone (subchondral, peripheral, and epiphyseal). This study suggests that pain in patients with 
knee OA may be associated with FE-based mechanical outcomes, especially minimum principal 
stress, which may have a role in OA-related pain pathogenesis.  
7.2.  Introduction 
Knee osteoarthritis (OA) is a painful debilitating joint disease, and a leading cause of pain and 
disability in the elderly184. Pain is the dominant symptom of OA2, and is often the primary 
motivation for treatment. Unfortunately, pain pathogenesis is poorly understood as it could be 
related to many contributing factors (e.g., altered subchondral bone properties, inflammation, 
bone marrow lesions, psychosocial factors). Of importance is nocturnal pain, or pain while lying 
in bed at night, as it is related to sleeplessness which disrupts quality of life5, and is a common 
indicator for surgical intervention74. Pain in bed at night is also one of the final activities where 
patients will experience pain in conjunction with OA progression73, and may be associated with 
underlying structural damage or remodelling238 within the bone tissue.  
 Nocturnal pain is associated with various bone-related structural elements such as higher 
lateral focal subchondral bone mineral density (BMD)209. Additionally, BMD alterations are 
associated with many other bony features, such as sclerosis13, BMLs14, 15, attrition16, and 
subchondral cysts17, 18. These individual image-based bone metrics may be interrelated at the 
structural level, thus incorporating a whole-joint approach including alignment, geometry, and 
material properties is important.  
 In subject-specific finite element (FE) modelling, QCT image volumes are used to 
generate computational models to measure the mechanical behaviour of joint tissues. This non-
invasive image-based technique able to incorporate regional variations in bone material 
properties and geometry as well as accounting for limb alignment. To date, FE analyses of OA 
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limbs have indicated that bone may have a structural role in OA initiation and development131. 
Subject-specific FE models have been used to identify differences in mechanical outcomes 
(stress, strain, stiffness) between knees with and without OA30; however, it is uncertain if these 
same metrics are associated with OA-related pain. Additionally, as pain may be related to 
localized bone remodelling238, which is partially driven by mechanical stimuli57, it is 
advantageous to explore relationships between mechanical quantities and pain in patients with 
painful knee OA.  
 The primary objective of this study was to first determine relationships between FE-
derived mechanical quantities (stress, strain, stiffness) and clinical characteristics of OA (OA 
severity, OA-related pain, alignment) in patients with knee OA. The secondary objective of this 
study was to then contrast FE-derived mechanical quantities across patients with differing levels 
of OA-related nocturnal knee pain when compared to those reporting no knee pain. To date, an 
FE analysis has not yet been conducted on a sample of participants with clinically diagnosed OA 
using subject-specific techniques. The results of this study provide further insight into how 
loading and the mechanical behaviour of bone may be related to pain in OA. 
7.3.  Methods 
7.3.1.  Study Participants 
We recruited 42 participants with OA (23M: 29F; mean age 64, SD ± 9.4 years; mean BMI 28.7 
± 3.7; 18L:24R) prior to total knee replacement (TKR). Exclusion criteria included: pregnant 
women, patients having a revision replacement instead of primary knee replacement, and patients 
with a prior history of bone pathology at the knee joint. The Institutional Research Board of the 
New England Baptist Hospital approved the study. We obtained informed consent from all study 
participants.  
7.3.2.  Participant Assessment  
OA severity was classified using Kellgren-Lawrence scoring59 and standardized radiographs. We 
also included knee alignment, as it may also affect medial or lateral loading at the proximal 
tibia27, 239, which was categorized as varus, neutral, or valgus and measured using coronal and 
sagittal CT reconstructions to determine an estimate of mechanical alignment217. In brief, medial 
and lateral joint space widths were evaluated at equal distances from the tibial spine permitting 
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an estimation of alignment between the femoral and tibial axes. Neutral alignment was defined 
as 176° to 180°, and malalignment of ± 2° from the neutral position (178o) was considered as 
either varus (-2°) or valgus (+2°) 217. Of note, the 2o offset (from 180o) pertains to inherent 
differences in medial: lateral cartilage thickness, with lateral cartilage being thicker than medial 
cartilage240. For this analysis, alignment was treated as a categorical variable, where participants 
exhibited either varus, neutral, or valgus alignment.  
 Pain severity was measured using the pain subscale of the Western Ontario McMasters 
Osteoarthritis Index (WOMAC)75. Participants were asked to assess the level of pain in the 
affected knee joint within the past 24-hours while walking on a flat surface, going up or down 
stairs, lying down in bed at night, sitting or lying down, and standing upright using a 5-point 
Likert scale (0 to 4). Individual element scores were then summed for a possible score out of 20, 
with 20 being the highest amount of pain. As this sample consisted of late-stage OA patients 
immediately prior to total knee replacement (TKR) surgery, all had very similar pain scores for 
weight-bearing activities (going up/down stairs, walking, standing) and pain while sitting. Pain at 
night in bed is one of the final activities where OA patients experience pain73, thus we used pain 
while lying down in bed at night (nocturnal pain) to categorize patients into differing pain 
groupings. Participants with a nocturnal pain score of 0 or 1 were considered to have ‘no 
nocturnal pain’, participants with a score of 2 were considered to have ‘moderate nocturnal pain’, 
and participants with a score of 3 or 4 were considered as ‘severe nocturnal pain’ as based on out 
previous study evaluating subchondral BMD in this same sample209. We also used the Self-
Administered Comorbidity Questionnaire212 to assess participants for any potential confounding 
comorbidities (e.g., diabetes, heart disease).  
7.3.3.  CT Acquisition 
We used a single energy clinical CT scanner (Lightspeed 4-slice, General Electric, Milwakee, 
WI, USA) for bone imaging. Participants were oriented supine within the CT gantry and both 
legs were simultaneously scanned for bone imaging. A solid quantitative CT (QCT) reference 
phantom of known bone mineral densities (Model 3T, Mindways Software Inc., Austin, TX, 
USA) was placed under each participant and included in all CT scans (Figure 1A). Scans 
included the distal femur, patella, proximal tibia, proximal fibula, and the 66% tibial shaft site 
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proximal to the distal tibial end-plate196. Image volumes were cropped to exclude the patella in 
this analysis (Figure 1B).  
 CT scanning parameters included: 120kVp tube voltage, 150mAs tube current-time 
product, axial scanning plane, 0.625mm isotropic voxel size (0.625 slice thickness, 0.625mm x 
0.625mm in-plane pixel size), ~250 slices, ~60s scan time. A standard bone reconstruction kernel 
(BONE) was used for CT image post-processing. The effective radiation dose was ~0.073mSv 
per scan, estimated using shareware software (CT-DOSE, National Board of Health, Herley, 
Denmark). For comparison, the average effective radiation dose during a transatlantic flight from 
Europe to North America is about 0.05mSv231.  
7.3.4.  CT Image Analysis 
Equivalent volumetric BMD (mg/cm3 K2HPO4) values were converted from grayscale 
Hounsfield units (HU) using subject-specific linear regression equations developed from known 
densities within the QCT phantom included in each individual axial image (r2>0.99) (Figure 7-
1A)162. All bones were semi-automatically segmented using commercial segmentation software 
(Analyze 10; Mayo Foundation, Rochester, MN, USA) and an interactive touch-screen tablet 
(Cintiq 21UX; Wacom, Krefeld, Germany) (Figure 7-1B & 7-1C). 
7.3.5.  FE Analysis 
We used an earlier developed finite element (FE) analysis technique30 to measure mechanical 
quantities, specifically principal compressive stress and strain (minimum principal stress and 
strain) as well as stiffness. For the purpose of comparing our results with prior studies, we also 
measured von Mises stress and strain30, 131, 241 (included in Supplemental Tables). A precision 
study30 was performed on an independent sample using recommended techniques213. Precision 
errors ranged from 3.7% to 10.5% for principal compressive stress, 3.2% to 7.6% for principal 
compressive strain, with similar errors for von-Mises stress and strain30.  
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Figure 7-1. Process for developing subject-specific FE models. Grayscale Hounsfield units from CT 
images were converted to bone mineral density (BMD) values (A), serial images (B) were segmented (C) 
– coronal view of femur in blue and tibia in green – to create imaged volumes for each included bone. 
Imaged volumes were rendered and smoothed to create three-dimensional geometries (D), which were 
meshed with 10-node tetrahedral elements (E). All meshed models included the femur, tibia, and fibula 
(not pictured) within a cylinder representing surrounding soft tissue. BMD-based material properties were 
assigned and mapped to each model (F). To calculate lateral stiffness, the medial side was isolated from 
the model by assigning soft tissue material properties to the medial distal femur (G).  
 
 In brief, supine CT image volumes were reoriented to neutral standing alignment to 
model a single-leg stance (MATLAB, MathWorks, Natick, MA, USA)30. These re-aligned image 
volumes were used to develop our FE models. Polygonal surface meshes were created from the 
segmented tibia, femur and fibula (Analyze10, Mayo Foundation, Rochester, MN, USA). We 
then used reverse engineering software (Geomagic Studio 12, Systems, Rock Hill, SC, USA) to 
smooth 3D surface meshes and ensure the bone geometries were topologically valid without 
holes or rough edges (Figure 7-1D). The maximum smoothing distance was less than one voxel 
(0.625mm) to maintain geometric complexity. Smoothed 3D volumes were then imported into 
FE software (Abaqus, Providence, RI, USA) and encapsulated within a cylinder simulating soft 
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tissue (e.g., cartilage, meniscus, etc.). The FE models were meshed using 10-node quadratic 
tetrahedral elements with a maximum 2mm mesh edge size throughout the bones, and a 20mm 
maximum mesh edge length around the edge of the encapsulating cylinder representing soft 
tissue (Figure 7-1E). A bonded contact interface was assumed between bone and soft tissue. 
Mesh convergence was performed on seven knees, and the results did not change more than 1% 
when element size was changed from 2mm to 1.8mm.  
 We used a custom algorithm176 to map image-based BMD values to element-based elastic 
moduli using the E-BMD relationship from Goulet et al179 for the proximal tibia and fibula 
(Appendix A, Table A-1), as recommended for subject-specific FE models of the proximal 
tibia176, 242. Elastic moduli ranged from 1 MPa to ~25 GPa for elements of the proximal tibia and 
fibula. As our analyses was focused on the proximal tibia, we modeled the femur as a rigid 
body243, 244 by assigning a high elastic modulus (500 GPa). All bone elements had isotropic linear 
material properties with a Poisson’s ratio of 0.3131. We modeled all soft tissue (e.g., cartilage, 
meniscus, etc.) as a minimally compressive homogeneous material (E=10MPa, Poisson’s 
ratio=0.495)131 (Figure 7-1F). The most distal sections of the fibula and tibia were constrained in 
all directions. The proximal femur was also constrained in all directions except for a uniform 
displacement (1mm) along the longitudinal axis of the femur.  
 To calculate medial and lateral stiffness, we modified femur mechanical properties and 
developed two additional models for each sample. To study medial stiffness, we assigned a low 
elastic modulus (E=10MPa) to all of the elements in the lateral compartment of the distal femur 
(Figure 7-1G), ensuring that total load was transferred to the medial compartment of the 
proximal tibia through the medial condyle of the distal femur30. The opposite was done for 
studying lateral stiffness. Stiffness of each of the medial and lateral compartments was calculated 
as the applied vertical load (obtained at the top surface of the distal femur from each model) 
divided by the average vertical displacement of the nodes in the respective compartment.  
 We acquired FE-based principal compressive stress and strain as well as von Mises stress 
and strain across the proximal tibia. Stress and strain results were normalized according to 
participant body weight and subject-specific reaction force. We obtained the vertical reaction 
force at the top surface of the femur for each subject-specific model and multiplied all stress and 
strain outcomes by the ratio of participant body weight to reaction force (Body weight/Reaction 
force). We evaluated FE outcomes across various regions of the proximal tibia using a custom 
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algorithm (Matlab), including cortical and trabecular bone at subchondral, epiphyseal, and 
metaphyseal depths (Figure 7-2). According to previous precision analysis30, we considered the 
following depths medially and laterally:  
1. subchondral cortical, 0-2.5mm from the tibial plateau surface, 
2. subchondral trabecular, 2.5-5mm from the tibial plateau surface, 
3. epiphyseal trabecular, 5-15mm from the tibial plateau surface, and 
4. metaphyseal trabecular, 15-35mm from the tibial plateau surface.  
In the central region, we considered the following depths: 
1. subchondral, 0-5mm depth from the top of the tibial spine, 
2. epiphyseal, 5-15mm from the top of the tibial spine, and 
3. metaphyseal, 15-35mm from the top of the tibial spine.  
Along the outer cortical region, we considered the following depths both medially and laterally: 
1. peripheral, 0-5mm depth from the tibial plateau surface, 
2. epiphyseal, 5-15mm from the tibial plateau surface, and 
3. metaphyseal, 15-35mm from the tibial plateau surface.  
 
Figure 7-2. Analysis at the proximal tibia included cortical and trabecular bone at subchondral, 
epiphyseal, and metaphyseal depths in medial, central, and lateral regions.  
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7.3.6.  Statistical Analysis 
We used Shapiro-Wilk test and Q-Q plots to assess normal distribution of FE-derived 
mechanical quantities. For our primary objective, we assessed associations between FE outcomes 
(stress, strain) and clinical characteristics of OA (OA severity, total WOMAC pain, nocturnal 
pain, alignment) using Spearman’s rank correlation coefficients.  
 For our secondary objective, we categorized participants into three groups based on their 
WOMAC score for pain while lying in bed at night (nocturnal pain)140, 209. As described above, 
participants were grouped as ‘no nocturnal pain’ (nocturnal pain score of 0 or 1), ‘moderate 
nocturnal pain’ (nocturnal pain score of 2), or ‘severe nocturnal pain’ (nocturnal pain score of 3 
or 4). We used multivariate analysis of covariance (MANCOVA) with Bonferroni adjustment for 
multiple comparisons to contrast differences in mechanical quantities across pain groups to the 
no nocturnal pain group, selecting age and sex as covariates based on observed correlation with 
WOMAC pain in our initial bivariate analyses232. We focused on contrasting participants with 
differing levels of nocturnal pain directly to participants with no nocturnal pain as differences 
already existing in our previous study evaluating subchondral BMD209 suggested that BMD in 
participants with severe nocturnal pain differed from BMD in participants with no nocturnal 
pain. We report mean and standard deviation (SD), absolute mean differences, and 95% 
confidence intervals. As this study is exploratory in nature, statistical significance was defined as 
p<0.05, and statistical analyses were performed using SPSS 23.0 (IBM, Armonk, NY, USA). 
7.4.  Results 
7.4.1. Participant Characteristics 
The characteristics of all participants, including BMI, side, OA severity, and alignment are 
shown in Table 7-1. OA severity ranged from 2 to 4. Pain at night lying in bed ranged from 0 
(none) to 4 (extreme), and participants were divided into three groups: ‘no nocturnal pain’ 
(n=17), ‘moderate nocturnal pain’ (n=16), and ‘severe nocturnal pain’ (n=9).   
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Table 7-1. Background characteristics and clinical data for study participants and groups.  
Characteristic All Participants No pain  (n = 17) 
Moderate pain  
(n = 16) 
Severe pain 
(n = 9) 
WOMAC (pain in bed at night)  0 or 1 2 3 or 4 
Sex Ratio (M:F) 14:22 7:10 7:9 3:6 
Age (mean ± SD) 64.7 ± 10.2 67.5 ± 9.1 61.8 ± 11.0 61.8 ± 9.3 
BMI (mean ± SD) 28.8 ± 3.7 28.3 ± 4.1 29.1 ± 3.6 28.7 ± 3.0 
Side (L:R) 14:22 7:10 6:10 5:4 
Kellgren-Lawrence score (0/1/2/3/4) 0/0/3/17/14* 0/0/2/8/6* 0/0/1/6/9 0/0/0/5/3* 
Alignment (varus/neutral/valgus) 28/6/8 12/4/1 12/1/3 4/1/4 
* Data not available for 2 participants 
7.4.2. Associations Between Mechanical Quantities and Clinical Characteristics 
Spearman’s rank coefficients showed various significant associations between mechanical 
quantities and clinical characteristics of OA. Principal compressive stress was associated with 
OA severity at the medial epiphyseal cortical region (r = 0.34, p=0.031), total WOMAC pain at 
the lateral peripheral cortical (r = 0.45, p=0.003) and lateral epiphyseal cortical (r = 0.47, 
p=0.002) regions, and nocturnal pain at all lateral regions except the lateral metaphyseal cortical 
region (r ranged from 0.33 to 0.50, p<0.05). Higher lateral principal compressive stress was also 
related to valgus alignment (r ranged from 0.56 to 0.65, p<0.05), while higher medial principal 
compressive stress was associated with varus alignment (r ranged from -0.53 to -0.65, p<0.05), 
(Table 7-2). Principal compressive strain was associated with nocturnal pain at the central 
metaphyseal region (r = 0.32, p=0.040), and higher principal compressive strain was associated 
with valgus alignment at all medial and central regions (r ranged from 0.34 to 0.56, p<0.05), and 
lateral regions at epiphyseal and metaphyseal depths (r ranged from 0.48 to 0.67, p<0.05) (Table 
7-3). Similar associations were observed with von Mises stress and strain (Appendix A, Tables 
A-2 and A-3). Lower medial stiffness was associated with varus alignment (r = -0.46, p=0.002) 
(Table 7-4).
 Table 7-2. Spearman’s rank correlation coefficients (ρ) for relationships between regional principal compressive stress and OA 
characteristics (OA severity, total WOMAC pain, nocturnal pain, and alignment). For alignment, positive relationships represent 
associations with valgus alignment, and negative relationships represent associations with varus alignment. Bolded values indicate p< 
0.05. 
Region OA severity (KL grade) Total WOMAC pain Nocturnal pain Alignment 
ρ p-value ρ p-value ρ p-value ρ p-value 
Medial peripheral cortical 0.29 0.072 0.02 0.900 -0.19 0.233 -0.59 <0.001 
Medial epiphyseal cortical 0.34 0.031 0.18 0.259 -0.05 0.771 -0.53 <0.001 
Medial metaphyseal cortical 0.15 0.373 0.13 0.415 -0.16 0.314 -0.61 <0.001 
Medial subchondral cortical -0.03 0.860 -0.03 0.845 -0.23 0.143 -0.60 <0.001 
Medial subchondral trabecular 0.01 0.943 -0.003 0.984 -0.20 0.196 -0.65 <0.001 
Medial epiphyseal trabecular 0.03 0.857 0.01 0.935 -0.24 0.131 -0.65 <0.001 
Medial metaphyseal trabecular 0.08 0.618 -0.07 0.661 -0.22 0.157 -0.64 <0.001 
Subchondral spine 0.07 0.657 0.19 0.233 0.20 0.209 0.31 0.050 
Epiphyseal central -0.17 0.296 0.14 0.376 0.21 0.182 0.30 0.057 
Metaphyseal central -0.26 0.105 -0.07 0.659 0.10 0.518 0.15 0.334 
Lateral subchondral cortical 0.08 0.636 0.21 0.175 0.40 0.008 0.62 <0.001 
Lateral subchondral trabecular 0.03 0.865 0.23 0.150 0.39 0.011 0.56 <0.001 
Lateral epiphyseal trabecular 0.05 0.758 0.17 0.284 0.33 0.034 0.60 <0.001 
Lateral metaphyseal trabecular -0.02 0.918 0.18 0.245 0.33 0.033 0.65 <0.001 
Lateral peripheral cortical 0.06 0.726 0.45 0.003 0.50 0.001 0.59 <0.001 
Lateral epiphyseal cortical 0.13 0.411 0.47 0.002 0.41 0.007 0.55 <0.001 
Lateral metaphyseal cortical 0.28 0.084 0.20 0.208 0.26 0.093 0.60 <0.001 
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 Table 7-3. Spearman’s rank correlation coefficients (ρ) for relationships between regional principal compressive strain and OA 
characteristics (OA severity, total WOMAC pain, nocturnal pain, and alignment). For alignment, positive relationships represent 
associations with valgus alignment, and negative relationships represent associations with varus alignment. Bolded values indicate p< 
0.05. 
Region OA severity (KL grade) Total WOMAC pain Nocturnal pain Alignment 
ρ p-value ρ p-value ρ p-value ρ p-value 
Medial peripheral cortical -0.14 0.408 0.23 0.149 0.25 0.118 0.55 <0.001 
Medial epiphyseal cortical -0.002 0.988 0.17 0.283 0.21 0.179 0.48 <0.001 
Medial metaphyseal cortical 0.25 0.119 0.16 0.307 0.21 0.173 0.37 0.016 
Medial subchondral cortical -0.24 0.144 0.14 0.384 0.09 0.568 0.53 <0.001 
Medial subchondral trabecular -0.06 0.719 0.20 0.214 0.16 0.302 0.56 <0.001 
Medial epiphyseal trabecular 0.02 0.891 0.19 0.229 0.20 0.215 0.52 <0.001 
Medial metaphyseal trabecular 0.21 0.199 0.19 0.224 0.28 0.071 0.47 <0.001 
Subchondral spine -0.20 0.217 0.09 0.564 0.15 0.354 0.34 0.026 
Epiphyseal central 0.001 0.996 0.20 0.211 0.1 0.261 0.51 <0.001 
Metaphyseal central 0.12 0.461 0.26 0.098 0.32 0.040 0.54 <0.001 
Lateral subchondral cortical 0.02 0.890 0.08 0.623 -0.02 0.918 -0.13 0.421 
Lateral subchondral trabecular 0.002 0.992 0.10 0.521 -0.08 0.636 -0.05 0.735 
Lateral epiphyseal trabecular 0.03 0.869 0.25 0.111 0.17 0.281 0.48 0.001 
Lateral metaphyseal trabecular 0.02 0.925 0.29 0.059 0.28 0.069 0.51 0.001 
Lateral peripheral cortical -0.02 0.891 0.17 0.272 -0.01 0.964 0.10 0.518 
Lateral epiphyseal cortical -0.06 0.693 0.29 0.062 0.21 0.179 0.50 0.001 
Lateral metaphyseal cortical -0.01 0.936 0.21 0.188 0.26 0.099 0.67 <0.001 
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 Table 7-4. Spearman’s rank correlation coefficients (ρ) for relationships between medial and lateral stiffness and OA characteristics 
(OA severity, total WOMAC pain, nocturnal pain, and alignment). For alignment, positive relationships represent associations with 
valgus alignment, and negative relationships represent associations with varus alignment. Bolded values indicate p< 0.05. 
Region OA severity (KL grade) Total WOMAC pain Nocturnal pain Alignment 
ρ p-value ρ p-value ρ p-value ρ p-value 
Medial stiffness 0.16 0.316 -0.25 0.111 -0.23 0.144 -0.46 0.002 
Lateral stiffness 0.16 0.334 -0.11 0.510 0.06 0.707 -0.23 0.149 
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7.4.3.  Differences Across Pain Groups 
Overall, principal compressive stress was higher in participants with moderate pain and severe 
pain through the lateral trabecular region, as well as distal cortical regions of both lateral and 
medial sides (Figure 7-3). Compared to participants with no nocturnal pain, participants with 
severe nocturnal pain had between 47% to 65% higher stress throughout lateral regions at 
subchondral, epiphyseal, and metaphyseal depths (Table 7-6, Figures 7-3 & 7-4). There were no 
differences between participants with no nocturnal pain and moderate nocturnal pain. Similar 
differences were observed for von Mises stress (Appendix A, Tables A-4 & A-5). There were no 
statistically significant differences across groups in principal compressive strain (Tables 7-7 & 7-
8), von Mises strain (Appendix A, Tables A-6 & A-7), or stiffness (Table 7-9).  
 96 
 
Figure 7-3. Representative finite element model outputs for principal compressive stress (top row) and 
principal compressive strain (bottom row) in one participant from each group. 
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Figure 7-4. Adjusted mean principal compressive stress of each group (‘no nocturnal pain’, ‘moderate 
nocturnal pain’, and ‘severe nocturnal pain’) at subchondral, epiphyseal, and metaphyseal depths of the 
lateral region of the proximal tibia. Statistically significant differences (p<0.05) across groups are noted 
with brackets. Error bars represent 95% confidence intervals. 
 Table 7-5. Comparison of regional principal compressive stress in patients with knee OA with no pain and moderate pain, including 
mean ± standard deviation (SD), adjusted mean difference, percent difference from no pain, 95% confidence intervals (CI), and p-
values. Bolded values indicate p<0.05. 
Region 
Minimum principal stress (MPa) 
Mean Difference* from No Pain (%) 
95% confidence interval 
p-value No Pain Moderate Pain 
Lower limit Upper limit 
Mean ± SD Mean ± SD 
Medial peripheral cortical 0.39 ± 014 0.43 ± 0.21 0.02 (5.0%) -0.13 0.16 1.000 
Medial epiphyseal cortical 0.60 ± 0.21 0.68 ± 0.29 0.04 (6.5%) -0.18 0.26 1.000 
Medial metaphyseal cortical 1.76 ± 0.62 1.80 ± 0.64 -0.03 (-1.1%) -0.57 0.50 1.000 
Medial subchondral cortical 0.41 ± 0.13 0.40 ± 0.11 -0.03 (-7.1%) -0.14 0.07 1.000 
Medial subchondral trabecular 0.37 ± 0.13 0.35 ± 0.11 -0.03 (-10.5%) -0.14 0.07 1.000 
Medial epiphyseal trabecular 0.36 ± 0.14 0.33 ± 0.11 -0.04 (-10.8%) -0.14 0.07 1.000 
Medial metaphyseal trabecular 0.40 ± 0.17 0.40 ± 0.20 -0.01 (-2.4%) -0.17 0.15 1.000 
Subchondral spine 0.23 ± 0.05 0.26 ± 0.10 0.03 (13.0%) -0.04 0.10 1.000 
Central epiphyseal trabecular 0.11 ± 0.03 0.12 ± 0.03 0.01 (0.0%) -0.02 0.03 1.000 
Central metaphyseal trabecular 0.09 ± 0.02 0.09 ± 0.02 -0.002 (0.0%) -0.02 0.02 1.000 
Lateral subchondral cortical 0.24 ± 0.06 0.28 ± 0.13 0.03 (16.7%) -0.06 0.13 1.000 
Lateral subchondral trabecular 0.19 ± 0.05 0.21 ± 0.09 0.02 (15.8%) -0.05 0.10 1.000 
Lateral epiphyseal trabecular 0.15 ± 0.04 0.17 ± 0.07 0.02 (13.3%) -0.04 0.08 1.000 
Lateral metaphyseal trabecular 0.12 ± 0.03 0.14 ± 0.06 0.02 (16.7%) -0.03 0.07 1.000 
Lateral peripheral cortical 0.17 ± 0.06 0.23 ± 0.11 0.06 (35.3%) -0.02 0.14 0.261 
Lateral epiphyseal cortical 0.23 ± 0.09 0.29 ± 0.16 0.05 (20.8%) -0.04 0.14 0.496 
Lateral metaphyseal cortical 0.57 ± 0.14 0.70 ± 0.29 0.12 (20.7%) -0.11 0.35 0.565 
*Mean values adjusted for age (64.1) and sex (1.6).   
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 Table 7-6. Comparison of regional principal compressive stress in patients with knee OA with no pain and severe pain, including 
mean ± standard deviation (SD), adjusted mean difference, percent difference from no pain, 95% confidence intervals (CI), and p-
values. Bolded values indicate p<0.05. 
Region 
Minimum principal stress (MPa) 
Mean Difference* from No Pain (%) 
95% confidence interval 
p-value No Pain Severe Pain 
Lower limit Upper limit 
Mean ± SD Mean ± SD 
Medial peripheral cortical 0.39 ± 0.14 0.28 ± 0.13 -0.13 (-30.0%) -0.30 0.05 0.238 
Medial epiphyseal cortical 0.60 ± 0.21 0.49 ± 0.27 -0.15 (-22.6%) -0.40 0.11 0.481 
Medial metaphyseal cortical 1.76 ± 0.62 1.38 ± 0.44 -0.46 (-25.0%) -1.09 0.17 0.221 
Medial subchondral cortical 0.41 ± 0.13 0.32 ± 0.11 -0.11 (-23.8%) -0.23 0.01 0.098 
Medial subchondral trabecular 0.37 ± 0.13 0.28 ± 0.11 -0.10 (-26.3%) -0.23 0.02 0.122 
Medial epiphyseal trabecular 0.36 ± 0.14 0.26 ± 0.11 -0.10 (-29.7%) -0.23 0.02 0.141 
Medial metaphyseal trabecular 0.40 ± 0.17 0.30 ± 0.13 -0.11 (-26.8%) -0.30 0.08 0.436 
Subchondral spine 0.23 ± 0.05 0.26 ± 0.07 0.03 (13.0%) -0.06 0.11 1.000 
Central epiphyseal trabecular 0.11 ± 0.03 0.13 ± 0.04 0.02 (18.2%) -0.01 0.05 0.462 
Central metaphyseal trabecular 0.09 ± 0.02 0.10 ± 0.03 0.01 (11.1%) -0.01 0.04 0.645 
Lateral subchondral cortical 0.24 ± 0.06 0.38 ± 0.13 0.13 (54.2%) 0.02 0.24 0.020 
Lateral subchondral trabecular 0.19 ± 0.05 0.28 ± 0.10 0.09 (47.4%) 0.01 0.18 0.026 
Lateral epiphyseal trabecular 0.15 ± 0.04 0.22 ± 0.08 0.07 (46.7%) 0.004 0.13 0.034 
Lateral metaphyseal trabecular 0.12 ± 0.03 0.18 ± 0.07 0.06 (50.0%) 0.004 0.12 0.034 
Lateral peripheral cortical 0.17 ± 0.06 0.28 ± 0.14 0.11 (64.7%) 0.02 0.21 0.019 
Lateral epiphyseal cortical 0.23 ± 0.09 0.32 ± 0.13 0.07 (29.2%) -0.03 0.18 0.233 
Lateral metaphyseal cortical 0.57 ± 0.14 0.80 ± 0.39 0.20 (34.5%) -0.07 0.47 0.208 
*Mean values adjusted for age (64.1) and sex (1.6).   
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 Table 7-7. Comparison of regional principal compressive strain in patients with knee OA with no pain and moderate pain, including 
mean ± standard deviation (SD), adjusted mean difference, percent difference from no pain, 95% confidence intervals (CI), and p-
values.  
Region 
Minimum principal strain 
(microstrain) Mean Difference* from No Pain 
(%) 
95% confidence interval 
p-value No Pain Moderate Pain 
Lower limit Upper limit 
Mean ± SD Mean ± SD 
Medial peripheral cortical 878 ± 612 1076 ± 599 231 (26.4%) -367 828 1.000 
Medial epiphyseal cortical 1375 ± 684 1537 ± 644 234 (17.4%) -386 855 1.000 
Medial metaphyseal cortical 1420 ± 575 1625 ± 618 197 (13.7%) -358 751 1.000 
Medial subchondral cortical 436 ± 194 483 ± 205 52 (11.7%) -136 239 1.000 
Medial subchondral trabecular 780 ± 413 974 ± 603 264 (35.2%) -252 780 0.623 
Medial epiphyseal trabecular 2362 ± 1155 2798 ± 1209 554 (23.9%) -566 1674 0.668 
Medial metaphyseal trabecular 2362 ± 949 2673 ± 984 275 (11.5%) -666 1216 1.000 
Subchondral spine 565 ± 186 604 ± 228 58 (10.2%) -133 249 1.000 
Central epiphyseal trabecular 2511 ± 970 2809 ± 974 363 (14.6%) -537 1263 0.956 
Central metaphyseal trabecular 2005 ± 863 2193 ± 788 168 (8.3%) -638 974 1.000 
Lateral subchondral cortical 625 ± 190 656 ± 224 26 (4.0%) -154 206 1.000 
Lateral subchondral trabecular 1128 ± 423 1171 ± 543 48 (43.%) -373 469 1.000 
Lateral epiphyseal trabecular 2390 ±1049 2601 ± 990 256 (10.7%) -640 1151 1.000 
Lateral metaphyseal trabecular 2001 ± 1072 2106 ± 924 77 (3.8%) -821 975 1.000 
Lateral peripheral cortical 1141 ± 516 1292 ± 616 130 (11.2%) -363 623 1.000 
Lateral epiphyseal cortical 1136 ± 630 1193 ± 549 72 (6.1%) -453 598 1.000 
Lateral metaphyseal cortical 726 ± 472 824 ± 459 126 (17.5%) -303 555 1.000 
*Mean values adjusted for age (64.1) and sex (1.6).   
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 Table 7-8. Comparison of regional principal compressive strain in patients with knee OA with no pain and severe pain, including 
mean ± standard deviation (SD), adjusted mean difference, percent difference from no pain, 95% confidence intervals (CI), and p-
values. Bolded values indicate p<0.05.  
Region 
Minimum principal strain 
(microstrain) 
Mean Difference* from No Pain (%) 
95% confidence interval 
p-value No Pain Severe Pain Lower 
limit Upper limit Mean ± SD Mean ± SD 
Medial peripheral cortical 878 ± 612 1432± 958 534 (61.4%) -167 1236 0.191 
Medial epiphyseal cortical 1375 ± 684 1832 ± 994 466 (34.6%) -262 1194 0.350 
Medial metaphyseal cortical 1420 ± 575 1755 ± 640 309 (21.6%) -342 960 0.726 
Medial subchondral cortical 436 ± 194 539 ± 267 92 (21.1%) -129 313 0.907 
Medial subchondral trabecular 780 ± 413 1188 ± 893 430 (57.4%) -176 1037 0.249 
Medial epiphyseal trabecular 2362 ± 1155 3250 ± 1829 892 (38.5%) -423 2207 0.292 
Medial metaphyseal trabecular 2362 ± 949 3253 ± 1235 824 (34.5%) -280 1929 0.207 
Subchondral spine 565 ± 186 686 ± 246 128 (22.8%) -97 352 0.486 
Central epiphyseal trabecular 2511 ± 970 3229 ± 1397 690 (27.7%) -367 1746 0.330 
Central metaphyseal trabecular 2005 ± 863 2875 ± 1069 819 (40.5%) -126 1765 0.109 
Lateral subchondral cortical 625 ± 190 686 ± 148 -25 (-4.0%) -154 206 1.000 
Lateral subchondral trabecular 1128 ± 423 1010 ± 311 -118 (-10.6%) -612 375 1.000 
Lateral epiphyseal trabecular 2390 ±1049 2883 ± 1199 449 (18.8%) -602 1500 0.871 
Lateral metaphyseal trabecular 2001 ± 1072 2815 ± 1133 784 (38.5%) -272 1836 0.212 
Lateral peripheral cortical 1141 ± 516 1117 ± 407 -60 (-5.2%) -638 519 1.000 
Lateral epiphyseal cortical 1136 ± 630 1556 ± 698 386 (33.9%) -231 1002 0.376 
Lateral metaphyseal cortical 726 ± 472 1127 ± 645 386 (53.7%) -117 890 0.186 
*Mean values adjusted for age (64.1) and sex (1.6).   
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 Table 7-9. Comparison of stiffness outcomes in patients with knee OA with no pain and moderate pain as well as severe pain 
including mean ± standard deviation (SD), adjusted mean difference, percent difference from no pain, 95% confidence intervals (CI), 
and p-values. 
Region 
Stiffness (N/mm) 
Mean Difference* from No Pain (%) 
95% confidence interval 
p-value No Pain Moderate Pain 
Lower limit Upper limit 
Mean ± SD Mean ± SD 
Lateral 4777 ± 1909 4804 ± 1651 -72 (-1.5%) -1579 1434 1.000 
Medial 7588 ± 3553 7202 ± 2678 -469 (-5.2%) -2994 2056 1.000 
       
Region 
Stiffness (N/mm) 
Mean Difference* from No Pain (%) 
95% confidence interval 
p-value No Pain Severe Pain 
Lower limit Upper limit 
Mean ± SD Mean ± SD 
Lateral 4777 ± 1909 5260 ± 1481 -50 (-1.0%) -1819 1719 1.000 
Medial 7588 ± 3553 5260 ± 2538 -2132 (-28.2%) -5096 831 0.238 
*Mean values adjusted for age (64.1) and sex (1.6).102 
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7.5.  Discussion 
In this study using subject-specific FE at the knee in patients with OA, we report associations 
between FE mechanical quantities (principal compressive stress, principal compressive strain, 
von Mises stress, von Mises strain, stiffness) and clinical OA characteristics (OA severity, total 
WOMAC pain, nocturnal pain, alignment). The results showed that higher principal compressive 
stress is associated with nocturnal pain at most lateral depths, valgus alignment was associated 
with higher lateral principal compressive stress, and varus alignment was associated with higher 
medial principal compressive stress. Higher principal compressive strain, both medially and 
centrally, was associated with valgus alignment. Our subject-specific FE study indicated higher 
principal compressive stress through cortical and trabecular regions at subchondral and 
epiphyseal depths at the lateral side of the proximal tibia in TKR patients with severe nocturnal 
pain, as compared to similar patients with no nocturnal pain. This exploratory study is the first to 
use QCT-based subject-specific FE techniques to investigate relationships between mechanical 
quantities at the proximal tibia and OA-related symptoms, such as pain, in a clinical sample of 
OA patients. These findings suggest that there may be previously unexplored associations 
between OA-related knee pain and mechanical quantities, such as principal compressive stress.  
 In participants with severe nocturnal pain, we observed 47% to 65% greater principal 
compressive stress at most depths at the lateral region of the proximal tibia than in participants 
with no nocturnal pain. These between-group differences are up to 10 times greater than 
associated precision errors, ranging from 4.6% to 5.9% at regions with significant between-group 
differences30, lending credence to the comparison and observation that high principal 
compressive stress at the lateral proximal tibia may be explain OA-related knee pain in patients 
awaiting TKR. To further ensure that this effect was related to the mechanical environment and 
not differences in BMD, we calculated regional BMD values raised to the power of 2.1 to 
coincide with our E-BMD conversion equation179 and performed between-group t-tests at each 
region. No differences were observed, with the exception of differences at the medial peripheral 
(p=0.048) and medial subchondral cortical (p=0.041) regions between participants with no pain 
and severe pain, as previously noted209, proposing that these differences may be related to 
structural characteristics not captured in the tissue modulus. In our previous precision study 
evaluating FE outputs in healthy participants and participants with OA30, OA participants had 
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higher stress in subchondral trabecular regions. We found similar trends in this study, where 
most participants with severe nocturnal pain had high principal compressive stress in trabecular 
regions at both lateral and medial plateaus. These findings further emphasize the importance of 
exploring mechanical behaviour in relation to pain, and that mechanical stress may be related to 
nocturnal pain, especially at trabecular regions deeper from the subchondral surface.  
 Our obtained mechanical quantities are within similar ranges as previously reported 
subject-specific FE outcomes at the knee30, 131, 241. Reported principal compressive stress and 
principal compressive strain values were within similar range as our previous precision study 
using this same technique, evaluating participants with and without OA30. Reported von Mises 
stress values were also within similar range as previous subject-specific modelling of the knee 
joint131 and the proximal tibia241. Although there were no differences in von Mises strain 
between groups, qualitative strain patterns in this work show higher principal compressive strain 
and von Mises strain values at the epiphyseal depth, which is similar to previous parametric FE 
studies of the proximal tibia166.  
 Study findings support our previous research using the same cohort, which investigated 
relationships between OA-related pain and subchondral BMD209 and epiphyseal BMD232. 
Specifically, high lateral stress may be related to the combination of low medial epiphyseal 
BMD232 and high lateral focal BMD209. First, in our previous work232, we proposed that lower 
epiphyseal BMD may be a chondroprotective process to lower medial stiffness, thereby 
lessening medial cartilage stress167. Lower medial stiffness would naturally transfer more load to 
the lateral compartment, leading to higher lateral BMD and higher stress. To determine if this 
may be contributing to our observations, we performed post hoc analysis of relationships 
between medial stiffness and lateral stress at all depths, which showed significant relationships 
between lower medial stiffness and higher lateral stress at the subchondral cortical (r = -0.35, 
p=0.023), peripheral cortical (r = -0.55, p<0.001), and epiphyseal cortical (r = -0.46, p=0.002) 
regions. In addition, stress is inversely proportional to tibial plateau surface area, where changes 
in load distributed over smaller areas will result in higher changes in resulting stress. As the 
lateral tibial plateau generally has a smaller contact surface area than the medial plateau245, any 
alterations in lateral loading may have a greater effect on lateral stress, than similar alterations in 
medial loading. In support of this, in this work there was a trend across all trabecular regions 
where participants with more severe nocturnal pain had higher stress at the lateral plateau and 
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lower stress at the medial plateau, showing that more load was being transferred laterally in 
participants with more severe pain, whereas participants with no nocturnal pain had more even 
stress between medial and lateral plateaus. Also, medial stiffness was quite low in participants 
with severe pain (about 2/3rds the stiffness of participants with no pain). Second, our prior work 
in this cohort identified that participants with severe nocturnal pain had ~30% higher focal BMD 
at the lateral region at the subchondral trabecular depth (2.5-10mm from the subchondral 
surface)209. Localized higher lateral BMD would equate with a higher elastic modulus, leading to 
localized loading, which would lead to more load being carried through the lateral regions of 
proximal tibia.  
 Our results indicate that high medial stress is related to varus alignment, high lateral 
stress is related to valgus alignment, and high medial and lateral strain are related to valgus 
alignment. Interestingly, alignment is not consistently associated with OA-related pain94, 95, 217, 
and was not associated with either total WOMAC pain or nocturnal pain in this sample114. 
Although these are strong associations, our models did not include any ligaments or soft tissue, 
which have been shown to be the primary load-bearing structures in FE models simulating 
malalignment246, thus we recommend further FE studies, which include ligaments and associated 
soft tissues at the knee to determine if our observed associations are still present when 
considering soft tissue.  
 We found no between-group differences in stiffness or principal compressive strain. 
Stiffness was highly variable in this sample, ranging from 2 046 MPa to 14 368 MPa at the 
medial plateau and 2 550 MPa to 8 913 MPa at the lateral plateau. That being said, mean medial 
stiffness tended to decrease as pain severity increased. Given this trend, combined with high 
stiffness variability, we believe we were underpowered to capture differences in stiffness 
between the groups. We recommend further studies including patients of varying degrees of OA 
severity to determine if stiffness is associated with disease progression, or able to discriminate 
pain severity at earlier stages of OA. Concerning minimum principal strain, the only between-
group difference was between patients with no pain and severe pain at the central metaphyseal 
region. Although previous studies report relationships between higher strain and patellofemoral 
pain183, there were few relationships between minimum principal strain and nocturnal knee pain 
in this study. This could be related to our model as associations between nocturnal pain and 
 106 
strain occurred at regions adjacent to the constrained distal tibia, thus should be interpreted with 
caution.  
 Although speculative, it may be worthwhile hypothesizing how these study findings may 
relate to cartilage stresses within the OA joint. Recent work using FE to evaluate tibial 
cartilage247 reported higher peak stress at the lateral tibial plateau in obese OA patients, 
compared to both OA patients with simulated weight loss and normal patients. These peak 
stresses were also associated with imaged cartilage defects at the lateral tibial plateau. As 
cartilage defects may result in higher subchondral bone stress levels176, 248, there may be 
additional alterations within the OA joint contributing to higher lateral stress in this sample. 
Unfortunately, as previously mentioned, soft tissue data was not available for this study. 
Although associations between cartilage damage and OA-related pain are conflicting66, 79, 249, it 
may be worthwhile including cartilage in future FE studies to consider the combined role of 
subchondral bone and cartilage and associated mechanical load transfer from one tissue to the 
other along with any potential relationships with OA-related pain.  
 This study has various merits. First, this study includes the largest known application of 
QCT-based subject-specific FE in patients with clinically diagnosed OA and will be valuable in 
guiding outcome and sample size selection for future FE studies. Second, our findings show that 
FE can discriminate differences in mechanical behaviour in patients with varying levels of 
nocturnal pain. Subject-specific FE is becoming a more widely used tool to evaluate the 
mechanical and loading behaviour of the knee, but the inclusion of clinical symptoms of OA, 
including pain, is limited. This study may aid in understanding the relationships between pain 
pathogenesis and related mechanical quantities. As these between-group differences are 
approximately 10 times larger than associated precision errors30, these results are trustworthy. 
Third, by using nocturnal pain scores as our grouping variable, we are excluding potential 
factors, such as inflammation, which may affect pain scores or severity during weight-bearing 
activities. Fourth, we report both principal compressive stress and principal compressive strain 
(compressive stress and strain), as these are more representative metrics for inhomogeneous 
materials, such as bone. We’ve also included von Mises stress and von Mises strain to compare 
our results with previous subject-specific FE studies reporting these metrics. Fifth, we considered 
the heterogeneity of bone mechanical properties and used a density-modulus equation that has 
been shown to lead to accurate QCT-based FE models176, 250. Sixth, although we used non-
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weight-bearing QCT scans in our model, a subject-specific re-alignment approach was used, 
resulting in similar 3D orientation based on individual knee landmarks and best-fit planes. This 
permitted similar comparisons of FE outcomes across all participants at various depths of the 
proximal tibia while still maintaining subject-specific alignment.  
 This study has certain limitations concerning both our sample, our FE technique, and 
multiple statistical tests. Pain severity and assessment was based on the entire knee joint, 
including multiple joint surfaces (tibiofemoral and patellofemoral) and tissues (e.g., bone, 
menisci, and synovium), and it is uncertain if pain originated within the proximal tibial bony 
structure, other tissues, or a combination of tissues. In our sample, although OA severity was 
homogeneous across participants, all were in late-stage OA (KL grade of 3 to 4), and it may not 
be possible to apply our findings to patients across all stages of OA. Concerning our model, we 
converted cortical and trabecular BMD to elastic moduli using a single E-BMD relationship 
(Supplemental Table 1). Applying cortical- or trabecular-specific E-BMD relationships may 
offer moderate improvements in stiffness predictions; however, in this work a single equation is 
justified to provide reasonable estimates of proximal tibial mechanical behaviour30, 176, 242 
without compromising the needs for additional computational resources. We were not able to 
include realistic subject-specific soft tissues, such as menisci, cartilage, or ligaments, as only CT 
images were available. To overcome this, we used a single homogeneous isotropic material to 
simulate simplified surrounding soft tissue in all FE models30, 131, using the same material 
properties for all samples. Additionally, all participants were supine during scanning, thus our 
model may overestimate cartilage thickness or joint space narrowing. Thinner cartilage or 
cartilage defects associated with OA or OA-related pain may lead to higher bone stress176, 248. 
Accordingly, this analysis provides a conservative measurement, potentially underestimating 
proximal tibial stress. We opted not to include soft tissues in this model, as our focus was the 
role of bone in OA-related pain, though further research and development are needed in 
developing a full-knee FE model which incorporates subject-specific bone, cartilage, meniscal, 
and ligamentous structures while still maintaining short development and processing time. For 
our correlation analysis, we used an unadjusted p < 0.05 to identify associations between 
mechanical quantities at various regions and clinical characteristics of OA in this preliminary 
exploratory. For our across-group comparison, we chose a more conservative Bonferroni 
correction for multiple testing.  
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7.6. Conclusion 
 In conclusion, our exploratory subject-specific FE analysis of patients with OA 
demonstrated that higher medial stress was associated with varus alignment while higher lateral 
stress was associated with valgus alignment. Additionally, higher medial and lateral strain were 
associated with valgus alignment. Patients with severe nocturnal pain had higher lateral principal 
compressive stress at subchondral, epiphyseal, and metaphyseal depths in the proximal tibia than 
patients with no nocturnal pain. This study suggests that FE modelling has potential to identify 
mechanical quantities, especially stress and strain, related to pain in participants with OA and 
thus, may have a role in OA-related pain pathogenesis. As FE modelling is able to incorporate 
and evaluate the mechanical behaviour of the entire knee joint, mechanical stress may reflect a 
more comprehensive analysis or combined effect of bone-related structural changes associated 
with OA and OA-related pain, as compared to the analysis of individual or regional image-based 
features. These results emphasize on the importance of studying the combined effects of 
individual alterations in OA and suggest including metrics that represent these combined 
alterations, such as mechanical stress or strain. These preliminary results provide insight into the 
capabilities of FE analysis and identify mechanical quantities to target when investigating the 
role of bone in OA-related pain.  
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8. DISCUSSION 
8.1. Overview of Findings 
The key finding of Chapter 4 was that local subchondral bone density appeared to have a role in 
OA-related pain pathogenesis. Specifically, this study identified that patients with severe 
nocturnal pain demonstrated higher lateral focal BMD at depths of 2.5-5mm (33% higher) and 5-
10mm (32% higher) than patients with no nocturnal pain. These differences were approximately 
7 times greater than associated precision errors22, and suggest that there may be previously 
overlooked characteristics in deeper subchondral bone layers that may have a role in OA pain 
pathogenesis. Although not significant, there was also a trend for lower average medial BMD in 
patients with more severe pain. As the medial tibial compartment supports proportionally greater 
load through the proximal tibia237, and OA more often affects the medial plateau33, similar or 
higher BMD would be expected through the medial compartment. This unexpected and unusual 
finding was the driving motivation for further exploration in studies presented in Chapters 5 and 
6.  
 The key finding of Chapter 5 was a relationship between lower epiphyseal and 
metaphyseal BMD and higher total WOMAC pain. Specifically, we report that total epiphyseal 
BMD, medial epiphyseal BMD, and total metaphyseal BMD are independent predictors of total 
WOMAC pain. These findings suggest that there may be previously overlooked regions and 
characteristics in proximal tibial BMD that may have a role in OA-related pain. This research 
focuses on often overlooked epiphyseal and metaphyseal regions of the proximal tibia, whereas 
most research studying the role of bone in OA commonly evaluates the subchondral region. The 
results of this study may be clinically important for TKR preparation and planning. Based on the 
findings of this study, there may be lower amount of bone in individuals with higher OA-related 
pain, potentially placing them at risk for poor implant fixation225, loosening223, 226, or surgical 
revisions224. Given the results of this study, it may be beneficial to use imaging to evaluate 
preoperative bone density or volume fraction in TKR patients with high amounts of pain.  
 The key finding of Chapter 6 was that lateral subchondral cyst number and volume were 
associated with lateral subchondral BMD and knee alignment, but were not associated with 
WOMAC pain. Specifically, we report that higher lateral BMD is associated with higher lateral 
cyst number and higher lateral cyst number per lateral proximal tibial volume. Higher lateral cyst 
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number and volume were also associated with valgus alignment; surprisingly, there were no 
relationships between cyst parameters and pain. Cyst size and presence were also associated with 
both JSN and alignment, providing evidence that cyst development may be a response to altered 
load distribution through the proximal tibia218, 234. In this work, we propose that higher lateral 
loading, as evidenced through lateral cyst presence and associated stress concentrations131 and 
higher localized BMD17, may be due to laterally shifted loading, either through disease 
progression or through patients’ efforts to actively unload the medial compartment in effort to 
relieve initial knee pain58, creating a precursor to lateral cyst formation. This study is important 
as there may be OA-associated changes in tibial load distribution leading to cyst presence and 
further joint deterioration. This study is also important as it indicates that cysts are not associated 
with OA-related pain, thereby ruling out potential pain initiators.  
 The key finding of Chapter 7, was that various mechanical outcomes are associated with 
clinical characteristics of OA. For example, higher principal compressive stress at various depths 
of the lateral region was associated with higher nocturnal pain. Specifically, patients with severe 
nocturnal pain had 47% to 65% higher principal compressive stress throughout trabecular and 
cortical bone at subchondral, epiphyseal, and metaphyseal depths of the lateral proximal tibial 
region than patients with no nocturnal pain. This study also noted a trend for lower medial 
stiffness in participants with high pain, which could be speculated reflecting a chondroprotective 
mechanism to lower medial cartilage stress. Prospective data is needed to assess if proposed 
lower medial stiffness would lead to lateral load transfer, resulting in higher lateral stress, higher 
remodelling and higher localized BMD. This lower medial stiffness may partially explain high 
lateral BMD found in individuals with high nocturnal pain. These results also emphasize the 
need for a more comprehensive ‘whole-joint’ or ‘whole-tibia’ approach when analyzing the role 
of bone in OA-related pain.  
 
8.2. Comparison to Existing Findings 
Direct comparisons between associations between these new findings (i.e., depth-specific BMD 
measurements or FE outcomes at the proximal tibia and OA-related pain) and existing findings 
are difficult given these are the only known existing works evaluating relationships between 
volumetric BMD, or FE outcomes, and pain at the proximal tibia; however, comparable studies 
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evaluating subchondral BMD exist at the patella19, 20. Additionally, BMD values can be 
compared to existing measures using pQCT23, HR-pQCT251, and QCT21, 22, 162, 252, 253, while FE 
outcomes can compared to existing measures from FE-based studies at the proximal tibia30, 131, 
241.  
 Relationships between pain and subchondral trabecular BMD proximal tibia were similar 
to previously reported relationships at the patella19; although these results are from the same 
sample. With regards to high focal BMD, prior work has reported high BMD in locations 
adjacent to BMLs15, which are strongly associated with pain78, 136. At epiphyseal depths, studies 
using animal models have reported associations between low bone density at locations further 
from the joint surface (epiphyseal and metaphyseal depths) and OA severity254-256.  
 The findings of our study evaluating associations between subchondral cysts and pain are 
similar to prior ex vivo research exploring cyst characteristics at the tibia using micro-CT17 where 
high cyst number per volume was associated with high trabecular thickness, and the hip using 
HR-pQCT18 where high cyst number per volume was associated with high BV/TV. Concerning 
relationships between cyst parameters and OA-related pain, similar trends were reported in 
various studies using MRI, where cyst presence104, 112 or size10, 66, 106 were not associated with 
OA-related knee pain.  
 Mechanical outcomes from our study evaluating relationships between mechanical FE 
outcomes and OA-related pain are within similar range as previously reported von Mises stress 
and strain 30, 131, 241, principal compressive stress and strain30, and stiffness166. Stress distributions 
from all participants in this study showed similar patterns as previously observed in patients with 
OA using similar techniques30 where stress in participants with OA was distributed through both 
trabecular and cortical regions. These findings support and combine results from our studies 
evaluating BMD at various depths from the subchondral surface and subchondral cyst 
parameters. As BMD is connected to stress (e.g., high BMD leads to a high elastic modulus, 
which will support load and bear high stress), high lateral focal BMD would be able to support 
high stress, whereas low medial BMD would support lower stress. Additionally, as subchondral 
cysts act as stress risers131, more numerous lateral subchondral cysts would lead to higher stress 
in lateral regions.  
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8.3. Strengths and Limitations 
These combined studies have various strengths requiring further explanation. First, these studies 
combined present a ‘whole-bone’ approach to determining how BMD and mechanical outcomes 
are associated with OA-related pain. A key weakness of similar image-based studies is the 
individual analysis of relationships between bony features and OA-related pain9, 10, 63, 66. 
Although it may be valuable to determine if there is a single key feature associated with OA-
related pain, these features are rarely observed in isolation in patients with more severe OA, i.e., 
osteophytes, sclerosis, and subchondral cysts may all be observed in the same patient and the 
severity of these features are combined to generate a single disease severity score. BMD is 
associated with various bony features associated with OA-related pain13-18, as well as OA 
severity21, 23, and is a key determinant of mechanical properties of bone25, 171. By including BMD 
analyses at various depths from the subchondral surface, along with associated FE outcomes, this 
work is able to evaluate bone across the entire proximal tibia. Additionally, this work is able to 
evaluate how bone characteristics at one region (e.g., medial epiphyseal region) may be 
associated with or influence bone characteristics at other regions or depths (e.g., lateral 
subchondral region), furthering our understanding of the structural role of bone in OA-related 
pain at the proximal tibia.  
 Second, and related to the first strength, the key findings of our FE study are reflective of 
our previous studies evaluating BMD at various depths and subchondral cyst characteristics. This 
would be expected, as mapped mechanical properties are directly proportional to BMD, but it is 
worth emphasizing as it enforces the importance of BMD and the role of structural and 
mechanical characteristics of bone at the proximal tibia in painful knee OA. This also 
demonstrates consistency and reliability between study outcomes and techniques, even though 
different metrics and processes are used. Each study provides outcomes that may reveal that 
patients with high OA-related pain may be shifting load to, or naturally over-loading, the lateral 
tibial plateau, as demonstrated through higher lateral focal subchondral BMD, lower medial 
trabecular BMD, larger and more numerous lateral subchondral cysts, and higher stress at most 
depths of the lateral compartment of the proximal tibia, each possibly contributing to increased 
chondroprotective bone remodelling processes. Combined, the results of these studies emphasize 
the need for further understanding in the structural role of bone in OA-related pain pathogenesis, 
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and may provide potential outcomes worth monitoring during OA-related pain progression to 
further develop targeted treatments.  
 Third, our imaging and modeling techniques are based on in vivo clinical QCT images 
from patients with clinically diagnosed OA, which provide a foundation for future clinical 
applications, such as patient-specific surgical planning (if sufficient resources and expertise are 
available). This combined work also provides evidence for potential previously overlooked target 
outcomes (e.g., density of epiphyseal and metaphyseal regions) for studies using similar QCT 
images in patients at various stages of knee OA and OA-related knee pain.  
 This thesis research has various limitations related to sample size and imaging or FE 
techniques warranting further discussion. First, the main limitation in this study is our sample 
size. Although previously discussed in each individual study, this also warrants discussion in 
relation to the collected studies. There were many noteworthy characteristics associated with 
total WOMAC and nocturnal pain, but some trends between studies were not consistent, possibly 
because we were underpowered to determine certain associations. For example, lower medial 
epiphyseal BMD was associated with total WOMAC pain, but subchondral cyst volume within 
the same region was not. Although low BMD is not completely analogous with cyst size, regions 
with larger cysts tend to have lower BMD than regions with smaller cysts. Future works with 
larger sample size and varying levels of OA-related pain will perhaps be able to elucidate and 
further understand these observations. Another limitation related to the sample of this study is 
the lack of a matched control group, either as a group of healthy participants or participants with 
moderate to severe OA but with little or no pain. A control group would allow for stronger 
analysis in determining the magnitude of the observed phenomena, and aid in reducing bias. 
Although the use of QCT doses patients with a small amount ionizing radiation, techniques are 
continuously improving and it may be worthwhile to consider and include healthy or control 
groups in future work evaluating BMD in patients with OA where possible. Second, these 
techniques have been developed for 0.625mm isotropic resolution, which may hinder the ability 
to translate these same techniques to CT images with smaller voxel sizes. Although 0.625mm 
isotropic voxel size is small enough to discriminate differences in BMD and FE outcomes in this 
work, improvements to CT imaging techniques have since been developed and it is possible to 
achieve CT images with smaller resolutions, e.g., to 0.3mm isotropic. The depth-specific image 
processing techniques used in this study may be easily transferrable to images with smaller voxel 
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size with minimal alterations, but transfer and mapping materials to FE models will require 
additional optimization and model validation. Similar techniques could be used with voxels 
measuring 0.5mm isotropic176, 257, but further analysis is required for even smaller voxel sizes, 
with additional precision testing and optimization. Third, our FE models used a uniform elastic 
modulus for all bone tissue. This may be problematic for two reasons: differences in the roles 
and modulus of cortical and trabecular bone as discussed in Chapter 7, and the understanding 
that bone elastic modulus is dependent on the degree of mineralization258, 259. In patients with 
OA, the degree of mineralization can vary throughout the subchondral and epiphyseal regions44, 
which may also lead to variations in structural orientation or tissue modulus distribution260. This 
is an inherent limitation in QCT imaging as QCT does not have the ability to distinguish 
alterations in bone volume fraction (BV/TV) from degree of mineralization (BM/BV) that occurs 
in different stages of OA261, 262 (BMD = BV/TV×BM/BV). These characteristics may not be 
represented in CT images and thus, are inherent limitations of our FE model as well. Fourth, 
there are certain limitations to consider before these techniques can be applied in a clinical 
setting. Tibial segmentation and object map generation can be time-consuming. Although it may 
be possible to fully automate the segmenting process, object maps will still need correction 
before applying depth-specific image processing tools. As an example, our semi-automatic 
segmentation process with manual correction (described in Chapter 4) takes approximately 45 
minutes to an hour to build and correct an object map for a single tibia. On object maps where 
splines are used to help expedite the segmenting process, manual correction at the subchondral 
surface is still required, and could take up to 30 to 45 minutes to correct an object map for a 
single tibia. Although this is the rate-limiting step, additional process streamlining is required 
before full implementation in clinical settings. Additionally, further analysis is required to 
determine the interrater precision of these imaging techniques. Precision errors are presented in 
each relevant chapter for each image processing technique, but as a single user performed most 
image processing and segmentations in this work, further analysis is required to determine 
precision between users before clinical implementation.  
8.4. Clinical Significance 
There is currently no cure for OA, the exact cause for disease initiation is unknown, and the 
exact mechanism of pain pathogenesis is also unknown. Bone is densely innervated7, 8 and may 
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be a source of pain, but current reported relationships between image-based bony features and 
pain are conflicting9, 10, 63, 105. Overall, this work suggested that BMD at various depths from the 
subchondral surface of the proximal tibia is related to pain and may be a promising image-based 
feature worthwhile monitoring during disease or pain progression. As BMD may be modified, 
these studies also provide important preliminary information to aid in developing pain 
management strategies in patients with OA. Additionally, these studies help in identifying a 
potential mechanical role of bone in pain pathogenesis where previous works have suggested that 
mechanically driven bone remodelling may have a role in OA progression45, 185, 193, 263 . This 
work further expands on this hypothesis by suggesting a mechanical component to pain, with a 
potential link to bone remodelling57, 264 and clinical symptoms of OA. Accordingly, rational 
therapeutic approaches may benefit through monitoring bone density while targeting to maintain 
bone mineral and limit deterioration in bone structure and mechanical outcomes.  
 These results may be important for various types of patients at various stages of OA. Our 
studies evaluating BMD at various depths of the proximal tibia provide specific potential metrics 
to identify and monitor patients in early stages of OA, potentially leading to earlier intervention 
in developing patient-specific pain management strategies and treatments. In patients with OA, 
depth-specific imaging techniques combined with subject-specific FE analysis could provide a 
series of new in vivo metrics to help monitor the success of pain management treatments such as 
assistive devices, braces, joint distraction, or bone-modifying pharmaceuticals. Our study 
evaluating epiphyseal and metaphyseal BMD provides specific potential metrics to monitor in 
patients with late stages of painful OA awaiting joint replacement. Knowing which specific 
regions to monitor for low BMD, depth-specific imaging techniques could be used to evaluate 
pre-operative BMD, aiding surgical planning and patient preparation and complimenting current 
customized surgical approaches.  
8.5. Conclusions 
Four primary conclusions were generated from this thesis research: 
1. QCT-based depth-specific imaging techniques demonstrated higher lateral maximum 
focal BMD in patients with severe nocturnal pain, compared to patients with no nocturnal 
pain at depths of 2.5-5mm (33% higher) and 5-10mm (32% higher) from the subchondral 
surface of the proximal tibia. There was also a non-significant trend for lower average 
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medial BMD in trabecular regions (2.5-5mm and 5-10mm from the subchondral surface) 
in patients with higher nocturnal pain.  
2. QCT-based imaging techniques demonstrated that low tibial epiphyseal BMD at the total 
and medial regions, and low total metaphyseal BMD were associated with higher OA-
related knee pain. 
3. QCT-based measures of cyst parameters indicated that greater cyst number was 
associated with BMD, alignment, and JSN. Cyst parameters were not associated with OA 
severity scores or OA-related knee pain.  
4. Subject-specific FE modeling of the proximal tibia in patients with OA, indicated that: 
a) Higher lateral principal compressive stress was associated with nocturnal pain. 
Specifically, OA patients with moderate nocturnal pain had 36% higher stress at 
the lateral peripheral cortical regions than patients with no nocturnal pain. OA 
patients with severe nocturnal pain had between 43% to 73% higher stress in 
lateral trabecular and cortical regions  
b) Higher medial stress was associated with varus alignment, higher lateral stress 
was associated with valgus alignment, and lower medial stiffness was associated 
with valgus alignment.  
8.6. Contributions 
This thesis research has generated many ‘firsts’, and many of the individual study results 
provided insights to the structural role of bone in pain pathogenesis in patients with knee OA:  
1. First studies to use depth-specific QCT imaging techniques to assess relationships 
between OA-related knee pain and BMD at various depths from the subchondral surface 
of the proximal tibia in patients with clinically diagnosed OA.  
2. First studies to demonstrate that QCT-derived BMD is associated with OA-related pain.  
3. First studies to demonstrate that lower trabecular BMD at subchondral, epiphyseal, and 
metaphyseal depths are associated with OA-related pain.  
4. First study to report that OA patients with severe nocturnal pain have higher localized 
lateral subchondral trabecular BMD, specifically at depths of 2.5-5mm (32% higher) and 
5-10mm (33% higher) from the subchondral surface, than patients with no nocturnal pain.  
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5. First study to evaluate commonly overlooked trabecular epiphyseal and metaphyseal 
regions of the proximal tibia, and report lower BMD at these regions in TKR patients 
with more severe knee pain.   
6. First in vivo study to use clinical QCT imaging at the proximal tibia to measure and 
evaluate associations between subchondral cyst parameters and OA-related pain, disease 
severity, and subchondral BMD. 
7. First in vivo study to report associations between lateral cyst number and lateral 
subchondral BMD, as well as associations between lateral cyst parameters and valgus 
alignment.  
8. First in vivo study to use subject-specific FE techniques at the proximal tibia in patients 
with clinically diagnosed OA to determine relationships between mechanical FE 
outcomes (stress, strain, stiffness) and OA-related pain. This study also currently reports 
the largest sample size of unique individuals (n=42) for any subject-specific QCT FE 
study of the knee.  
9. First study to report associations between mechanical FE outcomes (stress, strain, 
stiffness) and clinical characteristics of OA (OA severity, pain, alignment). These 
findings suggest that there may be previously unexplored associations between OA-
related knee pain and mechanical outcomes, emphasizing that bone may have a 
mechanical role in OA-related pain pathogenesis.  
8.7. Future Research 
This thesis research provides supporting rationale for future studies evaluating associations 
between bone and OA-related pain: 
1. Depth-specific imaging techniques are currently being modified and developed to 
determine subchondral cortical and trabecular BMD at the distal femur. These techniques 
will first be used in a sample of healthy and OA participants to determine tool precision 
and any potential differences between healthy and OA distal femora. Once precision 
errors and any BMD differences are identified, these techniques will then be used in this 
sample to determine if distal femoral subchondral BMD is associated with OA-related 
knee pain. 
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2. Image processing tools are currently being developed to determine cyst parameters 
(number, volume, etc.) at the distal femur. These techniques will be applied to this 
sample to determine if femoral cyst characteristics are related to pain, and to determine 
how femoral cyst characteristics may be related to tibial cyst characteristics.  
3. Currently, these depth-specific imaging and FE techniques are being used in the 
Multicenter Osteoarthritis Study (MOST), a longitudinal study at various locations in the 
USA consisting of over 5000 volunteers using MRI (for assessing cartilage) and CT (for 
assessing bone). This research will help us further understand the mechanical role of 
subchondral bone with cartilage degeneration in a larger sample over various stages of 
OA disease and symptomatic severity.  
4. We are currently modifying and adapting regional stress and strain extraction algorithms 
to determine stress and strain surrounding subchondral cysts using our previously 
segmented cyst image volumes. This research will build on aspects from both our 
regional FE study and our subchondral cyst study, complimenting previous simulated 
works from McErlain et al.131 and evaluating mechanical outputs in peri-cystic regions in 
patients with OA while incorporating OA-related pain.  
5. We are currently modifying our FE models to investigate if element failure is associated 
with nocturnal knee pain. In addition to FE outcomes, it may be possible to assign failure 
criteria (safety factor) to the elements within the FE model to determine if mechanical 
failure is associated with OA-related pain. Failed elements would represent bone that has 
yielded, thus requiring remodeling. These criteria could explain, in part, why pain is 
occurring at night and potentially that nocturnal pain in patients with OA may be related 
to bone remodeling. 
6. There may be additional FE outcomes worthwhile investigating that may be related to 
pain, such as hydrostatic stress, strain energy density, load distribution between medial 
and lateral plateaus, or fluid flow265, 266 that may not be related to OA severity, but may 
be related to pain.    
7. It may be possible to develop multi-modality co-registration techniques to co-register 
MRI and CT images to further determine relationships between bony features best 
analyzed using a single modality, such as BML on MRI and BMD on CT, and determine 
how these features are inter-related, along with OA-related pain. This work could 
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enhance the ability to further identify structures or bony changes related to pain in studies 
or centres with limited resources (i.e., if only CT or only MRI scanners were available in 
a clinical facility) and would also further our understanding of the mechanical role of 
bone in OA-related pain in relation to soft-tissue (cartilage) changes. These co-
registration techniques could also ease the inclusion of soft tissues (cartilage, menisci, 
ligaments) in FE models with accurate subject-specific geometry.  
8. Concerning FE modeling and computational simulations, there are always possibilities to 
improve modeling techniques and address limitations as computational resources become 
more available. For example, as processing speeds increase, it may be conveniently 
possible to map material properties from smaller voxels to smaller elements, and 
incorporate trabecular orientation.    
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APPENDIX 
 
Supplemental Tables for von Mises stress and strain from finite element analysis.  
 
Table A-1. Goulet’s density-modulus conversion relationships used in FE models 
Relationship Citation 
 Goulet et al.
179 
 Helgason et al.
170 
 Carter et al.
211 
 Helgason et al.
170 
 Keyak et al.
267 
( )2.1E=6310 BV/TV
ash appρ =0.55ρ
3
realρ =1.8 g/cm
 app realρ =ρ × BV/TV
ashρ =1.06 BMD + 0.0389
 Table A-2. Spearman’s rank correlation coefficients (ρ) for relationships between regional von Mises stress and OA characteristics 
(OA severity, total WOMAC pain, nocturnal pain, and alignment). For alignment, positive relationships represent associations with 
valgus alignment, and negative relationships represent associations with varus alignment. Bolded values indicate p< 0.05. 
Region OA severity (KL score) Total WOMAC pain Nocturnal pain Alignment 
ρ p-value ρ p-value ρ p-value ρ p-value 
Medial peripheral cortical 0.32 0.048 0.01 0.942 -0.18 0.266 -0.54 <0.001 
Medial epiphyseal cortical 0.37 0.018 0.20 0.205 0.004 0.980 -0.50 0.001 
Medial metaphyseal cortical 0.13 0.435 0.13 0.406 -0.15 0.341 -0.57 <0.001 
Medial subchondral cortical -0.18 0.261 -0.14 0.365 -0.20 0.202 -0.38 0.012 
Medial subchondral trabecular -0.04 0.831 -0.08 0.608 -0.19 0.230 -0.59 <0.001 
Medial epiphyseal trabecular 0.06 0.726 0.02 0.880 -0.23 0.152 -0.66 <0.001 
Medial meatphyseal trabecular 0.01 0.931 -0.05 0.771 -0.23 0.150 -0.61 <0.001 
Subchondral spine 0.12 0.477 0.27 0.087 0.27 0.079 0.40 0.009 
Epiphyseal central -0.10 0.534 0.17 0.292 0.21 0.179 0.31 0.045 
Metaphyseal central -0.31 0.049 -0.04 0.780 0.11 0.481 0.21 0.188 
Lateral subchondral cortical -0.04 0.791 0.19 0.223 0.44 0.003 0.71 <0.001 
Lateral subchondral trabecular 0.01 0.957 0.20 0.204 0.42 0.006 0.68 <0.001 
Lateral epiphyseal trabecular 0.04 0.787 0.20 0.211 0.35 0.023 0.59 <0.001 
Lateral metaphyseal trabecular -0.05 0.773 0.18 0.249 0.32 0.036 0.66 <0.001 
Lateral peripheral cortical 0.05 0.781 0.44 0.004 0.50 0.001 0.60 <0.001 
Lateral epiphyseal cortical 0.18 0.268 0.48 0.001 0.40 0.009 0.48 0.001 
Lateral metaphyseal cortical 0.25 0.121 0.28 0.076 0.32 0.036 0.60 <0.001 
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 Table A-3. Spearman’s rank correlation coefficients (ρ) for relationships between regional von Mises strain and OA characteristics 
(OA severity, total WOMAC pain, nocturnal pain, and alignment). For alignment, positive relationships represent associations with 
valgus alignment, and negative relationships represent associations with varus alignment. Bolded values indicate p< 0.05. 
Region OA Severity (KL Score) Total WOMAC pain Nocturnal pain Alignment 
ρ p-value ρ p-value ρ p-value ρ p-value 
Medial peripheral cortical -0.15 0.355 0.20 0.126 0.26 0.102 0.55 <0.001 
Medial epiphyseal cortical -0.001 0.996 0.16 0.301 0.22 0.170 0.50 0.001 
Medial metaphyseal cortical 0.25 0.114 0.16 0.306 0.23 0.137 0.40 0.009 
Medial subchondral cortical -0.19 0.249 0.15 0.341 0.13 0.425 0.58 <0.001 
Medial subchondral trabecular -0.06 0.701 0.20 0.202 0.17 0.284 0.56 <0.001 
Medial epiphyseal trabecular 0.01 0.977 0.21 0.173 0.22 0.171 0.52 <0.001 
Medial meatphyseal trabecular 0.19 0.251 0.20 0.196 0.28 0.074 0.47 0.002 
Subchondral spine -0.19 0.239 0.11 0.507 0.15 0.356 0.39 0.010 
Epiphyseal central 0.02 0.913 0.20 0.195 0.17 0.278 0.51 0.001 
Metaphyseal central 0.12 0.475 0.28 0.072 0.33 0.032 0.55 <0.001 
Lateral subchondral cortical 0.05 0.779 0.10 0.513 0.003 0.985 -0.05 0.736 
Lateral subchondral trabecular 0.002 0.992 0.14 0.384 0.04 0.802 0.04 0.824 
Lateral epiphyseal trabecular 0.03 0.861 0.26 0.098 0.17 0.283 0.48 0.001 
Lateral metaphyseal trabecular 0.02 0.906 0.30 0.053 0.27 0.077 0.53 <0.001 
Lateral peripheral cortical -0.03 0.872 0.18 0.247 0.001 0.994 0.10 0.538 
Lateral epiphyseal cortical -0.07 0.683 0.28 0.070 0.20 0.201 0.49 0.001 
Lateral metaphyseal cortical -0.01 0.947 0.19 0.219 0.24 0.135 0.66 <0.001 
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 Table A-4. Comparison of regional von Mises stress in patients with knee OA with no pain and moderate pain, including mean ± 
standard deviation (SD), adjusted mean difference, percent difference from no pain, 95% confidence intervals (CI), and p-values. 
Bolded values indicate p<0.05. 
Region 
von Mises stress (MPa) 
Mean Difference* from No Pain (%) 
95% confidence interval 
p-value No Pain Moderate Pain 
Lower limit Upper limit 
Mean ± SD Mean ± SD 
Medial peripheral cortical 0.46 ± 0.14 0.50 ± 0.20 0.02 (21.%) -0.13 0.16 1.000 
Medial epiphyseal cortical 0.69 ± 0.23 0.81 ± 0.33 0.06 (8.3%) -0.18 0.30 1.000 
Medial metaphyseal cortical 1.84 ± 0.62 1.87 ± 0.63 -0.04 (-2.6%) -0.58 0.49 1.000 
Medial subchondral cortical 0.62 ± 0.15 0.60 ± 0.13 -0.04 (-6.3%) -0.16 0.08 1.000 
Medial subchondral trabecular 0.49 ± 0.15 0.48 ± 0.13 -0.04 (-8.0%) -0.16 0.08 1.000 
Medial epiphyseal trabecular 0.38 ± 0.14 0.35 ± 0.11 -0.04 (-10.3%) -0.16 0.07 1.000 
Medial metaphyseal trabecular 0.42 ± 0.18 0.42 ± 0.20 -0.01 (-2.4%) -0.17 0.16 1.000 
Subchondral spine 0.28 ± 0.07 0.32 ± 0.10 0.03 (14.3%) -0.05 0.11 0.955 
Central epiphyseal trabecular 0.12 ± 0.03 0.13 ± 0.03 0.01 (0.0%) -0.02 0.04 1.000 
Central metaphyseal trabecular 0.09 ± 0.03 0.09 ± 0.02 -0.001 (0.0%) -0.02 0.02 1.000 
Lateral subchondral cortical 0.40 ± 0.09 0.49 ± 0.23 0.09 (22.5%) -0.08 0.27 0.590 
Lateral subchondral trabecular 0.26 ± 0.07 0.31 ± 0.16 0.05 (19.2%) -0.07 0.17 0.849 
Lateral epiphyseal trabecular 0.16 ± 0.04 0.18 ± 0.08 0.02 (12.5%) -0.04 0.08 1.000 
Lateral metaphyseal trabecular 0.14 ± 0.03 0.15 ± 0.06 0.02 (15.4%) -0.03 0.07 1.000 
Lateral peripheral cortical 0.23 ± 0.08 0.30 ± 0.13 0.07 (30.4%) -0.03 0.17 0.298 
Lateral epiphyseal cortical 0.28 ± 0.10 0.36 ± 0.14 0.06 (20.0%) -0.04 0.16 0.471 
Lateral metaphyseal cortical 0.68 ± 0.15 0.81 ± 0.32 0.12 (15.7%) -0.13 0.36 0.721 
*Mean values adjusted for age (64.1) and sex (1.6)..   
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 Table A-5. Comparison of regional von Mises stress in patients with knee OA with no pain and severe pain, including mean ± 
standard deviation (SD), adjusted mean difference, percent difference from ‘no pain’, 95% confidence intervals (CI), and p-values. 
Bolded values indicate p<0.05. 
Region 
von Mises stress (MPa) 
Mean Difference* from No Pain (%) 
95% confidence interval 
p-value No Pain Severe Pain 
Lower limit Upper limit 
Mean ± SD Mean ± SD 
Medial peripheral cortical 0.46 ± 0.14 0.35 ± 0.13 -0.13 (-27.1%) -0.30 0.04 0.192 
Medial epiphyseal cortical 0.69 ± 0.23 0.58 ± 0.29 -0.15 (-20.8%) -0.44 0.13 0.560 
Medial metaphyseal cortical 1.84 ± 0.62 1.51 ± 0.45 -0.41 (-21.7%) -1.04 0.22 0.334 
Medial subchondral cortical 0.62 ± 0.15 0.55 ± 0.15 -0.09 (-14.3%) -0.23 0.06 0.427 
Medial subchondral trabecular 0.49 ± 0.15 0.38 ± 0.15 -0.12 (-24.0%) -0.27 0.02 0.125 
Medial epiphyseal trabecular 0.38 ± 0.14 0.28 ± 0.12 -0.11 (-28.2%) -0.24 0.03 0.163 
Medial metaphyseal trabecular 0.42 ± 0.18 0.32 ± 0.14 -0.11 (-23.8%) -0.30 0.09 0.521 
Subchondral spine 0.28 ± 0.07 0.33 ± 0.10 0.04 (17.9%) -0.05 0.14 0.762 
Central epiphyseal trabecular 0.12 ± 0.03 0.14 ± 0.04 0.02 (16.7%) -0.01 0.06 0.274 
Central metaphyseal trabecular 0.09 ± 0.03 0.11 ± 0.03 0.01 (22.2%) -0.01 0.04 0.472 
Lateral subchondral cortical 0.40 ±0.09 0.66 ± 0.27 0.25 (62.5%) 0.05 0.48 0.011 
Lateral subchondral trabecular 0.26 ±0.07 0.44 ± 0.17 0.09 (65.4%) 0.08 0.27 0.010 
Lateral epiphyseal trabecular 0.16 ± 0.04 0.24 ± 0.08 0.08 (50.0%) 0.01 0.15 0.028 
Lateral metaphyseal trabecular 0.14 ± 0.03 0.20 ± 0.08 0.06 (53.8%) 0.003 0.12 0.038 
Lateral peripheral cortical 0.23 ± 0.08 0.37 ± 0.16 0.13 (56.5%) 0.02 0.25 0.021 
Lateral epiphyseal cortical 0.28 ± 0.10 0.39 ± 0.14 0.08 (26.7%) -0.04 0.20 0.272 
Lateral metaphyseal cortical 0.68 ± 0.15 0.95 ± 0.40 0.24 (32.9%) -0.05 0.53 0.142 
*Mean values adjusted for age (64.1) and sex (1.6).   
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 Table A-6. Comparison of regional von Mises strain in patients with knee OA with no pain and moderate pain, including mean ± 
standard deviation (SD), adjusted mean difference, percent difference from no pain, 95% confidence intervals (CI), and p-values. 
Bolded values indicate p<0.05. 
Region 
von Mises strain (microstrain) 
Mean Difference* from No Pain (%) 
95% confidence interval 
p-value No Pain Moderate Pain 
Lower limit Upper limit 
Mean ± SD Mean ± SD 
Medial peripheral cortical 840 ± 590 1021 ± 567 210 (25.2%) -364 784 1.000 
Medial epiphyseal cortical 1281 ± 638 1437 ± 590 217 (17.2%) -360 794 1.000 
Medial metaphyseal cortical 1284 ± 524 1470 ± 540 179 (13.8%) -320 678 1.000 
Medial subchondral cortical 446 ± 204 495 ± 229 55 (12.3%) -150 259 1.000 
Medial subchondral trabecular 767 ± 407 935 ± 546 226 (30.3%) -255 707 0.741 
Medial epiphyseal trabecular 2079 ± 1010 2454 ± 1032 465 (24.7%) -506 1436 0.713 
Medial metaphyseal trabecular 2073 ± 837 2349 ± 860 249 (11.9%) -578 1075 1.000 
Subchondral spine 550 ± 171 589 ± 218 55 (10.1%) -127 237 1.000 
Central epiphyseal trabecular 2238 ± 872 2493 ± 855 301 (13.5%) -497 1098 1.000 
Central metaphyseal trabecular 1769 ± 770 1938 ± 702 155 (8.7%) -559 869 1.000 
Lateral subchondral cortical 649 ± 195 684 ± 229 32 (4.9%) -156 220 1.000 
Lateral subchondral trabecular 1085 ± 402 1133 ± 493 52 (4.8%) -339 443 1.000 
Lateral epiphyseal trabecular 2149 ± 939 2338 ± 875 213 (9.9%) -578 1005 1.000 
Lateral metaphyseal trabecular 1786 ± 937 1883 ± 832 77 (4.2%) -715 870 1.000 
Lateral peripheral cortical 1121 ± 498 1249 ± 583 104 (9.1%) -366 575 1.000 
Lateral epiphyseal cortical 1089 ± 580 1143 ± 506 67 (6.1%) -416 551 1.000 
Lateral metaphyseal cortical 714 ± 446 796 ± 428 107 (15.3%) -292 507 1.000 
*Mean values adjusted for age (64.1) and sex (1.6).   
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 Table A-7. Comparison of regional von Mises strain in patients with knee OA with no pain and severe pain, including mean ± 
standard deviation (SD), adjusted mean difference, percent difference from no pain, 95% confidence intervals (CI), and p-values. 
Bolded values indicate p<0.05. 
Region 
von Mises strain (microstrain) 
Mean Difference* from No Pain (%) 
95% confidence interval 
p-value No Pain Severe Pain 
Lower limit Upper limit 
Mean ± SD Mean ± SD 
Medial peripheral cortical 840 ± 590 1377 ± 924 516 (62.1%) -158 1190 0.187 
Medial epiphyseal cortical 1281 ± 638 1720 ± 923 440 (35.0%) -237 1118 0.335 
Medial metaphyseal cortical 1284 ± 524 1624 ± 596 314 (25.6%) -271 900 0.559 
Medial subchondral cortical 446 ± 204 569 ± 289 112 (25.1%) -128 352 0.743 
Medial subchondral trabecular 767 ± 407 1150 ± 823 396 (53.3%) -169 961 0.260 
Medial epiphyseal trabecular 2079 ± 1010 2859 ± 1580 771 (37.7%) -369 1911 0.295 
Medial metaphyseal trabecular 2073 ± 837 2882 ± 1100 751 (37.5%) -219 1721 0.180 
Subchondral spine 550 ± 171 676 ± 241 130 (23.9%) -83 344 0.405 
Central epiphyseal trabecular 2238 ± 872 2869 ± 1227 594 (26.7%) -342 1530 0.360 
Central metaphyseal trabecular 1769 ± 770 2548 ± 954 732 (51.8%) -105 1570 0.104 
Lateral subchondral cortical 649 ± 195 632 ± 172 -15 (-2.3%) -235 206 1.000 
Lateral subchondral trabecular 1085 ± 402 1006 ± 310 -84 (-7.7%) -543 376 1.000 
Lateral epiphyseal trabecular 2149 ± 939 2599 ± 1048 397 (18.5%) -532 1326 0.873 
Lateral metaphyseal trabecular 1786 ± 937 2570 ± 1009 699 (44.8%) -231 1629 0.202 
Lateral peripheral cortical 1121 ± 498 1097 ± 393 -62 (-5.4%) -614 491 1.000 
Lateral epiphyseal cortical 1089 ± 580 1478 ± 646 354 (32.4%) -213 921 0.378 
Lateral metaphyseal cortical 714 ± 446 1101 ± 595 372 (41.9%) -98 842 0.163 
*Mean values adjusted for age (64.1) and sex (1.6). 
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